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1 List of abbreviations  
SHORT 
NAME 
FULL NAME 
AA Amino acids 
ADP Adenosine diphosphate 
AP Adaptor protein  
APS Ammonium persulfate 
ASN Asparagine 
ATF6 Activating transcription factor 6 
ATP Adenosine triphosphate 
BSA Bovine serum albumin 
BP Base pairs 
CADPR Cyclic adenine dinucleotide phosphate ribose 
CAB45 Calcium-binding protein of 45 kDa 
CAS9 CRISPR associated protein  
CATHD CathepsinD 
CD Circular dichroism 
CDG Congenital disorders of glycolyation 
CFL1 Cofilin 1 
CGN Cis Golgi Network 
COMP Cartilage oligomeric matrix protein  
COPII Coat protein complex II  
CRISPR Clustered regularly interspaced short 
palindromic repeat 
CRRNA CRISPR RNA 
CALU Calumenin 
CS Chondroitin sulfate 
COX Cyclooxygenase 
DAG Diacylglycerol 
DMEM Dulbecco’s modified eagle medium  
DNA Deoxyribonucleic acid 
DIA1 Deleted in Autism-1 
EFH EF hand  
EPSINR Epsin-related 
ER Endoplasmic reticulum  
ERAD Endoplasmic reticulum associated degradation 
ERC-55 ER calcium binding protein of 55 kDa 
ERES Endoplasmic reticulum exit sites 
ERGIC ER-Golgi intermediate compartment 
FAM Family with sequence similarity 
FBS Fetal bovine serum 
FGF23 Fibroblast growth factor 23 
FJ Four-jointed 
FJX1 Four-jointed box protein 1 
FT Flow through 
GAP GTPase activating protein 
GEF Nucleotide exchange factor 
GGA Golgi-localized, g-ear-containing, Arf-binding 
protein  
GLC Glucose 
GLCNAC N-acetylglucosamine 
GPI-AP Glycosylphosphatidylinositol anchored protein 
GRASP Golgi reassembly stacking proteins 
GS Golgi stack 
GTP Guanosine triphosphate 
HHD Haily-Haily disease 
HDR Homology directed repair  
HS  Heparin sulfate  
IP3 Inositol-1,4,5-triphosphate 
IP3R Inositol-3-phosphate receptor 
IRE1 Inositol-requiring enzyme 1 
KD Knockdown 
KDA Kilo dalton 
KDEL Lysine-aspartic acid – glutamic acid - leucine 
KO Knockout  
LIMP2 Lysosomal integral membrane protein type 2 
LYZC Lysozyme C 
MAN Mannose 
MAN6P Mannose-6-phosphate 
MCS Membrane contact site 
MGP Matrix Gla protein  
MIN Multifunctional integrase tag 
MMP Matrix metallo proteinase 
NAADP Nicotinic acid adenine dinucleotide phosphate 
NC Non-compact zone 
NE Nuclear envelope  
NHEJ Non-homologous end joining 
NUCB Nucleobindin 
OMIM Online Mendelian inheritance in man 
O.N.  Over night  
OST Oligosaccharyl transferase  
PAM Protospacer adjacent motif  
PBS Phosphate-buffered saline 
PERK PKR (dsRNA-dependent protein kinase)-like 
ER kinase 
PI4P Phosphatidylinositol-4-phosphate 
PIP2 Phosphatidylinositol-4,5-bisphosphate  
PKDCC Protein kinase domain containing, cytoplasmic 
PKL Protein kinase like 
PLC Phospholipase C 
PM Plasma membrane 
PMCA Plasma membrane calcium ATPase 
PTM Posttranslational modification 
RCN Reticulocalbin 
RER Rough endoplasmic reticulum 
RNA Ribonucleic acid 
RT Room temperature 
RUSH Retention using selective hooks 
RYR Ryanodine receptor 
SDF4 Stromal derived factor 4 
SER Smooth endoplasmic reticulum  
SERCA Sarcoplasmic/endoplasmic reticulum ATPase 
SER/PRO Serine/Proline 
SER/THR Serine/Threonine 
SSG Secretory storage granule 
SGRNA Single guide RNA 
SIBLING Small integrin-binding ligand N-linked 
glycoprotein 
SN Supernatant 
V-SNARE Vesicle soluble N-ethylmaleimide-sensitive 
factor attachment receptors  
T-SNARE Target soluble N-ethylmaleimide-sensitive 
factor attachment receptors  
SND SRP-independent protein 
SORLA Sortilin-related protein with A-type repeats 
SP Signal peptide 
SPCA Secretory pathway calcium ATPase 1 
SPCA1-
L2C1 
Secretory pathway calcium ATPase 1 C-
terminal loop 2 
SRP Signal recognition particle 
SR Signal recognition particle receptor 
STORM Stochastic optical reconstruction microscopy 
TALEN Transcription activator-like effector nucleases 
TBS  Tris-buffered saline 
TER Transitional endoplasmic reticulum 
TGN Trans Golgi Network 
TIMP Tissue inhibitor of metallo matrix proteinases 
TRC40 TMS recognition/insertion complex 40 
TRP Tryptophan  
UDP Uridine diphosphate 
UGGT UDP-glucose glycoprotein glycosyltransferase 
UPR Unfolded protein response 
UV Ultraviolet 
VLK Vertebrate lonesome kinase 
WT Wild type  
WCL Whole cell lysate 
ZFN Zink finger nucleases 

  
  
 
2 Summary  
Effective intracellular protein trafficking and secretion is one of the crucial aspects of cell 
viability and cell-cell communication. Thus, nature evolved highly elaborated and finely 
tuned machineries to transport and sort proteins and membranes to their correct 
destinations. For this purpose, the trans-most part of the Golgi apparatus, the trans Golgi 
Network (TGN), functions as central sorting hub for the cell. Although for example the 
sorting and transport of transmembrane proteins is already well described, a mechanism 
for the sorting of soluble secretory cargo for secretion remained elusive for a long time.  
In recent years, publications of our group could demonstrate that a sorting machinery 
consisting of three central components is required for the directional sorting of a subset of 
soluble, secretory cargo molecules: the actin-binding protein Cofilin 1 (CFL1), the TGN-
resident calcium pump Secretory Pathway Calcium ATPase 1 (SPCA1) and the Calcium-
binding Protein of 45 kDa (Cab45). Cell biological and biochemical assays revealed that 
dephosphorylated CFL1 interacts with a cytosolic loop of SPCA1 and recruits F-actin to 
TGN membranes. This interaction activates SPCA1 and stimulates calcium influx into the 
TGN lumen. The corresponding luminal increase in calcium concentrations enables the 
Golgi-resident Cab45 to sort and pack cargo molecules into transport carriers, however, 
the detailed mechanism underlying this process remained obscure. Therefore, this work 
was focused on structural and functional aspects of the Cab45 protein to gain detailed 
insights into the processes necessary for cargo secretion.  
In the framework of this thesis, I was able to demonstrate that Cab45 reversibly assembles 
into oligomers, probably due to conformational changes in the presence of calcium in vitro 
and in isolated Golgi fractions. These Cab45 oligomers specifically bind secretory proteins 
directly, such as COMP and LyzC, in a calcium-dependent manner. Furthermore, tyrosine 
phosphorylation of cargo was demonstrated to abolish Cab45-cargo interaction and might 
serve as release mechanism under physiological conditions. Finally, also several Fam20C-
dependent phosphorylation sites in Cab45 with so far unknown function were identified in 
this study.  
Taken together, this thesis shed light on several aspects of the CLF1/SPCA1/Cab45 
sorting machinery, including Cab45 Golgi retention, cargo interaction and 
posttranslational modifications and paved the way to a better understanding of secretion 
processes involved in a multitude of vital aspects of cellular function and life.  
 
Introduction 
 7 
3 Introduction 
3.1 The secretory pathway – the cellular protein highway 
At the beginning of evolution first cellular structures consisted of only one membrane 
enclosed space. However, the development of more diverse and complicated organisms 
required the formation of compartments with different properties, concerning e.g. pH, salt 
concentrations or lipid compositions. One severe problem that arose out of this process was 
the translocation of proteins – the molecular machineries – across membranes and also 
between these membrane compartments called organelles. Nature overcame this difficulty 
by establishing a protein transport system – the secretory pathway 1 (Figure 1). In highly 
developed cells the secretory pathway harbors and transports around one third of all 
cellular proteins 2.  
 
 
Figure 1: Schematic depiction of the secretory pathway. After cotranslational insertion into the endoplasmic 
reticulum (ER) lumen (grey), correctly folded proteins are transported in COPII coated vesicles (orange) 
across the ER-Golgi intermediate compartment (ERGIC, light grey) to the Golgi complex (blue). After 
traversing the different Golgi cisternae, proteins are sorted at the trans Golgi Network (TGN, light blue) by 
highly sophisticated mechanisms into a broad variety of transport carriers. These vesicles deliver the proteins 
to defined subcellular destinations including the apical and basolateral membrane (yellow and dark 
turquoise), endosomes (red), secretory granules (light turquoise), earlier Golgi cisternae (blue) or the ER (grey).  
The endoplasmic reticulum 
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It ensures not only that all organelles contain their crucial set of proteins to fulfill their 
function, but also that the cell can communicate with its environment by uptake or release 
of proteins. 
As this thesis is focused on the mechanisms of protein sorting at the Golgi apparatus, the 
introduction will describe the major organelles involved in this process, starting with the 
site of protein synthesis, the endoplasmic reticulum (ER) 3.  
3.2 The endoplasmic reticulum  
The endoplasmic reticulum (ER) is present in all eukaryotic cells. It is a membranous 
system which often comprises nearly 50 % of the whole cellular membranes and encloses 
around 10 % of the cell volume 4. This enclosed space – the ER lumen - provides a 
continuous sphere spanning the mammalian cell from the nuclear envelope (NE) to the 
plasma membrane (PM) 5 (Figure 2).  
 
 
Figure 2: Schematic depiction of the endoplasmic reticulum and other endomembrane systems. In 
mammalian cells the ER spans the whole cell in a complex network of ER tubules and sheets (green). In 
addition, this network is highly intertwined with other endomembrane compartments like endosomes 
(orange), mitochondria (purple), peroxisomes (red), lipid droplets (rose) as well as the Golgi apparatus (blue) in 
the perinuclear region (nuclear envelope depicted by dashed line). With all those organelles, the ER forms 
membrane contact sites (MCS, dashed circles) for enhanced vesicle-independent exchange between the 
different compartments. Figure was adjusted from Phillips and Voeltz, 2016 6.  
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The major structural elements of the ER are tubes of around 60 nm in diameter and 
sheets, which often appear in stacks and are connected by twisted membranes with helical 
edges 7,8. This complete meshwork is highly dynamic and constantly subject to 
rearrangements like tubule branching, branchpoint sliding, tubule retraction, ring closure 
or tubule-tubule membrane fusion 9,10. In mammals, many of these processes happen in 
close collaboration with the microtubule cytoskeleton 11-13.  
As one of the major secretory pathway compartments the ER is responsible for a multitude 
of different functions including protein synthesis, protein folding and quality control, 
protein modification and lipid biogenesis 14-18. To fulfil all these tasks, the ER subdivides 
into functional domains like the smooth ER (SER), the rough ER (RER), the transitional 
ER (TER), the nuclear envelop (NE) and membrane contact site (MCS) 19-22.  
RER is defined by a high density of ribosomes on the surface 23. As a consequence, RER 
consists mainly of sheet structures, because they offer enough space to accommodate large 
polysomes on their cytosolic surface 21. In contrast, the highly bend membranes of the 
tubules are often part of the SER, as ribosomes only rarely attached here. Cell lines 
producing high amounts of secretory or transmembrane proteins (like pancreatic or B cells) 
therefore prefer formation of RER or sheets 24,25. Thus, the RER is the origin of basically 
all secreted proteins. Their first two steps towards the PM are signal particle recognition 
and translocation across the ER membrane – two highly sophisticated and regulated 
processes, which will be shortly summarized in the following.  
3.2.1 Protein translocation across the ER membrane 
In general, there are two different ways of protein translocation across the ER membrane. 
The first possibility is the cotranslational import of the polypeptide chain into the ER, the 
second is a posttranslational transport mechanism 26,27. Which of these systems is preferred 
is dependent on the position of the so-called signal peptide (SP) inside the nascent 
polypeptide chain. The SP is a stretch of 16-30 amino acids with a hydrophobic core 
region of 6-12 amino acids flanked by positively charged residues 28,29. In case the SP is 
located at the N-terminal end of the sequence, proteins are imported cotranslationally, 
while a SP at the C-terminus triggers posttranslational ER import 30,31.  
The N-terminal SP is recognized immediately after emerging the 60S subunit of the 
ribosome by the signal recognition particle (SRP), which binds to the hydrophobic core by 
several methionine residues in its p54 subunit 28,32,33 (Figure 3). This interaction arrests 
The endoplasmic reticulum 
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protein translation, to provide the time necessary for the translocation of the ribosome-
RNA-SRP complex to the ER surface 28. 
 
 
Figure 3: Cotranslational import is regulated by a complex machinery. In proteins destined for the secretory 
pathway the signal peptide (SP) is recognized by the signal recognition particle (SRP) when the new 
polypeptide chain (orange) emerges from the ribosome (yellow). While protein translation is arrested the 
whole ribosome/SRP complex is translocated to the rough ER membrane (RER, pink), where the SRP 
interacts with its receptor (SRP receptor, dark blue). Subsequently, translation is reassumed and the 
polypeptide is translocated across the membrane into the RER cisterna. Figure was obtained from 
dehistology.blogspot.de/2011/06/ribosomes.html 16.05.2017 21.40 p.m. 
 
Here, the SRP interacts with the alpha subunit of the transmembrane signal recognition 
particle receptor (SR) and transports the ribosome-RNA-SRP complex to a huge pore 
complex called the translocon 34-36. The central part of the translocon consists of the 
heterotrimeric protein complex Sec61p 37,38 forming a gated channel in which 30 amino 
acids of the hydrophobic SP are directly inserted. Subsequently, SRP and SP dissociate 
from the complex in a GTP-dependent manner and translation of the protein directly 
through the translocon into the lumen of the ER is resumed 39. Inside the ER lumen, a 
cohort of enzymes including chaperones, isomerases and sugar modifying enzymes are 
responsible for proper folding and processing of the secretory pathway proteins.  
 
For proteins with C-terminal signal sequence translation occurs entirely in the cytosol 27,40. 
The SP peptide emerging at the end of translation from the ribosome is bound by the TMS 
recognition/insertion complex 40 (TRC40) to prevent aggregation of the hydrophobic 
stretches and to keep the protein in an unfolded state for subsequent protein translocation 
27,41. In a similar manner as for the cotranslational import, the Sec61p translocon 
machinery mediates the import and further processing of the proteins.  
Introduction 
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Recently, a high-content screen in S.cerevisiae revealed an additional pathway in parallel to 
the SRP and the TRC40 (GET pathway in yeast). The group of Maya Schuldiner showed 
that the three SRP-independent targeting proteins (SND proteins) act in a jointed pathway 
and preferentially target proteins with signal peptides located in the middle of the nascent 
polypeptide sequences for ER translocation 42. Therefore, the SND pathway acts in 
synergy to the SRP and the TRC40/GET to facilitate ER targeting of proteins bearing 
signal motifs in all possible positions. If the human homolog of SND2 fulfills a similar task 
remains to be elucidated.  
3.2.2 Protein modifications and processing after RER import  
During the translocation process via the Sec61p channel the cell already starts to modify 
the polypeptide on the luminal side of the ER membrane (Figure 4). First, the SP is cleaved 
by the transmembrane signal peptidase, which associates tightly with the import pore 
complex 43,44. Hence, the SP is not part of the mature secretory pathway proteins. 
Secondly, many of the imported proteins gain a Glc3Man9GlcNAc2 sugar modification en 
bloc at an Asn-X-Ser/Thr motif, which was previously assembled on a dolichol anchor at 
the ER membrane 45,46. This carbohydrate backbone subsequently enables the cell to track 
the folding state of the nascent polypeptide, because after removal of two glucose residues 
by glucosidase I, two chaperones of the lectin family namely calnexin and calreticulin are 
able to recognize and bind unfolded proteins and support their folding process 16,47-49. The 
chaperones do not only support the folding itself, but are also able to recruit additional 
enzymes like disulfide isomerases and peptidyl prolyl cis-trans isomerases to catalyze rate 
limiting steps along the way to a native protein conformation 50,51.  
Throughout this folding process, nascent proteins are constitutively subject of glucose 
removal and addition by glucosidase II or UDP-glucose glycoprotein glycosyltransferase 
(UGGT), respectively 52,53. Removal of the glucose leads to dissociation of the chaperones 
and access to specialized export platforms for further transport to later secretory pathway 
compartments. However, proteins still exposing hydrophobic regions retrieve the glucose 
modification as indicator for a new cycle of protein chaperoning as well as ER retention 54. 
In case proteins are unable to fold after a certain period or accumulate in the ER lumen, 
the unfolded protein response (UPR) is initiated by the three transmembrane sensors PKR 
(dsRNA-dependent protein kinase)-like ER kinase (PERK), inositol-requiring enzyme 1 
(IRE1) and activating transcription factor 6 (ATF6) 55-57. The UPR upregulates proteins 
involved in chaperoning and ER associated degradation (ERAD) and reduces global 
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protein synthesis to prevent massive aggregates in the cell. During ERAD, unfolded ER 
proteins are translocated back into the cytosol via hydroxymethyl glutaryl-coenzyme A 
reductase degradation protein 1 (Hrd1), where oligosaccharide modifications are removed 
and U3 ligases add ubiquitin modifications, which mark the unfolded proteins for 
proteasome-mediated degradation in the cytosol 58-60.  
 
 
Figure 4: Schematic depiction of ER-dependent protein modifications. During protein translation by the 
ribosome (red), the growing polypeptide chain (black line) is translocated across the ER membrane (grey box). 
In the ER lumen, the oligosaccaryl transferase (OST, orange) transfers a sugar modification (white, blue and 
red hexagons) en bloc from a membrane-incorporated dolichol anchor onto the polypeptide chain. In addition, 
the signal peptide (SP, dark green) is cleaved off by the signal peptide peptidase (light red). In the following 
chaperons (green) and isomerases (blue) help the protein to fold properly. After removal of two glucoses (red 
hexagons) by glucosidases the two chaperones calnexin (purple) and calreticulin (pink) of the lectin family 
control the folding state of the protein by interacting with the remaining glucose. To achieve its native 
conformation the proteins runs through several cycles of trimming of this glucose modification and re-
addition by UDP-glucose glycoprotein glycosyltransferase (UGGT, light blue). When the protein is either 
correctly assembled or needs to be degraded, one mannose residue (blue hexagon) is removed by 
mannosidases and the protein is either exported in COPII coated vesicles or is translocated by the ERAD 
machinery (yellow) into the cytosol for degradation in the proteasome. Figure was adjusted from McCaffrey 
et al., 2016 55.  
3.2.3 ER to Golgi transport  
Proteins which finally achieved their proper native conformation are exported from the ER 
at stable ER exit sites (ERES) in COPII coated vesicles 61,62 (Figure 5). ERES are part of 
the TER (section 3.2) and several hundreds of them are found per mammalian cell 63. The 
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first step in ERES formation is the activation of the small GTPase Sar1 by its 
transmembrane GTP activating protein (GAP) Sec12 64-66. Upon activation Sar1 exhibits 
an amphipathic helix, which is inserted in the outer leaflet of the ER membrane to anchor 
the protein 67. In the next step Sar1 recruits the heterodimer Sec23/Sec24 by direct 
interaction with Sec23 to the ER membrane, which forms the first layer of the COPII coat. 
Sec24 exhibits multiple cargo binding sites and recognizes a multitude of different cargo 
receptors and accumulates them inside the forming vesicle at ERES for efficient export to 
the Golgi 68-71.  
The three main ER cargo receptor families (ERGIC-53, p24 and Erv proteins) known to 
date contain Sec24 and COPI recognition sites within their cytoplasmic domains 72. This 
feature enables the receptors to cycle back and forth between the ER and post-ER 
compartments like the ERGIC or the cis Golgi (section 3.3 and 3.4.1) and release their 
attached cargo in the acceptor compartment, probably due to changes in environmental 
conditions like pH or calcium concentrations 73. While for example the lectin ERGIC53 
recognizes carbohydrate modifications and protein sequences of soluble proteins, Erv 
proteins interact with type II membrane proteins and connect them to the COPII coat for 
efficient transport 74,75. However, exact recognition signals and mechanisms need to be 
further investigated for all types of ER sorting receptors.  
 
 
Figure 5: Schematic depiction of COPII vesicle formation at ER exit sites (ERES). Cargo proteins (grey) 
which reached their native conformation in the ER lumen are exported at ERES in COPII coated vesicles 
for transport to the Golgi apparatus. Therefore, the small GTPase Sar1 (dark blue) is activated by Sec12 
(yellow/orange) and stabilized by Sec16 (purple). This activation recruits first the inner Sec23/24 (red) layer, 
which binds transmembrane cargos or their specific receptors and accumulates them inside the forming 
vesicles. Subsequently, the outer coat consisting of Sec13/31 (green) is recruited, which induces membrane 
curvature for pinching of the COPII vesicle. Figure was adjusted from Gillon et al., 2012 79.  
 
When the cargos are attached via the receptors to the inner coat components, 
Sec23/Sec24 bind the heterotetrameric Sec13/Sec31 complex of the outer COPII coat, 
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which induces membrane curvature necessary to bud the vesicle from the ER membrane. 
After vesicle release the newly formed vesicle soon uncoats due to GTP hydrolysis by Sar1 
to uncover its soluble N-ethylmaleimide-sensitive factor attachment receptors (SNAREs) 76. 
These vesicle SNAREs (v-SNAREs) interact with target SNAREs (t-SNAREs) and mediate 
the fusion of the vesicle with the correct acceptor compartment – in this case the ER-Golgi 
intermediate compartment 77,78.  
3.3 The ER-Golgi intermediate compartment 
The ER-Golgi intermediate compartment (ERGIC) is located between the ER and the 
Golgi apparatus and considered as the first anterograde/retrograde sorting station of the 
secretory pathway of mammalian cells (Figure 1). It consists of independent tubulovesicular 
membrane clusters distinct from ER or Golgi which are positive for the transmembrane 
lectin cargo receptor ERGIC-53 and for COPI coat proteins 80-85.  
The ERGIC is necessary to distinguish proteins destined for anterograde traffic to the 
Golgi from proteins for ER return 86,87. This differentiation is achieved by cargo receptors 
cycling between the three compartments, like the KDEL receptor, which mediates ER 
retention of ER-resident proteins 88. In contrast, proteins of the late secretory pathway pass 
the ERGIC and arrive at the central protein sorting station – the Golgi complex 89.  
3.4 The Golgi complex 
The Golgi complex or Golgi apparatus is one of the most prominent organelles in a 
mammalian cell and with a size ranging between 0.7 to 1.1 µm big enough for analysis by 
light microscopy 90-92. As a consequence, the Italian physician Camillo Golgi, the eponym 
of the Golgi apparatus, was the first to discover and describe the structure in nerve cells 
already at the end of the 19th century 93,94. But although fundamental advances in the area 
of electron and light microscopy contributed immensely to our understanding, many 
questions about Golgi organization, function and vesicular transport processes remain 
unanswered to this point 95-101.  
3.4.1 Golgi structure 
The Golgi complex is a membranous organelle present in all eukaryotic cells, including 
animals, plants, fungi and yeast. In mammalian cells the observed conglomerate of large 
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vacuoles, small granules and lamellae is arranged in several flat cisternae that form tightly 
packed stacks 100 (Figure 6). Dozens of these stacks accumulate in the supra- or 
juxtanuclear region and are interconnected by homo- or heterotypic membrane bridges. 
These can either form between two cisternae within one stack or also connect cisternae of 
adjacent Golgi stacks 102-108. This interconnected network is called Golgi ribbon 102,109.  
Within the stacks, single cisternae are not equal, but can be classified according to their 
protein and lipid content. Thereby, the most commonly used system for classification is 
based on the position of the cisternae inside the stack and divides the tubules and 
membrane sacks into cis Golgi Network (CGN), cis Golgi, medial Golgi, trans Golgi and 
trans Golgi Network (TGN) 110,111. Furthermore, it was suggested to categorize the different 
cisternae according to their vesicular import and export systems, which reflects more 
adequately the connection to their individual function 112. 
 
 
Figure 6: Schematic depiction of the highly dynamic Golgi structure. Proteins of the secretory pathway travel 
from the endoplasmic reticulum (ER) in COPII coated vesicles (black rimmed circles) via the ER-Golgi 
intermediate compartment (ERGIC) to the cis Golgi Network (CGN). Then they traverse the Golgi cisternae 
(light brown) before the arrive at the trans Golgi Network (TGN), where they are sorted in different transport 
carriers like clathrin vesicles (blue rimmed circles), constitutive secretory vesicles (yellow circles), secretory 
granules (Sg) or COPI vesicles (red rimmed circles). Inside the Golgi cisternae, proteins gain different 
modifications and sorting signals. To manage this crucial task and to guarantee fast and efficient transport the 
Golgi cisternae are tightly compressed into a Golgi stack (Gs). In addition, cells harbor more than one stack in 
the perinuclear region, which are laterally connected by homotypic or heterotypic membrane bridges in the 
non-compact zone (Nc). Figure was adjusted from Martinez-Alonso et al., 2013 113.  
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Maintaining either the position of the Golgi within the cell as well as its stacked 
morphology the Golgi is dependent on a multitude of interactions with its protein 
environment. These interactions are mediated in large part by a protein network 
surrounding the Golgi like tentacles called the Golgi matrix 114,115. The major component 
of this Golgi matrix are proteins of the Golgin family 116. Golgins contain several cytosolic 
coiled-coil domains and are anchored in the Golgi membrane either by transmembrane 
domains or by interaction with small GTPases like Arl1 or Arf1 via GRIP and GRAP 
domains, respectively. The long and flexible domains extend into the cytosol and support 
processes like vesicle capture and fusion by interaction with the small Rab GTPases as well 
as interaction with cytoskeleton dependent motor proteins 117-120. In addition, Golgins 
collaborate with GRASP proteins to establish the Golgi ribbon and the stacked 
morphology of the Golgi. GRASP65 and GRASP55 are both peripheral membrane 
proteins that are attached to the cytosolic Golgi membranes via an N-myristoylation 
anchor 121-123. The conserved N-terminal GRASP domains form trans-oligomers, which 
serve as proteinaceous bridges between adjacent cisternae and link them together. During 
mitosis, the C-terminal Ser/Pro-rich domains of GRASPs are phosphorylated by mitotic 
kinases which induces dissociation of the oligomers and unstacking of the Golgi 124-126.  
Based on this multitude of interactions a tremendous amount of possible modifications 
renders the Golgi a highly dynamic compartment, which can rapidly adjust to 
environmental changes and cellular requirements.  
3.4.2 Golgi functions and intra Golgi transport 
The stacked shape of the Golgi is ideally adjusted to fulfil the main functions – protein and 
lipid transport, protein sorting, protein and lipid modifications and production of complex 
carbohydrates. Although the stacked morphology slows protein transport, the small gaps 
between the stacks minimize transport distances and energy consumption and enable the 
cell to coordinate consecutive posttranslational modifications (PTMs) by a cohort of 
enzymes, which localizes exclusively to certain cisternae, each offering certain conditions 
for optimal enzymatic reactions 127. However, this morphology also poses the problem of 
constant protein transport across the cisternal membranes. Although a couple of possible 
scenarios are discussed in literature, leading scientists of the field agreed in 2009 that the 
cisternal progession/maturation model is able to accommodate most of the recent findings 
and results 128-131. This idea of Golgi protein trafficking suggests that new cis Golgi 
cisternae arise by homotypic fusion of ER-derived COPII vesicles. These cis Golgi 
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cisternae gradually mature into medial and trans cisternae and finally disintegrate into 
different kinds of transport carriers at the TGN. During this process COPI coated vesicles 
are responsible to maintain the asymmetric distribution of Golgi-resident proteins by 
retrograde transport to younger cisternae.  
Based on this, proteins enter the Golgi at the cis cisterna, pass the medial Golgi and finally 
arrive at the trans Golgi cisternae, whose trans-most cisterna is connected to the tubular 
network of the TGN. Here, they get packed into diverse carriers for transport to their final 
subcellular destination or for secretion. This stepwise transport offers also the possibility to 
add posttranslational modifications to proteins on their way through the stack. But which 
modifications are necessary for secretory pathway proteins and how are they connected to 
the transport mechanisms?  
3.4.3 PTMs in the Golgi 
Several kinds of PTMs were described in connection with the Golgi. They can either occur 
at the cytoplasmic side of the Golgi membrane or inside the lumen and can either directly 
influence trafficking by modifying cargo proteins or indirectly by changing Golgi function 
and morphology. Therefore, it seems not surprising that mutations in corresponding genes 
were connected to a variety of different diseases in human patients 132. Although this was 
also true for PTMs like acetylation 133,134, sulfation 135,136, methylation 137, palmitoylation 
138 and proteolytic cleavage 139 the next two sections are focused on glycosylation and 
phosphorylation, as both PTMs are directly connected to this work.  
3.4.3.1 Glycosylation in the Golgi 
Approximately 80 % of all secreted or membrane proteins receive covalently linked 
carbohydrate chains on their travel through the secretory pathway 140. Hence, 
glycosylation is one of the most frequent and most important PTM in mammalian cells. 
The most significant modification in this context is N-liked glycosylation as this process is 
involved in the regulation of crucial cellular mechanisms like ER quality control, the UPR, 
ERAD, migration and adhesion as well as transport and sorting.  
As already described above, secretory pathway proteins receive a preassembled 
carbohydrate modification during entry into the ER lumen (section 3.2.2 and Figure 4). 
This is used in the following to ensure proper folding of the proteins. When the native state 
is achieved ER mannosidase I removes one mannose residue (“trimming”), which functions 
as a signal for ER-Golgi export (Figure 4). In the Golgi, the different cisternae house Golgi 
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mannosidases and transferases in a specific succession. These cycles of trimming and 
processing provide a multitude of possibilities how the sugar backbones can be arranged 
and, as a consequence, also many opportunities to fine-tune cellular processes like protein-
protein interactions or protein stabilization and turnover 140,141. Taken together sugar 
modification influence immensely overall Golgi function and trafficking and are critical 
players in the maturation of secretory pathway proteins.  
3.4.3.2 Phosphorylation of secretory pathway proteins 
Phosphorylation is the key mediator of cellular signal transduction. Furthermore, it extends 
the functionality of proteins inside and outside the cell. Therefore, phosphate modifications 
on substrates can influence multiple crucial processes like metabolism, transcription, cell 
cycle progression, cytoskeletal rearrangement, cell movement, apoptosis and differentiation 
142-146. In order to master all these challenging tasks, 1.7 % of human genes encode the 
human “kinome”, which corresponds to more than 500 kinases 147. Although the first hints 
concerning protein phosphorylation were already detected by Hammersten at the end of 
the 19th century in the secreted milk casein protein, kinases localizing to the secretory 
pathway remained elusive for more than 100 years 148. Finally, the D.melanogaster protein 
Four-jointed (Fj) was shown to exhibit kinase activity on the extracellular cadherin domains 
of the Dachsous protein 149. Nonetheless, the number of secretory pathway kinases remains 
small to date and is subject to ongoing research.  
 
 
Figure 7: Phylogenetic trees for secretory pathway kinases. Phylogenetic trees show relationships of Fam20C 
(A) and TPK-PKDCC/VLK (B) to their respective family members. Trees were built with MOLPHY using 
distances (-J option) calculated from an alignment of representative human proteins. (Fjx, four-jointed box 1; 
DIA1, Deleted in Autism 1; DIA1R, DIA1-related). Figure originates from Tagliabracci et al., 2015 150.  
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3.4.3.2.1 Fam20C and the Fjx family of secretory pathway kinases 
The human homologue of Four-Jointed Box protein 1 (Fjx1) was the first member of the 
Fxj1 family of protein kinases (Figure 7A). The six members of this family Fjx1, Family 
with sequence similarity 20 A (Fam20A), Fam20B, Fam20C and Family with sequence 
similarity 198 (Fam198A) and Fam198B belong to the 40 atypical human kinases, because 
they contain a protein kinase like (PKL) fold instead of the canonical motif in the 
eukaryotic protein kinase catalytic domain 147,151. All of them localize to the secretory 
pathway, though only Fxj1 and Fam198B contain a transmembrane domain with their 
catalytic domains facing the Golgi lumen149,152. The other members are considered as 
soluble proteins, as no transmembrane domains are known 152.  
Member C of the Fam20 kinases was identified in 2012 as the physiological casein kinase 
152. Fam20C is ubiquitously expressed, although especially high in mineralized tissues 
153,154. In addition to the conserved structural features mentioned above, Fam20C contains 
predicted disulfide bonds and three N-glycosylated asparagine residues. These sugar 
modifications were shown to be crucial for protein folding and stability and as a 
consequence also for kinase activity 150,152. Besides a remarkable resistance to the broad-
spectrum kinase inhibitor staurosporine and a preference for manganese as divalent cation, 
Fam20C exhibits autophosphorylation in vitro, which seems not to be essential for kinase 
activity and secretion 149,150,152.  
Although initially especially proteins involved in biomineralization were designated as 
Fam20C targets, recent mass spectrometry based screens in combination with GO Term 
analysis identified more than 100 proteins, which are involved in wound healing, lipid 
homeostasis, endopeptidase inhibitor activity, cell adhesion and cell migration150. These 
targets were mainly phosphorylated at a serine residue inside an S-X-E/pS or an S-X-Q-
X-X-D-E-E motif 150,152,155. This and other studies prove that Fam20C generates a 
majority of the secreted phosphoproteome 156-158, including targets like the fibroblast 
growth factor 23 (FGF23), small integrin-binding ligand N-linked glycoprotein (SIBLING) 
proteins and osteopontin 149,150,152,159,160.  
Mutations of Fam20C in humans cause a severe autosomal recessive osteosclerotic bone 
dysplasia known as Raine syndrome 161. The crystal structure of C.elegans Fam20C indicates 
that these Raine syndrome associated mutations cause impaired substrate binding 162. 
Finally, recent reports about Fam20A regulating secretion and kinase activity of Fam20C 
linked the kinase also to amelogenesis imperfecta, a disease causing improper enamel 
formation in teeth 163-165.  
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3.4.3.2.2 Tyr phosphorylation by extracellular tyrosine-protein kinase PKDCC 
Extracellular tyrosine-protein kinase PKDCC (in the following TPK-PKDCC) is the 
human homolog of mouse vertebrate lonesome kinase (Vlk). The first description of Vlk by 
Kinoshita and colleagues in 2009 opened the long-expected research field for secreted 
tyrosine kinases of the secretory pathway 166 (Figure 7B). TPK-PKDCC is highly conserved 
in vertebrates, however, no invertebrate homologs were detected so far 167. It is distantly 
related to the poorly characterized Family with sequence similarity 69 A to C (Fam69), 
Deleted in Autism-1 (DIA1) and DIA1-related, but not to Fam20 proteins, which indicates 
that the two families of secretory kinases developed independently of each other and not 
from a primordial secreted kinase 168,169.  
As indicated above, TPK-PKDCC is a soluble tyrosine kinase, which localizes to the Golgi 
as well as the ECM and was shown to phosphorylate several resident or secreted proteins 
throughout the secretory pathway in an ATP-consuming manner 169,170. It contains a 
characteristic N-terminal SP for ER import, but the canonical DFG HRD motif in the 
catalytic C-terminal domain is replaced against other functional residues 151. Furthermore, 
TPK-PKDCC exhibits several glycosylation sites and an autophosphorylated tyrosine 
residue, however, modification of this residue seems not to be involved in kinase activity or 
secretion 169. In contrast, indeed necessary for its activity is the presence of calcium and 
magnesium as divalent cations, because manganese only poorly supports the kinase activity 
of TPK-PKDCC 169. But although several targets of TPK-PKDCC are known, including 
matrix metallo proteinases (MMPs), no consensus pattern for target phosphorylation could 
be determined to date 168.  
TPK-PKDCC/Vlk activity was linked to several pathobiological processes. For example, 
experiments conducted in mice revealed the involvement of the kinase in tissue 
morphogenesis and organogenesis 166,171. In addition, Vlk null mice showed defects in long 
bone and lung formation 172. In trabecular meshwork cells secreted proteins 
phosphorylated by VLK controlled cell shape, actin stress fibers and focal adhesion 
formation170. Interestingly, overexpression of the wild type kinase or a kinase dead mutant 
caused delayed transport of a viral protein in NIH3T3 cells from Golgi to PM, although 
the detailed mechanism remained elusive 166. Nonetheless, this last observation already 
indicates that phosphorylation is closely linked to protein sorting and secretion. However, 
which other factors are important for efficient Golgi function and, as a consequence, 
organized protein sorting and transport?  
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3.4.4 Calcium in the secretory pathway 
The divalent cation calcium governs all aspects of cellular life. Therefore, cells put high 
effort in controlling calcium influx and efflux processes by a cohort of pumps, channels, 
transporters and buffering proteins. So far, one of the most important aspects of secretory 
pathway function was neglected in this introduction, as the secretory pathway components, 
especially the ER, are the major regulators of intracellular calcium signaling 173.  
In general, cells try to uphold a steep gradient between extracellular calcium (in mM area) 
and a very low cytosolic calcium concentration 50 – 100 nM 174,175 (Figure 8). This 
characteristic enables the cell to signal extracellular stimuli to the cell interior by small 
changes of cytosolic calcium levels. The calcium necessary for this change is released from 
internal stores, mainly the secretory pathway, but also other organelles like peroxisomes 
and mitochondria 176. This system requires active, energy-consuming transport of calcium 
ions out of the cytosol into the lumina of the secretory calcium compartments and the 
organelles when no calcium signal is required.  
 
 
 
But not only the differences in concentrations between the inside and the outside of the cell 
are vital for calcium homeostasis, but also a gradient across the secretory pathway itself 178. 
According to fluorescence-based calcium sensors, the ER houses calcium concentrations of 
about 400 µM, while concentrations gradually decrease across the Golgi from 250 µM in 
cis Golgi, to around 130 µM in trans Golgi and 80 µM in secretory vesicles 179-182. 
However, absolute numbers vary according to cell line and technique used in the studies. 
Although, for a long time only the ER was considered as the main calcium release 
organelle, also the Golgi apparatus contains all elements, namely calcium pumps, 
Figure 8: Calcium gradient and 
homeostasis at the Golgi apparatus 
(GA) is maintained by several 
players. Calcium concentrations 
inside the secretory pathway decline 
gradually from around 400 µM in 
the ER to around 80 µM in vesicles 
(SV). These concentrations are 
regulated by the two calcium pumps 
SERCA (blue circles) and SPCA1 
(red circles) and by the release 
channels IP3 receptor (IP3R; red 
cylinders) and Ryanodine receptor 
(RyR, green cylinders). The figure 
depicts the assumed distribution of 
channels and pumps along the 
secretory pathway. Figure originates 
from Pizzo et al., 2010 177.  
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transporters and binding proteins (see below), to act as a bona fide calcium store and gains 
more and more importance in intracellular calcium signaling 183-186.  
3.4.4.1 Calcium pumps 
A well-studied aspect of calcium transport is the active pumping of the cation across the 
membranes. Three mammalian calcium pumps of the P-type ATPases are described to 
guarantee calcium homeostasis of the cytosol: (1) the Sarcoplasmic/endoplasmic reticulum 
ATPase (SERCA), (2) the Secretory Pathway Calcium ATPase (SPCA) and (3) Plasma 
Membrane Calcium ATPase (PMCA). As indicated by their names, all pumps are 
integrated into certain membranes and pump calcium in an ATP-consuming manner into 
the lumen of the ER, the Golgi or into the extracellular space, respectively. However, the 
localization of SPCA and SERCA partly overlaps in the Golgi, i.e. SERCA also 
contributes to calcium influx at the cis Golgi cisternae, while SPCA is more accumulated in 
the medial and trans Golgi membranes 184-186. The contributions of both ATPases on total 
calcium influx varies in different cell lines.  
 
 
Figure 9: Structure and reaction scheme of calcium pump P-type ATPases using the example of SPCA1. (A) 
Cartoon of SPCA1 structure depicts domain structure of the Golgi-resident ATPase calcium pump. The 
cytosolic loops contain the actuator domain (A, pink), the nucleotide binding domain (N, blue) and the 
phosphorylation domain (P, purple), which assemble in the three-dimensional structure of the protein. The 
ten TM domains (green, Arabic numerals) bind the calcium ion for transport between domain 4 and 6. (B) 
Simplified reaction scheme of calcium transport across the membrane by P-type calcium pumps. In the high 
calcium affinity state E1 the pump binds calcium from the cytosolic side inside the membrane. ATP 
hydrolysis and attachment of phosphate to a highly conserved aspartic acid residue in the regulatory P-
domain switches the pump to a low calcium affinity state E2. The whole process is accompanied by major 
structural changes in the protein. This drop in affinity leads to release of the calcium ion at the luminal side of 
the membrane. Part of the figure was adjusted from Brini et al., 2009 191.  
 
Several key architectural features are shared by the three proteins. They are all single 
subunit integral membrane proteins with ten TM domains and large cytosolic loops (Figure 
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9A). The cytosolic head groups contain a nucleotide binding (N) domain for ATP binding, 
a phosphorylation (P) domain, which becomes phosphorylated on a catalytic asparagine 
residue in an ATP-dependent manner, and an actuator (A) domain, which catalyzes 
dephosphorylation of the P domain after completed cation transport. The critical catalytic 
amino acid is part of the highly conserved SDKTGTLT sequence and mutations abolished 
calcium transport activity in yeast 187.  
The structural similarities pave the way to a common mode of action for calcium transport 
across the membranes, although some details of this process still remain to be elucidated 
188,189 (Figure 9B). First, the pumps bind calcium ions at the cytosolic interface with high 
affinity (so called E1 state). Subsequently, the conserved asparagine residue is 
phosphorylated by hydrolysis of ATP (ADP sensitive state). This phosphoenzyme 
intermediate occludes the cations and undergoes a rate-limiting step towards the low-
energy E2 state, which includes major conformational changes either of the cytosolic as 
well as six of ten transmembrane domains (ADP insensitive state). In this condition, 
calcium is released into the lumen or the ECM and the pumps are dephosphorylated by 
the actuator domains in the presence of water for regeneration of the enzymes (transition of 
E2 back to E1 state). Then a new cycle of transport can occur 190.  
This process enables SERCA to transport two calcium ions across the membrane, because 
it contains 2 calcium binding sites between TM domain M5 and M8 (site I) and between 
M4 and M6 (site II). However, due to point mutations SPCA and PMCA lack one of the 
crucial oxygen atoms, which disrupts calcium binding site I 192-194. Therefore, SPCA and 
PMCA transport calcium only with a stoichiometry of 1:1 instead of 2:1 observed for 
SERCA 188,189,194,195. Nonetheless, SPCA exhibits the highest calcium affinity with a 
dissociation constant around 10 nM, probably necessary because SPCA transition from E1 
to E2 is retarded. Another difference between the three pumps is the fact that SERCA and 
PMCA, but not SPCA, countertransport protons during calcium translocation. This is 
probably due to the poor conservation of necessary, protonable residues in SPCA1 and 
also the fact that some proteins inside the Golgi lumen are dependent on the presence of 
protons for proper activity 189,196,197.  
The ubiquitously expressed SPCA1 (encoded by up to four splice variants of ATP2C1) is 
highly conserved in C.elegans, D.melanogaster, S.cerevisiae, mammalians and humans 198-201 and 
is therefore considered as house keeper variant of this protein. In contrast, the expression of 
SPCA2, is much more restricted and mainly found in mucus-producing cells like in the 
gastrointestinal tract, rectum, trachea, salivary gland, thyroid gland, keratinocytes, prostate 
tissue, mammary gland and brain testis 195,202,203.  
The Golgi complex 
 24 
As already outlined above SPCA1 localizes to the Golgi compartment and regulates 
luminal calcium concentrations in synergy with SERCA (Figure 8). In epidermal 
keratinocytes SPCA1 is highly abundant and in this cell line up to 70 % of whole Golgi 
calcium is dependent on SPCA1 activity 204,205.  
A unique feature of SPCA1 is the efficient transport of not only calcium, but also 
manganese into the Golgi lumen 188,189. Although manganese acts cytotoxic in high 
concentrations in the cytosol, several enzymes in the Golgi including mannosyl and fucosyl 
transferases and the Fam20C kinase 152,206,207 need the cation for proper activity 
188,189,195,202,203,208-210.  
But what is the physiological relevance of SPCA1-dependent luminal calcium? A variety of 
mutations in one allele of ATP2C1 were connected to a disease called Familial benign 
chronic pemphigus (OMIM 16960) or Haily-Haily disease (HHD) 211,212. Reduced Golgi 
calcium content due to impaired SPCA1 activity caused acantholysis of epidermal cells, 
erosions and blistering of skin in human patients 198,213. These observations underline the 
importance of SPCA1-dependent calcium homeostasis at the Golgi.  
3.4.4.2 Calcium release channels of the Golgi 
Since the discovery of the SERCA calcium pump in the 1960s the question arose, how 
calcium is released from the secretory pathway compartments 214,215. In the past decades, 
several studies proofed that calcium can be released from the ER upon extracellular stimuli 
by Inositol-1,4,5-triphosphate (IP3) 182,216 (Figure 8). Therefore, heterotrimeric G protein-
coupled receptors are activated by ligand binding to their extracellular domains. This 
interaction activates the cytosolic G protein, which binds via its alpha domain to 
phospholipase C (PLC). PLC catalyzes the cleavage of phosphatidylinositol-4,5-
bisphosphate (PIP2) to diacylglycerol (DAG) and IP3. Subsequently, IP3 then opens the IP3 
receptor (IP3R) channels in the membrane of the ER and calcium is released into the 
cytosol where it acts as secondary messenger 217-220.  
However, the question of calcium release from the Golgi remained unanswered for several 
more years. Finally, in 1998 Pinton and colleagues presented data on the existence of the 
IP3 release channels in the Golgi membranes by a calcium sensitive photoprotein 184. This 
finding was further supported by immunofluorescence analyses performed during studies 
on the calcium binding protein CALNUC (section 3.4.4.3) in the lab of Marilyn Farquhar 
185. Lin and colleagues were able to show that IP3Rs localize to the Golgi and the ER and 
that calcium can be released form these compartments in an IP3-dependent manner. In 
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addition, the observations that ryanodine receptor (RyR) channels were absent from Golgi 
membranes as well as the lack of reports that other established release factors like cyclic 
adenine dinucleotide phosphate ribose (cADPR) or nicotinic acid adenine dinucleotide 
phosphate (NAADP) can trigger calcium release, strengthened the opinion that IP3R 
channels are the only release mechanism 186,221. In contrast, a publication of 2001 proposed 
the Golgi as a RyR sensitive compartment and a putative role in intracellular calcium 
signaling in rat sympathetic neurons 222. Furthermore, caffeine stimulation of neonatal 
cardiac myocytes resulted in calcium release especially of the trans Golgi 181.  
In summary, the possibilities of calcium release from the Golgi compartment need further 
investigation. For example, questions concerning the correlation between SPCA/SERCA 
and RyR/ IP3R channel expression, the proportional contributions of the mechanisms on 
overall calcium signaling or the influence of calcium waves on the enzymatic activity of 
Golgi resident proteins need to be addressed in the future 223.  
3.4.4.3 Calcium binding proteins in Golgi 
The last critical component necessary to define the Golgi as a bona fide intracellular calcium 
store are luminal calcium binding proteins that bind the free cation and function as 
buffering system 221. In contrast to the multiple ER-resident calcium binding proteins, only 
the four proteins nucleobindin 1 (Nucb1), nucleobindin 2 (Nucb2), Calcium binding 
protein of 45 kDa (Cab45) and calumenin (CALU) were so far associated with the Golgi 
lumen 224-227.  
Nucb1 (also known as CALNUC) and Nucb2 (also known as p54/NEFA) are highly 
conserved and share 61 % sequence homology 228. Both proteins contain two canonical EF 
hand motifs, a consensus pattern responsible for calcium binding, first identified in 
parvalbumin and named after the E and F loop of its crystal structure 229-231 (Figure 10). 
Structural analysis by Circular dichroism (CD) revealed that calcium binding induces 
conformational changes in the secondary structure of Nucbs to a more a-helical fold, while 
the EF hand remains unstructured in the absence of the cation 230-232. Furthermore, the 
same studies also showed that the two EF hand motifs bind calcium with different affinities 
in both Nucbs. An additional prove that Nucbs indeed contributes to in intra-Golgi 
calcium homeostasis is the observation by Lin and colleagues that HeLa cells 
overexpressing Nucb1 were able to store 2.5-fold more calcium inside the Golgi than 
comparable wild type cells 185.  
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Finally, in contrast to the soluble Cab45 and CALU (see below), Nucbs are not only tightly 
attached to the luminal leaflet of the Golgi, but can also be observed in the cytosol 233. 
Here Nucbs, by interaction of the acidic region between the EF hands with the GTP 
bound a-subunit of G-proteins, potentially modify intracellular signaling cascades 233-235. 
 
 
 
Calumenin (CALU) is a member of the CREC protein family, a group of EF hand motif 
containing proteins localized throughout the secretory pathway 236. Other members and 
eponyms of this family are 45 kDa calcium binding protein (Cab45), reticulocalbin (RCN) 
and ER calcium binding protein of 55 kDa (ERC-55). Today also other non-mammalian 
proteins like D.melanogaster SCF or DCB45, or C.elegans CCB39 are included into this family 
237-240. The ubiquitously expressed CALU has two splice isoforms of the same length, both 
containing a N-terminal SP and a C-terminal HDEF sequence 227,241. Although the protein 
itself is soluble and also secreted it is attached to the membrane via its interactors 227. For 
example, CALU was shown to bind RyR and SERCA and negatively regulate both 242-244. 
This fact and the data that CALU binds calcium via 7 potential EF hand motifs with an 
affinity of 1.59x103 M-1 strengthens the assumption that CALU acts, similar to Nucbs as 
regulator for luminal calcium levels inside the secretory pathway 227,242,245,246. Since the 
other CREC family member Cab45 is of major interest for this work structural and 
functional details will be discussed in a later section (section 3.5.3.4).  
 
 
Figure 10: Structure of EF hand motif. Figure 
depicts ribbon diagram of highly conserved 
EF hand motif present in many calcium 
binding proteins. The two helices E (dark blue) 
and F (light blue) are connected by a loop, 
which coordinates the calcium ion (green). 
Figure was adjusted from 
www.protopedia.org/wiki/index.php/EF_han
d 17.05.2017 6 p.m.  
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3.5 The TGN – the sorting hub 
The last sections of the introduction summarized several characteristics crucial for efficient 
function of the Golgi and also central stages in protein maturation. However, all these steps 
are mainly a prerequisite for the actual function of the Golgi – the sorting of proteins and 
transport to different cellular destinations. The TGN functions herein as a sorting hub of 
the cell, a central station for protein identification, segregation and packaging for 
subsequent transport. To fulfil all necessary requirements the TGN needs to be highly 
dynamic in respect to volume and surface area and the morphology can be adjusted due to 
the required amount of protein transfer 247,248.  
Furthermore, not only the cargo proteins are diverse in terms of nature, topology and size, 
ranging from soluble (or large soluble aggregates) to 12 transmembrane domains (or even 
multimers of them) including uncountable posttranslational modifications, but there also 
exist a multitude of diverse cellular destinations: the apical and basolateral plasma 
membrane in polarized cells, early/sorting endosomes, late and recycling endosomes, the 
Golgi stack or the ER for retrograde transport and also some more specialized 
compartments in certain cell types 2,249. Therefore, cells developed sophisticated sorting 
machineries to supervise and control these various exit routes. Complicated systems for 
protein identification, segregation and packaging evolved, which are in addition fine-tuned 
by environmental conditions like pH, salt concentrations and lipid composition of the 
TGN membranes. Unfortunately, only few of these sorting principles are well understood 
to date and observations that cargos for example destined for the same compartment use 
different sorting signals and different carriers still contribute to innumerable unresolved 
questions in the field. In the following, some well-studied sorting routes will be discussed in 
more detail.  
3.5.1 Sorting by lipids 
The special characteristic of the TGN compartment is a very distinct composition of 
membrane lipids in comparison to ER or cis Golgi. Therefore, not only cation and protein 
concentrations regulate biological functions at the TGN, but also the localization of 
different lipids is highly controlled within the cellular export routes. Thus, TGN 
membranes are especially enriched in cholesterol and sphingolipids like sphingomyelin 
249,250. The observations that depletion of both 251-253 influences sorting processes in 
polarized MDCK cells gave rise to the lipid raft hypothesis 254,255, which is based on the 
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assumption that biological membranes are heterogeneous in their lateral composition. 
Cholesterol can form short-lived microdomains in the TGN thereby changing the thickness 
and stiffness of the membrane in these areas 256,257. Certain proteins preferentially associate 
to those microdomains (Figure 11). However, binding alone seems not to be sufficient for 
vesicle formation, but oligomerization of these proteins is required to cluster several lipid 
rafts into bigger domains 258,259. Upon a certain size of these sorting platforms vesicle 
budding is induced and proteins can be transported in an adaptor and coat independent 
manner to their respective target membrane 256.  
 
 
 
The best studied examples for this kind of lipid-dependent TGN export are 
glycosylphosphatidylinositol anchored proteins (GPI-APs). The GPI anchor is a lipid 
moiety with a glycan backbone, which is stepwise assembled at the luminal side of the ER. 
In a transamidation reaction the glycolipid is then transferred onto the C-terminus of 
soluble secretory cargo proteins, which attaches them to the luminal leaflet of the secretory 
pathway 261,262. For TGN export the more saturated lipid environment supports first 
homodimerization of the GPI-APs and subsequently formation of bigger clusters. These 
lipid rafts are then sorted mainly to the apical membrane as shown in polarized cells 255,263. 
However, the sorting by lipids rafts for proteins except the GPI-APs and secretory granules 
(section 3.5.3.1) is very poorly examined and still controversially discussed in literature.  
3.5.2 Sorting of TM proteins 
A better understood principle was described for the sorting of transmembrane proteins 
(TMPs). TMPs contain at least one cytosolic domain, which offers the possibility to interact 
directly with cytosolic proteins via short amino acid motifs 264,265. These interactions enable 
Figure 11: Schematic depiction 
of lipid raft model for sorting of 
proteins. Cholesterol-rich 
microdomains in the TGN 
membrane provide a special 
microenvironment and 
accumulate certain proteins like 
GPI-anchored proteins. Upon a 
certain size of the raft these 
domains bud from the TGN 
and are exported for transport 
to their subcellular destination. 
Figure originates from 
Malchiodi-Albedi et al., 2011 
260.  
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at the same time recognition, accumulation and segregation of cargo proteins into certain 
TGN subdomains for export.  
The best understood examples are tyrosine based (NPXY or YXXF) or dileucine based 
motifs ([DE]XXXL[LI]), which target the cargos to the endosomal or the basolateral 
membranes 265. The transport is mediated by clathrin-coated carriers. Clathrin forms 
triskelion shaped envelopes which are composed of three heavy and three light chains and 
induces membrane curvature similar to the COPII coat during vesicle formation 266,267. 
However, also for this process TMPs need a cohort of accessory proteins like adaptors, 
GTPases and also lipids for efficient clathrin coat assembly 268, which will be discussed in 
the following.  
 
The small GTPases of the manifold Arf family play a crucial role in sorting and vesicle 
formation at the TGN, because they initiate the recruitment of a wide variety of proteins 
2,269. Similar to Sar1, guanine nucleotide exchange factors (GEFs) activate Arfs by 
substituting GDP and GTP. This activation leads to a conformational change and the 
insertion of an amphipathic helix into the TGN membrane, bending the membrane and 
marking the point of vesicle formation 270-274. In addition, the change in conformation 
enables Arfs to recruit accessory proteins to the membrane including clathrin adaptor 
proteins (see below) and the Cdc42/N-WASP/Arp2/3 complex required for actin 
polymerization 270-273,275. In collaboration with Arfs, the presence of the highly-enriched 
phosphatidylinositol-4-phosphate (PI4P) supports the recruitment of adaptors and BAR-
domain containing proteins by direct interaction.  
The actual physical connection between the TMPs and the clathrin coat form adaptor 
proteins. The four groups of adaptors known to date are so called adaptor protein 
complexes (APs), Golgi-localized, g-ear-containing, Arf-binding proteins (GGAs), Epsin-
related proteins (EpsinRs) and Exomer in yeast 2,276-279.  
Five different AP proteins (AP1 to AP5) are known to date and especially AP1, AP3 and 
AP4 were linked to TGN-endosome sorting and transport 2,280. The heterotetrameric APs 
contain binding sites for tyrosine-based as well as for dileucine based motifs, which are 
often at the C-terminus of the cargo proteins, but can also be embedded inside the tertiary 
structure 281-284. In addition, the selectivity of APs for their cargo proteins can be fine-tuned 
by expression of different isoforms and by the nature of amino acids surrounding the 
sorting motifs 285,286.  
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Another adaptor family present in mammalian cells are the monomeric GGA proteins. 
GGAs bind acidic-cluster dileucine motifs (DXXLL) similar to APs by their N-terminal 
VHS (Vps27, Hrs, STAM) domain. If APs and GGAs interfere or collaborate due to the 
similarity in their recognition motifs or how they are spatiotemporally regulated in detail is 
an ongoing discussion in this research field.  
The only mammalian protein of the epsin-related family acting at the TGN binds directly 
to various SNARE proteins and PI4P via its N-terminal ENTH domain. The unstructured 
C-terminal domains interact with the accessory binding domains of APs and GGAs 287,288. 
EpsinR was also shown to be required for retrograde transport of TGN46 or the mannose-
6-phosphate receptor from early endosomes to the TGN 289.  
 
Finally, when the coat is stably attached to the TMPs, tubular vesicles are pulled out of the 
TGN via actin- and microtubule-based motors proteins 290,291. Presumably, after 
elongation of the tubules GTPases of the dynamin family constrict the membrane at the 
newly formed carrier pinches off upon GTP hydrolysis. Thereafter, vesicles are further 
transported along the cytoskeleton to their acceptor compartments for vesicle fusion, 
however, this mechanism requires further investigations.  
3.5.3 Sorting of soluble proteins  
The fact and obvious advantage that TMPs can interact with cytosolic components is 
simultaneously the biggest obstacle for sorting of soluble proteins. Evidently, the membrane 
bilayer prevents crosstalk and direct interaction between luminal cargo and the cytosolic 
coat machinery. Therefore, nature established different mechanisms to overcome this 
barrier.  
Besides the sorting by lipid rafts (section 3.5.1) three principals were described in literature 
so far, namely sorting of soluble proteins into specific storage granules, receptor-mediated 
sorting and sorting by the Cofilin1/SPCA1/Cab45 machinery, which will be explained 
below in more detail (Figure 12).  
3.5.3.1 Sorting into secretory storage granules 
The sorting of soluble proteins into secretory storage granules (SSG) is a specialized storage 
and release mechanism observable in exocrine and endocrine cells (e.g. neuroendocrine 
cells). Thereby, usually enzymes and hormones like Chromogranin A and B, 
secretogranins, prohormone convertase or carboxypeptidase are packed at the TGN into 
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vesicles of several hundred nanometers and released upon an external stimulus at the 
plasma membrane 249,292-294.  
For this process two basic steps are necessary: (1) aggregation of cargo inside the TGN 
lumen and (2) maturation of the immature SSG and removal of mislocalized proteins.  
Cargo proteins inside the SSG appear as dense cores in electron microscopy and they are 
highly condensed to enable a fast and concentrated release 19,295,296. This condensed state 
requires efficient aggregation of proteins already inside the TGN lumen, which also helps 
to segregate these proteins from other TGN luminal components.  
 
 
Figure 12: Different mechanisms for sorting of soluble cargo proteins in the TGN lumen. (A) and (B) Soluble 
proteins are sorted at the TGN by a variety of different mechanisms. They can either be modified by a M6P 
modification which can be recognized in the TGN by a TM receptor (dark blue) or they can directly bind to 
sortilin (purple). The TMPs in turn interact with adaptor proteins (dark green) and clathrin coat proteins 
(light green) and vesicles are transported to the endo-lysosomal system. (C) Proteins destined for secretory 
storage granules (SSG) accumulate in TGN subdomains with low pH and high calcium concentrations. 
These aggregates are then packed into vesicles which mature into SSGs and are stored inside the cell until an 
external stimulus releases them. (D) Many proteins that are not under the control of one of the other 
pathways also need to be sorted at the TGN, however, for a long time a suitable mechanism remained 
elusive. In recent years, it became evident that the receptor-independent sorting by CFL1/SPCA1/Cab45 is 
responsible for the sorting of a subset of soluble molecules at the TGN for transport to the plasma membrane. 
Nonetheless, other yet unknown mechanisms might be involved. Figure was adjusted from Kienzle and von 
Blume, 2014 309.  
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The signal for oligomerization can either be due to intrinsic properties of the SSG proteins 
or be a receptor-mediated process 249,294,297. However, in both cases certain environmental 
requirements like high calcium concentrations and an acidic compartment were necessary 
to induce aggregation 298,299. Cargo conglomerates ready for export interact with 
cholesterol-rich membrane domains and subsequently formed vesicles pinch off in a GTP-
consuming manner as immature SSGs 300-303. These carriers then shrink while condensing 
their content and removal of mislocalized proteins like furin or mannose-6-phosphoate 
receptor by GGA-dependent export in clathrin-coated vesicles 294,304-306. Mature SSGs are 
translocated upon external stimuli to the plasma membrane, where they secrete their 
cargos. In parallel, secretion triggers a positive feedback loop for mRNA stabilization and 
transcriptional activation to restore the SSG contingent 294,307,308.  
A similar sorting by selective aggregation mechanism was also observed for the apical 
transport of N-and O-linked glycan oligomers, which helps to isolate these proteins and 
transport them via lectin receptors to the plasma membrane 297.  
3.5.3.2 Sorting by receptors 
The second possibility is the sorting of soluble proteins by receptors that link them to the 
cytosolic clathrin coat machinery. To date mainly two of these receptors namely mannose-
6-phosphate receptor (M6PR) and Vps10p-domain-containing receptors (VDCRs) for 
transport to the endosomal membranes are well documented.  
In the cis Golgi soluble lysosomal proteins including hydrolyses, proteases, nucleases and 
lipases receive a mannose-6-phosphate (M6P) modification onto the subterminal mannose 
residues in the outer branches of their N-linked oligosaccharide by UDP-N-
acetylglucosoamine-1-phosphotransferase 310,311. In a second enzymatic step the 
“uncovering enzyme” N-acetylglucosamine-1-phosphodiester a-N-acetylglucosaminidase 
removes the N-terminal GlcNAc to expose the M6P recognition signal for subsequent 
receptor interaction 312,313. The two corresponding type I transmembrane receptors reside 
mainly in the TGN and differ in the size of the luminal domain, the number of M6P 
binding sites and their requirement for calcium 314-316. The observation that expression of 
one receptor cannot fully compensate for the loss of the other indicated complementary 
functions of both, although this aspect remains to be elucidated in more detail 314,315. Acidic 
dileucine clusters in the cytosolic domain of the M6PRs recruit GGA and AP1 adaptor 
proteins (section 3.5.2) and subsequently the clathrin coatomers for vesicle transport to the 
early or late endosomes 317-319. The low pH of about 5.5 inside the endosomal system then 
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induces dissociation of the lysosomal enzymes from M6PRs. While the enzymes remain, 
the receptors are recycled to the TGN via the retromer complex in an Rab9/TIP47-
dependent manner for a new cycle of sorting 310,320-322.  
Misfunction of this system leads to secretion of lysosomal enzymes from cells and to 
lysosomal storage diseases in human patients 315. However, samples from patients suffering 
from I-cell disease (a lysosomal storage disorder with impaired function in M6P addition) 
indicate that also M6P-indpendent transport of lysosomal proteins exist 323,324.  
 
One possibility for M6P-independent transport is the sorting of lysosomal proteins by 
sortilin and sortilin-related protein with A-type repeats (SorLA), both members of the 
mammalian Vps10p-domain-containing receptors (VDCRs) family 325-327. The type I 
transmembrane proteins share several characteristics with M6PRs including typical 
consensus patterns in their cytosolic domains for adaptor protein interaction and are both 
involved in endosome-TGN transport 325,328-330. The N-terminal, luminal Vps10p domain 
of sortilin and SorLA contains a propeptide and conserved more C-terminal motif of 10 
cysteines 325,331. The propeptide prevents premature ligand binding and is cleaved by furin 
in the TGN 332,333. The active protein forms a conical tunnel of a 10-bladed beta-propeller 
which houses binding sites for several ligands 334. In addition, reports indicate that the 
conserved disulfide bridges formed by the 10 cysteine motif are essential for affinity for 
receptor-specific ligands 335. In addition, SorLA contains low-density lipoprotein receptor 
class A repeats which are able to interact with several more cargos 336. Due to their 
similarities it seems not surprising that sortilin and SorLA localize with M6PR in 
endosome-to-TGN carriers and seem to employ a common AP1-dependent retrograde 
transport mechanism via retromer 326,337,338.  
Besides M6PR and VDCRs also lysosomal integral membrane protein type 2 (LIMP2) and 
Wntless were suggested as sorting receptors functioning via similar sorting motifs. 
However, poorly described cargo pools or mechanisms require more research on these 
sorting principles 2.  
3.5.3.3 Sorting by the Cofilin1/SPCA1/Cab45 machinery 
For decades, the idea of secretion of soluble cargo was dominated by the hypothesis that 
soluble proteins can just be constitutively and randomly transported to the cell surface by 
bulk flow 339. Although receptor-dependent mechanisms for sorting to the endo-lysosomal 
compartments were described, a corresponding particular system seemed irrelevant. As a 
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result, the sorting of soluble proteins by the specific CFL1/SPCA1/Cab45 machinery was 
only recently discovered and the main focus of this thesis. Although the individual 
components of the system were known for several years, the connection was established 
only in 2006 by a genome wide screen in D.melanogaster S2 cells aimed to identify new 
components necessary for secretion of soluble secretory proteins 340. This experiment 
revealed the drosophila homologue of mammalian Cofilin1 (CFL1)/actin depolymerizing 
factor (ADF), twinstar, as an essential regulator of secretion.  
Mammalian cells express the three isoforms ADF, CFL1 and CFL2 from three different 
genes 341,342. All three are small proteins of about 18 kDa and share high sequence 
similarity up to 80 % and a highly conserved single folded ADF homology domain 341,343. 
Their common potential to regulate actin dynamics by binding filamentous and globular 
actin via a long a-helix 344-346 renders them key regulators of many cellular processes 
including contractility, apoptosis and nuclear actin import, transcription and nuclear 
architecture 347-350. Besides several levels of regulation like PIP2 binding, competition with 
other actin binding proteins, cytosolic pH and mechanical forces on actin fibers 345,351-357, 
CFL1/ADF is inactivated by phosphorylation of Ser3 by LIM or TES kinases and 
reactivated by SSH phosphatases 359-361. Although it seemed surprising that a cytosolic 
protein, with a well-established function in actin dynamics, was responsible for secretory 
cargo sorting, subsequent analysis in HeLa and yeast cells proved, that siRNA knockdown 
of CFL1/ADF results in a missorting phenotype of soluble, but not the membrane-
associated cargo proteins VSV-G or p75 362,363. 
 
Figure 13: Schematic depiction of the SPCA1 domain structure and the CLF1 binding site. (A) Cartoon of 
SPCA1 structure depicts domain structure of the Golgi-resident ATPase calcium pump. The cytosolic loops 
(L1 to L4) contain the actuator domain (A, pink), the nucleotide binding domain (N, blue) and the 
phosphorylation domain (P, purple). In the C-terminal part of L2 (L2C1, red box) in the P-domain CLF1 
binds to a patch of four amino acids and activates the calcium pump by parallel recruitment of F-actin. (B) 
Structural model of the CFL1 binding domain in the SPCA1-L2C1 domain (purple). The red spheres and 
numbers represent the four amino acid residues required for SPCA1- CFL1 interaction. Figure was adjusted 
from Kienzle et al., 2014 358.  
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Later work revealed that only active, dephosphorylated CFL1 interacted directly with the 
C-terminal part of the cytosolic loop 2 of SPCA1 (SPCA1-L2C1) (Figure 13), as only KD of 
the SSH phosphatase, but not the LIM kinase resulted in impaired secretion of soluble 
proteins 358,362,364. Furthermore, the CLF1/SPCA1 interaction was crucial for actin 
recruitment to the Golgi, efficient calcium uptake and sorting. In vitro experiments proofed 
CLF-1-dependent actin recruitment onto beads covered with SPCA1-L2C1 358. In 
addition, CLF1 localized to the TGN membranes only in the presence of polymerized 
actin in HeLa cells, because disruption of actin dynamics by drugs like latrunculin 
dispersed CLF1 into the cytosol 364. Finally, overexpression of SPCA1-L2C1 inhibited 
cargo sorting and trafficking due to diminished CLF1 TGN recruitment358. In that line, a 
FRET-based calcium sensor targeted to the TGN lumen indicated less calcium influx upon 
overexpression of the SPCA1 loop2 or siRNA KD of CLF1 or SPCA1358,364. As a 
consequence to the disturbances in actin recruitment and calcium uptake, soluble cargo 
proteins were inefficiently sorted and accumulated in the yeast and HeLa TGN lumen, 
which increased the volume as observed before upon temperature-dependent export block 
248,362,363.  
Taken together these studies underlined the importance of CFL1/actin recruitment to the 
TGN and the subsequent SPCA1-dependent calcium influx into the TGN lumen for 
efficient cargo sorting. However, the question how calcium levels subsequently regulate 
protein transport remained unanswered.  
3.5.3.4 Cab45 – the missing link 
The ´missing link` to this problem Cab45 was identified in 2012 by the research group of 
Vivek Malhotra as key regulator of secretory cargo sorting at the TGN 365.  
Initially, Cab45 was identified by Scherer and colleagues as the first soluble, Golgi 
apparatus resident protein in 1996 in mouse 3T3-L1 adipocytes, however, the function 
remained elusive at this time 226. The protein is encoded by the SDF4 gene, which contains 
seven exons on chromosome 1.p36.33 and an ORF of 1086 bp 236,366. Some years later the 
splice isoforms cytosolic Cab45 (Cab45-C) and the secreted form (Cab45-S) were described 
in literature 367-369.  
The originally identified mouse protein was found to be highly conserved in mammalian 
tissues sharing 95 % with rat and 87 % with the human sequence. Especially the EF hand 
motifs show 100 % and 97 % homology to rat and human, respectively 370. In addition, 
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Cab45 shares high homology to RCN1 and Erc-55 also outside the calcium binding 
domains 226.  
The Cab45 protein contains 361 amino acids and is ubiquitously expressed, e.g. in lung, 
liver and brain, but also especially in adipose tissue 226 (Figure 14). The characteristical N-
terminal SP for cotranslational import into the ER contains a charged arginine preceding a 
stretch of hydrophobic amino acids 29,226. The proline residue located two amino acids 
downstream of the SP was suggested to act as crucial signal for ER export, since a mutation 
of the same residue in the calcium binding protein Nucb1 was shown to inhibit COPII 
mediated ER-Golgi transport 371. As a member of the CREC family (section 3.4.4.3) six 
potential EF hand motifs enable Cab45 to bind calcium ions. Two of those EF hands fit 
perfectly the described EF hand motif of Szebenyi and Moffat, 3 EF hands have single 
point mutations and EF hand 3 shows 3 substitutions in the amino acid sequence 237,372. At 
the very C-terminal end the four amino acids HEEF were suggested several times in 
literature as Golgi retention signal, analogous to the well-characterized KDEL retention 
motif of ER-resident proteins 225,227,370,373.  
 
 
Figure 14: Schematic depiction of the Cab45 domain structure and the 6EQ mutant. The whole Cab45 wild 
type protein consists of 361 amino acids. It contains an N-terminal signal peptide (SP) for recognition by the 
SRP and ER import, a glycosylation site at asparagine 39 (green) and six EF hand motifs (dark blue boxes; 
Roman numerals) for calcium binding. In the 6EQ mutant all six calcium binding sites were disrupted by E 
to Q single point mutations (orange lines and numbers).  
 
Already in the first description a N-glycosylation site of Cab45 was predicted for an 
asparagine residue on position 39 226. This hypothesis was verified 10 years later by pulse 
chase experiments in pancreatic INS-1 cells, which indicated that Cab45 indeed gained a 
digest-resistant protein pool within 4 h after protein synthesis 374. Although the structure 
and function of this sugar modification was so far not analyzed in detail, Delcourt and 
colleagues 375 identified Cab45 in a mass spectrometric SILAC screen performed in 
zebrafish, which proves that Cab45 exhibits the typical sialic acid modification of Golgi-
located proteins.  
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But how can the CFL1/SPCA1/Cab45 regulate secretion of soluble cargo proteins? Von 
Blume et al. showed in HeLa cells that Cab45 was released from the TGN if cellular 
calcium levels were depleted by addition of an ionophore to the cell medium 365. 
Furthermore, not only high calcium, but also the presence of SPCA1 at the Golgi was 
necessary to retain Cab45 inside the cells. In secretion assays, either the model cargo SP-
HRP and physiological cargo molecules like the cartilage oligomeric matrix protein 
(COMP) or Lysozyme C (LyzC) were accumulated at the TGN upon SPCA1 or Cab45 
siRNA KDs, while the sorting of the lysosomal hydrolase Cathepsin D (CathD) remained 
unaffected. These observations were in line with follow-up immunoprecipitation 
experiments. For these IPs, the 6EQ mutant of Cab45 was established, a calcium-binding 
deficient mutant with single point mutations in all six EF hand motifs (Figure 14). In 
contrast to the GST-fusion wild type protein purified from E.coli cells, the 6EQ mutant was 
not able to interact with COMP or LyzC.  
Taken together, the results presented in this publication gave the first hints that calcium is 
an essential component for correct intracellular localization of Cab45 and also for Cab45-
dependent cargo sorting. However, many crucial aspects of this sorting mechanism around 
the CFL1/SPCA1/Cab45 machinery remained unanswered and were hence central 
questions of this thesis. 	
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4 Aims of this thesis 
Efficient protein transport and secretion is a crucial requirement for a multitude of cellular 
aspects including cell homeostasis, cell-cell communication and tissue integrity. Therefore, 
malfunctioning of the system often leads to severe diseases. As a consequence, transport 
and sorting mechanisms are tightly regulated in cells, however, often only poorly 
understood so far. A more comprehensive knowledge about sorting of soluble proteins 
would deepen the insights into many vital cellular processes. Therefore, the specific aims of 
this thesis were:  
 
1. Establishment of biochemical and cell biological tools to analyze the 
CLF1/SPCA1/Cab45 sorting machinery 
2. Analysis of the role of calcium for the sorting mechanism 
3. In detail study on the Cab45-cargo interaction  
4. Analysis of Cab45 posttranslational modifications 
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5 Material and Methods 
In the framework of this thesis, ImageJ (version 2.0.0-rc-43/1.51f), Prism software (Version 
6.0h; GraphPad Software Inc., La Jolla, USA), Adobe illustrator CS6 (Version 16.0.0) and 
SnapGene (Version 2.4.3) were used for different applications (see below).  
5.1 Molecular biological methods 
For generation of expression vectors, the following general cloning protocols were applied. 
If not indicated differently, all enzymes were purchased from NEB (Ipswich, USA) and 
used according to the manufacturer’s advice. For all PCR reactions, a Mastercycler Nexus 
Gradient (Eppendorf, Hamburg, Germany) PCR machine was used. GeneArt Strings 
DNA Fragment for MGP 3A insertion were purchased from Thermo Fisher Scientific 
(Waltham, USA).  
5.1.1 Polymerase Chain Reaction (PCR) for standard cloning  
For amplification of plasmid DNA 150 ng of template vector were incubated with 200 µM 
dNTPs, 0.5 µM forward and reverse primer (section 0) and 0.01 units of Phusion High-
Fidelity DNA Polymerase (Thermo Fisher, Waltham, USA) in the corresponding 1x HF 
buffer in a total volume of 50 µl.  
To denature DNA strands samples were incubated for 5 min at 95 °C, before 35 cycles of 
denaturing (30 sec at 95 °C), annealing (30 sec dependent on the primer pair between 53 
and 58 °C) and elongation (30 sec/500 bp at 72 °C) were performed. For final elongation, 
PCRs were kept for 10 min at 70 °C before storage cooling to 10 °C.  
5.1.2 Annealing of sgRNAs and insertion into pX backbone vectors  
For annealing of sgRNAs (sections 5.2.7 and 5.2.8) before insertion into backbone vectors, 
100 µM top and bottom oligo nucleotides were incubated in 1x T4 ligase buffer 
supplemented with 10 units polynucleotide kinase according to the following scheme: 37 
°C for 30 min, 96 °C for 5 min, 95 °C for 1 min, 85 °C for 5 min, 80 °C for 1 min and 
then 0.1 °C/sec to 70 °C. Subsequently, annealed oligo nucleotides were stored at 10 °C. 
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Annealed oligo nucleotides were diluted 1:200 in water before standard ligation into o.n. 
BbsI digested, CIP-treated pX backbones (compare section 5.1.10).  
5.1.3 Agarose gel analysis and DNA purification  
Amplified DNA fragments of PCRs were analyzed by a 1 % agarose gel in TAE buffer 
stained by SYBR safe DNA gel stain (Thermo Fisher Scientific, Waltham, USA). 
Therefore, PCR samples were mixed with 10x DNA loading dye, applied on the agarose 
gel and run for 25 min at 100 V. For size standard, 8 µl of DNA ladder mix (Thermo 
Fisher Scientific, Waltham, USA) were analyzed along with the samples. Correct bands 
were extracted by mi-Gel Extraction Kit (Metabion, Martinsried, Germany) according to 
the manufacturer’s protocol.  
5.1.4 Restriction digest 
Purified PCR products and corresponding vectors were digested o.n. at 37 °C with 
enzymes indicated in Table 2. 5’ Phosphate of vectors was additionally removed by 
treatment with alkaline phosphatase for 1 h at 37 °C. After removal of enzymatic 
components by mi-PCR Purification Kit (Metabion, Martinsried, Germany), inserts were 
ligated into backbone vectors.  
5.1.5 Ligation 
Required amounts for ligation reactions were calculated by online tool provided by the 
university of Düsseldorf (www.insilico.uni-duesseldorf.de/Lig_input.html). For all 
reactions, a vector amount of 100 ng and a molar vector/insert ratio of 1/3 was used. 
Ligation reactions were performed for at least 1 h at RT with 10 units of T4 ligase in the 
corresponding buffer in a total volume of 20 – 30 µl.  
5.1.6 Transformation of ligated DNA into E.coli cells 
10 µl of the ligated DNA constructs were transformed into 50 µl chemically competent 
OmniMAX 2 T1 E.coli cells (section 5.1.9). Therefore, DNA and cells were incubated for 
30 min on ice and then for 90 sec at 42 °C. After addition of 300 µl LB growth medium, 
cells recovered for at least 1 h at 37 °C while shaking constantly. For o.n. cultures, 20 µl of 
transformed cells were plated on ampicillin-containing LB agar plates (final concentration 
100 µg/ml) and incubated at 37 °C. 
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5.1.7 Single clone isolation, DNA preparation and sequencing 
Grown colonies were picked and cultured in 4 ml LB medium, supplemented with 
ampicillin (final concentration 100 µg/ml) o.n. at 37 °C while shaking. Plasmid DNA was 
isolated from colonies by NucleoSpin Plasmid EasyPure Kit (Macherey-Nagel, Düren, 
Germany) and DNA concentration was determined by Nanodrop 2000 spectrometer 
(Thermo Fisher Scientific, Waltham, USA). Correct DNA sequence was validated by 
sequencing. All sequencing reactions were performed with SmartSeq Kits from Eurofins 
Genomics (Ebersberg, Germany). 
5.1.8 Mutagenesis for introduction of single point mutations  
PCR reactions were carried out as described above (section 5.1.1), but with 400 µM dNTPs 
and 0.6 µM primers. Only 16 repeat cycles were performed for multiplication of the 
plasmids. After analysis of PCR product on agarose gel and purification (section 5.1.3), 
DNA was digested by DpnI for 1 h at 37 °C to destroy template DNA. 2.5 µl of treated 
DNA was subsequently transformed into 50 µl of competent OmniMAX 2 T1 E.coli cells 
and further treated as described previously (section 5.1.6 and 5.1.7).  
5.1.9 Generation of chemically competent E.coli cells 
100 ml LB growth medium were inoculated with 2 ml of o.n. E.coli OmniMax 2 T1 culture 
and grown until OD 0.5 at 37 °C in shaker. Then cells were cooled to 4 °C on ice and 
centrifuged for 15 min at 3000 rpm at 4 °C. SN was discarded and pellet was resuspended 
in 10 ml TSS buffer supplemented with 2.5 ml of 87 % glycerol. Aliquots were snap frozen 
and stored at -80 °C.  
5.1.10 Plasmids 
Backbone 
plasmid 
Insert Description/Function Origin 
pI-
secSUMOstar 
Cab45 Cab45 wt with N-terminal insect SP and His-
SUMO tag for protein purification  
This work 
pI-
secSUMOstar  
Cab45 EFh1 Cab45 mutated at EF hand motif I (E122Q) and 
II (E161Q) with N-terminal insect SP and His-
SUMO tag for protein purification 
This work 
pI-
secSUMOstar  
Cab45 EFh2 Cab45 mutated at EF hand motif III (E220Q) 
and IV (E257Q) with N-terminal insect SP and 
His-SUMO tag for protein purification 
This work 
pI-
secSUMOstar  
Cab45 EFh3 Cab45 mutated at EF hand motif V (E302Q) 
and VI (E338Q) with N-terminal insect SP and 
His-SUMO tag for protein purification 
This work 
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pI-
secSUMOstar  
Cab45 NFrag N-terminal fragment of Cab45 (aa 1 to 206) 
with N-terminal insect SP and His-SUMO tag 
for protein purification 
This work 
pI-
secSUMOstar  
Cab45 CFrag C-terminal fragment of Cab45 (aa 207 to 361) 
with N-terminal insect SP and His-SUMO tag 
for protein purification 
This work 
pI-
secSUMOstar  
Cab45 MVKR Cab45 with M104K and V105R mutations with 
N-terminal insect SP and His-SUMO tag for 
protein purification 
This work 
pIRESneo3 SP-SBP-EGFP-
MGP 
MGP wt fusion construct with N-terminal signal 
peptide-streptavidin binding protein-EGFP tag 
for RUSH assays 
This work 
pIRESneo3 SP-SBP-EGFP-
MGP 3A 
MGP with Y82A Y86A Y88A mutations fusion 
construct with N-terminal signal peptide-
streptavidin binding protein-EGFP tag for 
RUSH assays 
This work 
pLPCX  Cab45 WT-HA Cab45 wt with C-terminal HA tag for 
expression in HeLa cells 
365 
pLPCX  Cab45 6EQ-HA Cab45 with E122Q E161Q E220Q E257Q 
E302Q E338Q mutations with C-terminal HA 
tag for expression in HeLa cells  
365 
pLPCX  Cab45 EFh1-HA Cab45 mutated at EF hand motif I (E122Q) and 
II (E161Q) with C-terminal HA tag for 
expression in HeLa cells 
This work 
pLPCX  Cab45 EFh2-HA Cab45 mutated at EF hand motif III (E220Q) 
and IV (E257Q) with C-terminal HA tag for 
expression in HeLa cells 
This work 
pLPCX  Cab45 EFh3-HA Cab45 mutated at EF hand motif V (E302Q) 
and VI (E338Q) with C-terminal HA tag for 
expression in HeLa cells 
This work 
pLPCX  Cab45 MVKR-
HA 
Cab45 with M104K and V105R mutations with 
N-terminal insect SP and C-terminal HA tag for 
expression in HeLa cells 
This work 
pLPCX  SS-HA-Cab45 Cab45 with N-terminal HA tagged inserted 
after signal sequence of Cab45  
This work 
pLPCX  SS-eGFP-Cab45 Cab45 with N-terminal eGFP inserted after 
signal sequence of Cab45 
This work (during 
supervision of 
Master student 
Judith Vlaar) 
pLPCX  Fam20C-HA Fam20C wt with C-terminal HA tag for 
expression in HeLa S3 cells for Golgi 
preparations 
This work 
pLPCX  Fam20C KD-HA Fam20C with K478A mutation with C-terminal 
HA tag for expression in HeLa S3 cells for 
Golgi preparations 
This work 
pLPCX LyzC-FLAG LyzC wt with C-terminal triple FLAG tag for 
expression in HeLa cells 
365 
pX458 pSpCas9-hGEM-
GFP-sgRNA3 
CRISPR/Cas9 construct with sgRNA3, Cas9-
GFP controlled by hGEM peptide for MIN-tag 
integration 
This work 
(section 5.2.8) 
pX459 pSpCas9-
sgRNA1 
CRISPR/Cas9 construct with sgRNA1 and 
Cas9 protein for KO targeting 
This work 
(section 5.2.7) 
pX459 pSpCas9-
sgRNA2 
CRISPR/Cas9 construct with sgRNA2 and 
Cas9 protein for KO targeting 
This work 
(section 5.2.7 
Table 1: Overview of expression constructs used in this thesis.  
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5.1.11 Primers and restriction enzymes 
Name Sequences  Restriction 
enzymes 
Cab45 fwd for pI-
secSUMOstar 
5’ CAGCGTCTCAAGGTCGGCCTGCCAACCAC 
TCGTC 3’ 
BsmBI 
Cab45 rev for pI-
secSUMOstar 
5’ CAGTCTAGATTAAAACTCCTCGTGCACGCTGCG 3’ XbaI 
Cab45 fwd NFrag fwd 
for pI-secSUMOstar 
5’ GGGCGTCTCGAGGTCGGCCTGCCAACCAC 3’ BsmBI 
Cab45 rev NFrag rev 
for pI-secSUMOstar 
5’ GCTCTAGATTACTGGTACCAGCGGTCCTTC 3’ XbaI 
Cab45 fwd CFrag fwd 
for pI-secSUMOstar 
5’ GGGCGTCTCCAGGTGCGGACAGCCCCCC 3’ BsmBI 
Cab45 rev CFrag rev 
for pI-secSUMOstar 
5’ GCTCTAGATTAAAACTCCTCGTGCACGC 3’ XbaI 
Cab45 fwd for SP-
HA-Cab45  
5’ GGG AGATCTATGGCTACAGGCTCCCGGAC 3’ BglII 
Cab45 rev for SP-HA-
Cab45 
5’ GGCGGCCTTAAAACTCCTCGTGCACGC 3’ NotI 
E122Q muta + 5’ AGATCAGTGCCAAGCAGATGCAGCGCTGG 3’ Not required 
E122Q muta - 5’ CCAGCGCTGCATCTGCTTGGCACTGATCT 3’ Not required 
E161Q muta + 5’ GTCACGTGTCTTGGGACCAGTATAAGGTGA 3’ Not required 
E161Q muta - 5’ AAACTTCACCTTATACTGGTCCCAAGACACGT 3’ Not required 
E220Q muta + 5’ TGCTGACGGAGGAGCAGTTCCTGTCGTTC 3’ Not required 
E220Q muta - 5’ GAACGACAGGAACTGCTCCTCCGTCAGCA 3’ Not required 
E257Q muta + 5’ AGCTCTCTGTGCCCCAGTTCATCTCCCTG 3’ Not required 
E257Q muta - 5’ CAGGGAGATGAACTGGGGCACAGAGAGCT 3’ Not required 
E302Q muta + 5’ GTGACCGCCGAGCAGCTGGAGAGCT 3’ Not required 
E302Q muta - 5’ AGCTCTCCAGCTGCTCGGCGGTCAC 3’ Not required 
E338Q muta + 5’ CCTGGAGCCCGAGCAGGTGCTCAAGTA 3’ Not required 
E338Q muta - 5’ TACTTGAGCACCTGCTCGGGCTCCAGG 3’ Not required 
Fam20C muta 
K478D + 
5’ ATCATCCACTTAGCCAATGGAAGAGGGTTT 3’ Not required 
Fam20C muta 
K478D - 
5’ AAACCCTCTTCCATTGGCTAAGTGGATGAT 3’ Not required 
GFP fwd  5’ CCGGAATTCCGGGGCGGCGGTCACGAACTC 
CAGCAG 3’ 
EcoRI 
GFP rev 5’ CCCAAGCTTGGGATGGTGAGCAAGGGCGAGGA 
GCTG 3’ 
HindIII 
MGP 3A Gstring for 
pIRES 
5’ CCGGAATTCTGTGAATCACATGAAAGCATGGA 
ATCTTATGAACTTAATCCCTTCATTAACAGGAGA 
AATGCAAATACCTTCATATCCCCTCAGCAGAGAT 
GGAGAGCTAAAGTCCAAGAGAGGATCCGAGAAC 
GCTCTAAGCCTGTCCACGAGCTCAATAGGGAAG 
CCTGTGATGACTACAGACTTTGCGAACGCGCCG 
CCATGGTTGCTGGAGCCAATGCTGCCTATAATC 
GCTACTTCAGGAAGCGCCGAGGGACCAAATAAG 
CGGCCGCAAAAGGAAAA 
  
EcoRI/NotI 
MGP fwd for pIRES 5’ TGTACAAGGCCGGCCTCTCGAGTACCCATACGA 
CGTCCCAGAC 3’ 
BsrGI 
MGP rev for pIRES 5’ TTAATTAATTATTTGGTCCCTCGGCGC 3’ PacI 
MVKR muta + 5’ CCACCTTGGAAAAGATGCGCTTCAGCTTCCTC 
CGGCTC 3’ 
Not required 
MVKR muta - 5’ GAGCCGGAGGAAGCTGAAGCGCATCTTTTCCA 
AGGTGG 3’ 
Not required 
SeqPrim pLPCX fwd 5’ AGCTGGTTTAGTGAACCGTCAGATC 3’ Not required 
SeqPrim pLPCX rev 5’ ACCTACAGGTGGGGTCTTTCATTCCC 3’ Not required 
SeqPrim pI 5’ CAAGTAAAACCTCTACAAATGTG 3’ Not required 
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secSUMOstar fwd 
SeqPrim Cab45 fwd 5’ AGCTACATGGACCCCATGAAC 3’ Not required 
SeqPrim Cab45 rev 5’ CCGGTCAGTGTTCACATCCAC 3’ Not required 
SeqPrim pX plasmids 5’ GAGGGCCTATTTCCCATGATTCC 3’ Not required 
Table 2: Overview of primers for generation of cloned vectors used in this thesis and required restriction 
enzymes.  
5.2 Cell culture methods 
5.2.1 General culture conditions 
HeLa cells were generally cultured in a standard incubator at 37 °C and 5 % CO2 in 
Dulbecco’s Modified Eagle Medium (DMEM), high glucose, GlutaMAX, supplemented 
with 10 % fetal bovine serum (FBS) and 1 % streptomycin/penicillin antibiotics. If not 
indicated otherwise all cell culture media, additives and other liquids including DPBS and 
DNA/RNAse-free water were purchased from Thermo Fisher Scientific (Waltham, USA). 
All cell culture dishes were purchased from Corning Inc. (Corning Inc., Corning, USA) 
For passaging adherent cells were washed once with sterile DPBS and incubated for 5 min 
in trypsinization solution at 37 °C. After centrifugation for 5 min at 1000 g and 
resuspension of cells in growth medium, cells were transferred to a new cell culture dish at 
the desired density and further supplemented with growth medium.  
5.2.2 Freezing and thawing of cells  
For long term storage, cells were detached as for passaging, centrifuged for 5 min at 500 g 
and resuspended in Freezing medium. After complete freezing at -80 °C of cells in cryo 
freezing containers cells were preserved in liquid nitrogen at – 196 °C.  
For quick thawing cells were incubated shortly in a 37 °C water bath. After addition of 
growth medium, cells were centrifuged for 5 min at 500 g. DMSO containing supernatant 
was discarded and cells resuspended in growth medium for transfer to cell culture dishes 
for further cultivation.  
5.2.3 Plasmid transfection of cells  
For plasmid transfection cells were cultured until approximately 50 % density under 
standard conditions. For transfection of a six-well dish by polyethylenimine (PEI) 
OptiMEM medium and 1.5 to 2.0 µg DNA were mixed and 7.5 µl PEI were added and 
vortexed for 5 min. After incubation for 15 min at RT PEI-DNA mixture was applied 
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dropwise onto the cells. Cells were incubated at least o.n. or until further use under 
standard conditions. Amounts of reagents were adjusted according to size of cell culture 
dishes.  
For transfection of cells by TransIT HeLaMONSTER reagent (Mirus Bio LLC, Madison, 
USA), cells were also cultured till 50 % density. Per 6-well dish, 4 µl TransIT reagent were 
mixed with 2 µg plasmid DNA in 100 µl OptiMEM medium and vortexed. After 
incubation for 20 min at RT mixture was applied dropwise before addition of a 20 µl of 
1:10 dilution of HeLaMONSTER mix in water. Subsequently, cells were cultured at least 
o.n. or till further use.  
5.2.4 Fluorescence activated cell sorting (FACS) of HeLa cells 
HeLa cells were detached, pelleted and centrifuged as described above. Cell pellet was 
resuspended in FACS buffer and cells were filtered by cell strainer (Corning,Inc., Corning, 
USA) to avoid cell clumps. EGFP positive cells were isolated by a BD FACSAria II (BD 
Biosciences, San Jose, USA), pooled and seeded for single clone isolation.  
5.2.5 Single clone isolation 
For isolation of single clones, cells were detached as described above, counted by the 
Countess II system (Thermo Fisher Scientific, USA), and 100 cells were seeded in a 15 cm 
culture dish. When single cell clones were big enough, cells were manually scratched off the 
dish by pipette tip, transferred to a 96 well plate and cultured to the desired number.  
5.2.6 Generation of stable cell line  
Cells stably expressing Cab45 or its mutants were transfected by VSV-G pseudotyped 
retroviral particles produced by transiently transfected HEK293T cells as described before 
by Pfeifer and colleagues 376. Viral particles were concentrated from cell culture 
supernatants and used for infection of HeLa cells. On the next day, HeLa cells were 
selected in 2 µg/ml puromycin (Sigma-Aldrich, Munich, Germany) for 24 h and stored or 
used for experiments.  
5.2.7 Generation of CRISPR/Cas9 KO cell lines 
The CRISPR/Cas9 method, which gained more and more importance during recent 
years, was applied to generate first a KO and secondly a cell line containing a 
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multifunctional integrase (MIN) tag. Besides zinc finger nucleases (ZFN) and transcription 
activator-like effector nucleases (TALEN), CRISPR/Cas9 is the best studied system to edit 
the genome of mammalian cells 377. Although first attempts of genome editing were already 
performed in the eighties 378,379, the first stable approach for modulating human cells was 
presented by Jinek and colleagues just recently 380. They exploited a part of the bacterial 
and archaeal adaptive immune system which protects the aforementioned against phage-
derived genomes or plasmids 381,382. In the simplest model derived from S.pyrogenes only 
three basic components, an endonuclease and two RNAs, are necessary to readily delete or 
insert regions of interest. The two guide sequences (Table 3) necessary for the targeting of 
exon 2 of SDF4 were designed using the CRISPR/Cas9 design tool at www.genome-
engineering.org/crispr 383. The guides were cloned into a mammalian expression vector 
(pX459) bearing the Cas9 coding sequence, the sequences encoding the RNA components 
and a puromycin selection cassette (Addgene plasmid 48139;384). The Cas9 endonuclease 
used here belongs to the serine subfamily and contains the two active centers, HNH and 
RuvC, which cleaves the complementary or non-complementary DNA strand, respectively, 
thereby inducing a double strand break 380,385. This double strand break can be repaired by 
non-homologous end joining (NHEJ) or by homology directed repair (HDR) (Figure 17). 
HeLa parental cells were transfected with TransIT HeLaMONSTER reagent as described 
above and selected in puromycin (2 µg/ml) for 48 h. Subsequently, single clones were 
isolated (see above), expanded and analyzed by western blotting, immunofluorescence 
microscopy and sequencing (see corresponding paragraphs). For sequencing, genomic 
DNA was isolated by GenElute Mammalian Genomic DNA Miniprep Kit according to 
manufacturer’s protocol (Sigma-Aldrich, Munich, Germany). Screening primers were 
designed using the Primer-BLAST tool provided by the NCBI homepage 
(www.ncbi.hlm.nih.gov).  
 
sgRNA 1 top oligo 5’ TTG ATG AGG ACG CGG AGC CG 3’ 
sgRNA 1 bottom oligo 5’ CGG CTC CGC GTC CTC ATC AA 3’ 
sgRNA 2 top oligo 5’ TTC ACC CCG TTC AGG TGG TC 3’ 
sgRNA 2 bottom oligo 5’ GAC CAC CTG AAC GGG GTG AA 3’ 
SDF4 screening primer fwd 5’ CCG GAG AAA ACA AAT GCC ACG TGT GGT 
CCA GAG AAA AC 3’ 
SDF4 screening primer rev 5’ CAC AGA GGC AGC AAG AGG GTC TCG GGA 
C 3’ 
sgRNA 1 off target screening primer fwd 5’ TGC CCT ACC AGC ACC GGA TGG A 3’ 
sgRNA 1 off target screening primer rev 5’ ACG CGG GCA CTG AGC CCA TTC 3’ 
Table 3. Overview of DNA primers for generation of SDF4 KO cell line including sgRNA oligo nucleotides 
and screening primers for sequence verification for on and off targets.  
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5.2.8 Generation of CRISPR/Cas9 MIN-tagged cell line 
For integration of the MIN tag, a guide and a donor sequence were designed by the MIN-
tag targeting guide (human.bio.lmu.de/_webtools/MINtool/MIN_guide.html). The guide 
sequence (Table 4) was cloned into the mammalian expression vector (pX459) encoding 
the guide mRNAs and the Cas9-eGFP fusion protein with an additional hGEM peptide to 
control protein expression during cell cycle 386. Cells were transfected by PEI reagent with 
2 µg pX459 vector and 2 µg donor DNA. The 200 bp donor DNA was purchased as 
Ultramer DNA Oligonucleotides from Integrated DNA Technologies (IDT, USA). After 
FACS sorting of eGFP positive cells, cells were seeded for single clone isolation. Isolated 
colonies were screened by PCR as described in the protocol by Mulholland and colleagues 
386.  
 
sgRNA 3 top oligo 5’ GTT GGC TAC TCT CTC TCG AG 3’ 
sgRNA 3 bottom oligo 5’ CTC GAG AGA GAG TAG CCA AC 3’ 
MIN screening primer fwd 5’ GGA TTG GAT TGG AGC CAG GA 3’ 
MIN screening primer rev 5’ CAC ATG GCG GCA CCT ACT T 3’ 
MIN donor peptide  5’ GTG GGG TCC CCT CAT TGG CCT GGC TCC GTG CTG CCT 
CTG GCT CCT GGG GGC AGT CCT TCT GAT GGA CGC GTC 
TGC AGG TTT GTC TGG TCA ACC ACC GCG GTC TCA GTG 
GTG TAC GGT ACA AAC CCG GCC TGC CAA CCA CTC GTC CAC 
TCG AGA GAG AGT AGC CAA CAG GGA GGA ATG AGA TCC 
TGC CCC CAG ACC ACC 3’ 
Table 4: Overview of DNA primers for generation of SDF4 MIN tag cell line including sgRNA oligo 
nucleotides, screening primers and donor construct.  
5.3 Biochemical methods  
5.3.1 Sample preparation for SDS Page analysis and western blotting 
For cell lysate preparation cells were washed three times in DPBS, incubated for 20 min in 
1 % TritonX-100 in DPBS on ice and finally scratched off the cell culture dish with cell 
scrapers (Sarstedt, Newton, USA). To remove cell debris lysates were centrifuged 20 min at 
13200 rpm at 4 °C and transferred to a new tube. Required protein amounts were 
normalized by relative Bradford assay using Quick Start Bradford 1x Dye Reagent (Bio-
Rad, Germany) and a SunriseTM absorbance reader (Tecan, Männedorf, Switzerland). 
Samples of supernatants and lysates were finally incubated with 1 x loading dye for 5 min 
at 95 °C before application on SDS Page.  
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5.3.2 Western blot analysis 
For western blot analysis samples were applied on either 12 % self-made SDS Pages for 
90 min at 130 V or on 1 mm NuPAGEâ Novex 4-12 % Bis-Tris protein gels (Invitrogen, 
Waltham, USA) for 45 min at 200 V. Therefore, SDS running buffer or NuPageâ MES 
SDS Running Buffer (Invitrogen, Waltham, USA) were used, respectively. Gels were 
subsequently blotted either by Mini-PROTEAN Tetra cell electrophoresis chamber with 
Transfer buffer for 70 min at 100 V onto membrane or by iBlotâ Dry Blotting system with 
corresponding iBlotâ Gel Transfer stacks for 8 min in program P0 (Invitrogen, Waltham, 
USA). After analysis of membranes by Ponceau S (AppliChem, Darmstadt, Germany) 
solution and blocking of membrane in 5 % BSA in TBS for at least 1 h, first antibodies 
diluted in 5 % BSA in TBS were incubated for 1 h at RT or o.n. at 4 °C (dilutions for 
primary antibodies are listed in Table 5). After washing in TBS buffer supplemented with 
0.1 % Tween-20 several times, secondary HRP-coupled antibodies (Santa Cruz 
Biotechnology, Dallas, USA) diluted 1:10000 in 5 % BSA in TBS were incubated for 1-2 h 
at RT. For detection Immobilon Western HRP Substrate (Merck Millipore, Darmstadt, 
Germany) and a ChemiDocTM Touch Western Blot Imaging System (Biorad, Hercules, 
USA) was used.  
 
Antibody Dilution Company Product ID 
a-actin 1:2000 Sigma-Aldrich A5441 
a-Cab45 1:2000 Self-made Crevenna et al., 2016 387 
a-COMP 1:1000 Abcam Ab74524 
a-Flag 1:500 Sigma-Aldrich F3165 
a-HA 1:1000 Roche 11867423001 
a-TGN46 1:1000 AbD Serotec AHP500G 
a-mouse-HRP 1:10000 Santa Cruz Sc-2314 
a-sheep-HRP 1:10000 Santa Cruz Sc-2473 
a-rabbit-HRP 1:10000 Santa Cruz Sc-2004 
a-rat-HRP 1:10000 Santa Cruz Sc-2303 
Table 5: Overview of antibodies used for western blotting with the corresponding dilutions.  
5.3.3 Protein expression and purification  
Recombinant His-SUMO-tagged Cab45 proteins were expressed in SF9 insect cells by a 
pI-secSUMOstar based plasmid system by the MPIB Biochemical Service Facility. Proteins 
were then purified from cell supernatants using nickel-affinity chromatography with 
cOmplete His-tag Purification Resin (Roche, Penzberg, Germany) and His Binding Buffer. 
After washing of column in the same buffer, protein was eluted in His Elution buffer and 
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proteins were dialyzed in GeBAflex tubes 3.5 kDa (Scienova, Jena, Germany) against 
Cab45 buffer for storage at -80 °C. For visual analysis of the purification steps, samples 
were analyzed on SDS Page as described for western blotting (section 5.3.2). Subsequently, 
SDS Pages were stained in Coomassie solution for 30 min and destained in Destain 
Solution until proper visualization was possible. 
5.3.4 Protein fluorescence labeling  
Recombinant Cab45 was labeled with NHS-ATTO488 (Sigma Aldrich, Munich, 
Germany) or NHS-Cy5 dye (GE Healthcare, Little Chalfont, UK) according to the 
protocol of the manufacturer. The protein was first concentrated in Amicon Ultra 
Centrifugal Filters (MWCO 10000; Millipore, USA) to a concentration of 2 mg/ml and 
rebuffered in Zeba Spin Desalting Columns (Thermo Fisher Scientific, USA) to Solution 
C. Subsequently, the protein was incubated with a 3 x access of NHS-dye ester for 25 min 
at RT in the dark while shaking gently. Unbound dye was then removed by gel filtration of 
the protein in DextraSEC PRO2 columns (AppliChem, Darmstadt, Germany) with 
Solution A. Using again Amicon Ultra Centrifugal Filters (MWCO 10000; Millipore, 
USA), residual unbound dye was removed and Cab45 was rebuffered and concentrated to 
Solution A. After determination of labeling efficiency proteins were snap frozen and stored 
at – 80 °C. NHS-Cy5 labeling for Cathepsin D (Creative Biomart, Shirley, USA) was 
conducted accordingly.  
 
Recombinant COMP was labeled with maleimide Alexa Fluor 647 dye (Thermo Fisher 
Scientific, USA). COMP was first concentrated in Amicon Ultra Centrifugal Filters 
(MWCO 10000; Millipore, USA) to a concentration of 1.5 mg/ml. After addition of 10 x 
DTT and 2 x Alexa Fluor 647 protein was stirred o.n. at 4 °C. On the next day, unbound 
dye was removed by DextraSEC PRO2 columns (AppliChem, Darmstadt, Germany) and 
Illustra AutoSeq G50 Dye Terminator Removal Kit (GE Healthcare, Little Chalfont, UK) 
using Solution A. After determination of labeling efficiency proteins were snap frozen and 
stored at – 80 °C. 
5.3.5 NativePage analysis  
Golgi membranes extracted from HeLa cells (detailed protocol see section 5.5.1) were 
diluted in Breaking buffer (BB) and pelleted by centrifugation at 100,000 x g for 1 h. The 
pellet was resuspended in 50 µl BB and incubated with DMSO or BAPTA-AM (25 µM) for 
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15 min at 37 °C. Membranes were subsequently lysed in NativePAGE sample buffer 
(ThermoFisher Scientific, Waltham, USA) supplemented with 1 % DDM for 15 min and 
centrifuged at 20,000 g for 30 min at 4 °C. The same protocol was followed for 
membranes extracted from the cell lines Cab45 KO, Cab45 KO rescued with Cab45 and 
Cab45 KO rescued with 6EQ. Supernatants were aliquoted into microcentrifuge tubes and 
stored at -80 °C. Recombinant His-Sumo-tagged Cab45 was either left untreated or 
incubated with 1 mM calcium or 1 mM calcium/1 mM EGTA for 15 minutes on ice prior 
to electrophoresis.  
Golgi membranes or recombinant Cab45 were supplemented with 5 % G-250 sample 
additive (ThermoFisher Scientific, Waltham, USA) and loaded on a NativePAGE™ Novex 
Bis-Tris Gel (3 – 12 %) (ThermoFisher Scientific, Waltham, USA). Gels were then either 
stained by Coomassie brilliant blue (section 5.3.3), or transferred onto PDVF membranes. 
After transfer of the proteins onto a PDVF membrane for 90 min, the membrane was 
immersed in 6 % acetic acid for 15 min, then air-dried and washed with 100 % methanol. 
Finally, membranes were blocked with 4 % BSA in TBS for 30 min and subsequently 
treated as for western blotting as described above (section 5.3.2).  
5.3.6 In vitro IPs with recombinant full-length proteins 
Recombinant His-SUMO-tagged Cab45 was incubated with Protino NiNTA beads 
(Macherey-Nagel; Düren, Germany) in PIPES Buffer and 1 mM calcium o.n. at 4 °C. 
After washing beads three times with PBS by centrifugation, purified LyzC (NANOCS, 
New York, USA), COMP or CathD (both Creative Biomart, Shirley, USA) was added and 
incubated for 1 h at 4 °C on turning wheel. After again washing three times with PBS, 
soluble fraction was removed and beads were boiled in 1 x loading dye and applied on 
SDS Page, as described above for western blotting (section 5.3.2). Subsequently, SDS Pages 
were stained in Coomassie solution for 30 min and destained in Destain Solution until 
proper visualization was possible.  
5.3.7 In vitro IPs with peptides 
Biotin-labeled, freeze-dried peptides (produced by MPIB Biochemical Service facility; 
Table 6) were weight and dissolved in PIPES Buffer to a final concentration of 1 mM and 
solubilized o.n. at 4 °C in rotating wheel.  
On the next day, Dynabeads MyOne Steptavidin C1 beads (20 µl per condition; Thermo 
Fisher Scientific, Waltham, USA) were added and incubated for 6 h as before. After 
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washing of beads three times in PIPES Buffer by a DynaMag Spin (Thermo Fisher 
Scientific, Waltham, USA), 350 µl cell lysate per condition (equates a 90 % confluent 10 
cm culture dish; lysates were prepared as described in section 5.3.1) of HeLa cells stably 
overexpressing Cab45 wt was added and incubated o.n. at 4 °C in turning wheel. 
 
Name Sequence MW (in Da; incl. biotin label and 
GS linker) 
MGP1 ERYAMVYGYN 1633.702 
COMP1 DDYAGFIFGYQ 1663.698 
RCN1 DDYAGFVFGYQ 1649.682 
scr MGP1 AYMRVNGYYE 1633.702 
scr COMP1 GAYIQFFGDYD 1663.698 
scr RCN1 FFDVAYGYDGQ 1649.682 
MGP1-1 ERAAMVAGAN 1357.621 
MGP1-2 AAAAMVYGYN 1398.604 
MGP1-3 ERYAMVAGAA 1406.642 
MGP1-4 ERYAAAAGAN 1361.613 
MGP1-5 ERYAMVAGAN 1305.594 
MGP1-6 ERYAMVFGFN 1457.657 
MGP1-7 ERYAMVEGEN 1421.605 
MGP1-8 ERYAMVYGAN 1397.620 
MGP1-9 ERYAMVAGYN 1397.620 
MGP1-10 ERpYAMVYGYN 1713.666 
MGP1-11 ERYAMVpYGYN 1713.666 
MGP1-12 ERYAMVYGpYN 1713.666 
MGP1-13 ERpYAMVpYGpYN 1873.599 
Neg. ctrl.  GSGSGSGSGSG 1107.424 
Table 6: Overview of peptides used for in vitro peptide IPs to study the interaction of cargo proteins with 
Cab45. Peptides were produced by the MPIB Biochemical service facility. All peptides contained a GS-linker 
at the N-terminus, a biotin modification and were protected at the C-terminus. Molecular weights were 
determined by mass spectrometry. Mutated aa residues were highlighted in red.  
 
Before boiling of beads in 70 µl 1 x loading dye for 5 min at 95 °C, beads were again 
washed three times with PIPES Buffer. Subsequently, samples were applied on SDS Page 
and analyzed by western blotting with a–HA antibody as described in section 5.3.2. 
5.4 Cell biological method  
5.4.1 Sample preparation for analysis of overexpressed Cab45 in HeLa cells 
To analyze secretion of cells, cells were seeded and cultured until 80-90 % confluence. 
Then cells were washed in PBS or DMEM medium five times and incubated in 500 µl (6 
well culture dish) or 5 ml (10 cm culture dish) for 4 h under normal culture conditions. 
Supernatants were subsequently collected and if necessary concentrated in Amicon Ultra 
Centrifugal Filters (MWCO 10000; Millipore, USA) to required amounts. Lysates were 
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prepared as described in section 5.3.1. Supernatants and lysates were adjusted by Bradford 
assay and analyzed by western blotting.  
5.4.2 Cargo secretion assays  
HeLa control cells and Cab45 knock-out cells or cells stably expressing Cab45 wild type or 
Cab45 6EQ, respectively, were transfected with Flag-LyzC. Cells were washed five times 
with serum-free medium and then grown in serum-free medium for 4 h. Cells were then 
counted and lysed in PBS supplemented with 1 % CHAPS. Media from each cell line were 
collected, clarified by passage through a 0.45 µm filter (Millipore, Darmstadt, Germany) 
and centrifuged at 5,000 × g for 15 min. Samples were then concentrated using Amicon 
Ultra Centrifugal Filters (MWCO 3000; Millipore, Darmstadt, Germany). Cell lysates and 
concentrated media were subsequently analyzed by western blotting using and anti-COMP 
antibody or anti-Flag antibody (to detect LyzC) as described above (section 5.3.2).  
 
5.4.3 Proliferation assays 
For comparative analysis of cell growth cell lines of interest were seeded (20 000 cells / 12 
well) in triplets and cell numbers were counted by Countess II (Thermo Fisher Scientific, 
Waltham, USA) on four consecutive days. For technical replicates, Countess II chambers 
were measured three times each. Experiment was performed three times. Data was 
visualized by Prism software and illustrated as interleaved scatter blot of mean with SEM.  
5.5 Physical methods and bioinformatics methods 
5.5.1 Isolation of Golgi membranes for NativePage analysis and mass 
spectrometry 
HeLa cells stably expressing Cab45 wild type or Cab45 6EQ mutant (for NativePage 
analysis; 5 15 cm dishes per condition) and or HeLa S3 cells stably expressing Fam20C or 
Fam20C-KD (for mass spec analysis; 4 l roller culture per condition) were harvested and 
pelleted. Pellets were then washed once in Breaking Buffer (BB), diluted 1:5 in BB 
supplemented with cOmplete Tablets Mini EDTA-free (Roche, Basel, Switzerland) and 
homogenized with an EMBL cell cracker (ball size 8.002 mm; 9 µm gap). After addition of 
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1 mM EDTA, the sucrose concentration of the homogenate was adjusted to 37 % (w/v) 
and overlayed with 35 % and 29 % sucrose in 10 mM Tris (pH 7.4). Cellular components 
were separated by ultracentrifugation for 3 h at 133,000 g. The Golgi membrane fraction 
was extracted, adjusted to BB conditions and snap-frozen in liquid nitrogen for storage at -
80 °C.  
5.5.2 Mass spectrometry for phosphoproteomic analysis 
Golgi fractions of HeLa S3 suspension cells stably overexpressing Fam20C or the kinase-
dead mutant Fam20C-KD were isolated as described in section 5.5.1. All samples were 
lysed in MS lysis buffer, boiled and sonicated, and precipitated o.n. using ice-cold acetone 
(v/v = 80 %). After centrifugation (4000 g) the pellet was washed at least twice with 80 % 
ice-cold acetone before air drying and resuspension (sonication) in TFE buffer. Proteins 
were digested using LyzC and trypsin (1:100), over-night at 37 °C and phosphopeptides 
enriched as described previously 388.Samples were prepared in triplets.  
For LC-MS/MS sample preparation peptides were purified using in-house prepared stage 
tips 389 Empore™ SPE disks SDB-RPS (Sigma-Aldrich, St. Louis, USA) before LC-
MS/MS analysis as described previously 390. Briefly, stage tips were prepared by inserting 
two layers of SDB-RPS matrix into a 200 µl pipette tip using an in-house prepared syringe 
device. Stage-tips were first activated with 100 µl MS buffer C and then washed with 100 µl 
MS buffer D before loading of the acidified peptides (1 % trifluoroacetic acid v/v). After 
centrifugation, the stage-tips were washed three times (200 µl each) with MS buffer D. 
Elution was performed using 60 µl MS buffer E. Eluates were collected in 200 µl PCR 
tubes and dried using a Concentrator plus SpeedVac centrifuge (Eppendorf, Hamburg, 
Germany) at 60 ⁰C. Peptides were resuspended in MS buffer F and briefly sonicated 
(Branson Ultrasonics, Danbury, USA) before LC/MS-MS analysis.  
For LC-MS/MS measurements peptides were loaded on a 20 or 50 cm reversed phase 
column (75 µm inner diameter, packed in-house with ReproSil-Pur C18-AQ 1.9 µm resin 
(Dr. Maisch, Ammerbruch, Germany). Column temperature was maintained at 55 °C 
using a homemade column oven. An EASY-nLC 1200 system (Thermo Fisher Scientific, 
Waltham, USA) was directly coupled online with the mass spectrometer (Q Exactive) via a 
nano-electrospray source, and peptides were separated with a binary buffer system of MS 
buffer A and MS buffer G, at a flow rate of 250 or 350 nl/min. Peptides were eluted with a 
nonlinear 270-minute gradient of 5–60 % MS buffer G. After each gradient, the column 
was washed with 95 % MS buffer G for 5 min. The mass spectrometer was programmed to 
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acquire in a data-dependent mode (Top10) using a fixed ion injection time strategy. Full 
scans were acquired in the Orbitrap mass analyzer with resolution 60,000 at 200 m/z (3E6 
ions were accumulated with a maximum injection time of 25 ms). The top intense ions (N 
for TopN) with charge states ≥2 were sequentially isolated to a target value of 1E5 
(maximum injection time of 120 ms, 20% underfill), fragmented by HCD (NCE 25, Q 
Exactive) and detected in the Orbitrap (Q Exactive, R= 15,000 at m/z 200). 
Raw mass spectrometry data were processed using MaxQuant version 1.5.3.15 391 with an 
FDR < 0.01 at the level of proteins, peptides and modifications. Searches were performed 
against the Mouse or Human UniProt FASTA database (September 2015). Enzyme 
specificity was set to trypsin. The search included cysteine carbamidomethylation as a fixed 
modification and N-acetylation of protein, oxidation of methionine, and/or 
phosphorylation of Ser, Thr, Tyr residue (PhosphoSTY) as variable modifications. Up to 
two missed cleavages were allowed for protease digestion. ‘Match between runs’ was 
enabled, with a matching time window of 0.5-0.7 min. Bioinformatic analyses were 
performed with Perseus (www.perseus-framework.org) and Microsoft Excel and data 
visualized using Graph Prism (GraphPad Software Inc., La Jolla, USA) or Perseus 392. 
Significance was assessed using one sample t-test, two-sample student’s t-test and ANOVA 
analysis, for which replicates were grouped, and statistical tests performed with 
permutation-based FDR correction for multiple hypothesis testing. Were indicated, missing 
data points were replaced by data imputation after filtering for valid values (all valid values 
in at least one experimental group). Error bars are mean ± SEM or mean ± SD. 
5.5.3 Mass spectrometric screen for comparison of secretomes 
For sample preparation 9 15 cm dishes of HeLa wt cells or Cab45 CRISPR/Cas9 KO cells 
were seeded and cultured until 90 % density. Cells were washed five times in DMEM 
without serum and incubated for 4 h in 7.5 ml of the same medium under normal culture 
conditions. Subsequently, SN was collected and concentrated in Amicon Pro Ultra 
Centrifugal Filters (MWCO 3500; Millipore, USA) to a final volume of 200 µl. The 
samples were then washed three times on the filter with 500 µl Urea buffer by centrifuging 
at 10000 g at RT. The samples were incubated with 500 µl Urea buffer containing 50 mM 
chloroacetamide at RT for 60 minutes. Following reduction and alkylation of proteins the 
sample was further treated three times with 50 mM ammonium bicarbonate solution. To 
this sample 1 µg of trypsin (Promega V5111, Madison, USA) was added and digested o.n. 
at 37 °C. Peptides after o.n. digestion were collected from the filter by inverting the filter 
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with additional rinse of the filter with 200 µl of ammonium bicarbonate solution in order to 
recover the maximum peptides possible from the filter surface. The collected peptides were 
then purified via C18 StageTips 393. Triplets of samples were prepared and analyzed in the 
following setup.  
Peptides were loaded on to a C18 column (15 cm long inner diameter of 75 µm packed 
with 1.9 µm Reprosil beads from Dr Maisch, Ammerbruch, Germany) via the autosampler 
of the LC system (Thermo Easy nLC 1200, Thermo Scientific, Waltham, USA). Peptides 
were eluted over a 120 min gradient using MS buffer A and B and directly sprayed into 
bench top Orbitrap mass spectrometer (Q Exactive HF, Thermo Scientific, Waltham, 
USA). The column was maintained at a constant temperature of 50 °C for reproducible 
retention times and better resolution of separation. The mass spectrometer was operated in 
data dependent mode with survey scans acquired at 60.000 resolution after accumulating 
up to 3E6 charges in the C-trap. Up to 15 peptides like features were selected for 
fragmentation by HCD and fragmentation scans were acquired at 15.000 resolution (at 
m/z = 200). In order to minimize futile repeat sequencing dynamic exclusion was enabled 
and precursors selected for fragmentation were excluded for 30s 394.  
The raw data were processed using MaxQuant computational platform version 1.5.2.2 391. 
Peak lists generated were searched using Andromeda search engine against human Uniprot 
reference proteome sequence 395. Initial precursor and fragment tolerance were set to 4.5 
and 20 ppm, respectively. Carbamidomethylation of cysteine was set as fixed modification 
together with methionine oxidation and N-terminal protein acetylation as variable 
modification. Match between the runs feature in MaxQuant was enabled and protein 
quantification was performed using the MaxLFQ algorithm inbuilt in the software 396. 
Initial bioinformatics and statistical analysis were performed using Perseus software 392.  
5.5.4 Peptide identification 
Proteins with at least 50 % change in secretion extracted by mass spectrometric screen of 
the proteome comparing HeLa wt cells and Cab45 KO cells were given to the group of 
Bianca Habermann (former MPI of Biochemistry Munich, now IBDM Marseille) for 
analysis. Based on this protein list, a putative Cab45 interaction model was extracted by a 
Hidden Markov Model comparison published in Prytuliak et al., 2017 397.  
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5.5.5 Structural model of Cab45 
The structural model of Cab45 was assembled by the collaborating group of Bianca 
Habermann (former MPI of Biochemistry Munich, now IBDM Marseille). The methods 
applied in this case were published in Crevenna et al., 2016 387.  
5.5.6 Circular dichroism spectroscopy (CD) 
CD measurements were performed in a 1-mm (path length) cuvette at 10 °C on a JASCO 
J-715 spectrometer. Protein samples (0.2 mg/ml) were dissolved in CD buffer, and the 
indicated amounts of calcium were added before spectra were recorded. An average of 10 
(± calcium analysis) or 4 (titration assay) independent spectra (from 195 to 250 nm with 0.1 
nm spacing) were documented. Data was normalized to molecular elipticity of protein and 
FFT filter was applied. CONTIN analysis was done using CDPro. CONTIN decomposes 
the CD signal into 6 secondary structure elements: regular alpha-helical, distorted alpha-
helical, regular beta sheet, distorted beta sheet, turn and unordered. Reported values for 
the alpha-helical and beta sheet content were the sum of regular and distorted fractions for 
each secondary element.  
5.6 Microscopy methods 
5.6.1 Immunofluorescence (IF) analysis 
For immunofluorescence stainings, cells were cultured on 1.5 mm Menzel glass slides 
(12 mm diameter; Thermo Fisher Scientific, Waltham, USA), fixed for 10 min at RT in 
4 % paraformaldehyde in PBS, washed with PBS and subsequently permeabilized for 
5 min in permeabilization solution. After washing again in PBS and blocking of slides for at 
least 1 h in 4 % BSA in PBS, cells were incubated with primary antibodies for at least 1 h 
at RT or o.n. at 4 °C. After washing several times in PBS the secondary antibody (all 
diluted 1:500 Invitrogen, Waltham, USA) was subsequently incubated for 1 h at RT, 
before washing and mounting the glass slides with Prolong Gold Antifade reagent onto 
SuperFrost Microscope slides (90 °C ground edges; 1 mm) (both Thermo Fisher Scientific, 
Waltham, USA). DAPI (Sigma-Aldrich, Munich, Germany) was always used 1:6000 and 
incubated together with the secondary antibody. Dried samples were imaged on a ZEISS 
confocal laser-scanning LSM 780 microscope equipped with 40x (NA 1.4 oil) or 100x 
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(NA 1.46 oil) Plan-Apochromat objectives (ZEISS, Oberkochen, Germany). Pictures were 
acquired using ZEN 2010 software and processed in ImageJ.  
 
Antibody Dilution Company Product ID 
a-Cab45 1:300 Self-made Crevenna et al., 2016 387 
a-Calnexin 1:300 BD BioSciences 610523 
a-GM130 1:300 BD BioSciences 610822 
a-HA 1:250 Roche 11867423001 
a-p230 1:300 BD BioSciences 611281 
Table 7: Overview of antibodies used for immunofluorescence stainings with the corresponding dilutions. All 
secondary fluorescently labeled antibodies were diluted 1:500 and purchased from Invitrogen (Waltham, 
USA).  
For improved visualization images were processed in ImageJ, background of all pictures 
was subtracted and contrast enhanced. If necessary, contrast was manually adjusted by 
enhance contrast function.  
5.6.2 Quantifications of vesicular structures in calcium-binding deficient 
mutants 
For quantification, images of HeLa Cab45 KO cells stably expressing Cab45 wt, Cab45 
6EQ, Cab45 EFh1, Cab45 EFh2 or Cab45 EFh3 were acquired with 40x oil objective as 
described above (section 5.6.1).  
For data analysis in ImageJ, the background was automatically subtracted and the contrast 
enhanced. Median filter was applied and the picture transformed into an 8-bit image. 
Suitable cells were manually selected by drawing a region of interest. Threshold was set 
automatically, and binary image (generated by thresholding) was analyzed by “analyze 
particle function” for chosen regions of interest. Thereby, only particles of the size of 4 to 
20 pixels were included in the analysis. Data was visualized by Prism Software.  
5.6.3 Retention using selective hooks (RUSH) 
For tracking of MGP wt or its 3A mutant along the secretory pathway, HeLa wt or HeLa 
CRISPR/Cas9 Cab45 KO cells were seeded on glass slides. Cells were transfected by PEI 
reagent as described above with pIRES constructs (section 5.2.3 and Table 1) and cultured 
for 24 h. On the next day, cells were washed twice with DPBS and incubated for indicated 
periods (0 min, 20 min or 40 min) in 100 µM biotin in growth medium. Subsequently, cells 
were immediately washed twice, fixed, permeablized and stained with a-p230 antibody as 
described above. Z-stacks were acquired with LSM780 as indicated previously (section 
5.6.1) with a constant distance of 0.35 µm between layers.  
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For data analysis in ImageJ, the background was automatically subtracted and the contrast 
enhanced. After maximum intensity projection of the Z-stacks, Median Filter was applied 
and the picture transformed into an 8-bit image. Suitable cells were manually selected by 
drawing a region of interest. For thresholding, the algorithms yen or otsu were used and 
controlled, and if necessary adjusted, by hand. The binary image (generated by 
thresholding) was analyzed by “analyze particle function” for chosen regions of interest. 
Thereby, only particles of the size of 4 to 20 pixels were included in the analysis.  
For statistical evaluation, the two highest and two lowest values were eliminated for each 
cell line and time point and a non-parametrical test (Kolmogorov-Smirnov-Test) was 
performed by Prism software.  
5.6.4 Oligomerization assays 
For oligomerization assays all proteins were thawed on ice and centrifuged 15 min at 
13200 rpm at 4 °C to remove aggregates. Protein concentrations were adjusted to 2.5 µM 
in PBS pH 7.4. For measurements proteins were diluted 1:100 in a total volume of 100 µl 
in PBS pH 7.4 and analyzed in Lab-Tek 8 Chamber #1.0 borosilicate coverglass system 
(Nunc, Rochester, USA) with a LSM780 confocal microscope as described above (section 
5.6.1) under the indicated conditions. Proteins used in this assay were either selfmade 
(section 5.3.3) or purchased (compare section 5.3.6). LyzC-Cy5 protein was purchased 
from Nanocs (New York, USA) and Cathepsin D (Creative Biomart, Shirley, USA).  
5.6.5 Fluorescence recovery after photobleaching (FRAP) 
Fluorescence recovery after photobleaching (FRAP) experiments of recombinant 
fluorescently labeled proteins were conducted on a spinning-disk confocal microscope 
system (Revolution system; Andor Technology, Belfast, UK) consisting of a Nikon base 
(TE2000E; Nikon, Tokyo, Japan) and a spinning-disk unit (CSU10; Yokogawa) with a 
Nikon 100× oil immersion objective (NA 1.49) at 20 °C. The detection path was equipped 
with an Optosplit II (Cairn Research Ltd., Faversham, UK) for dual-color detection, a 
filter set for enhanced green fluorescent protein (eGFP) and Cy5 (BS562, HC525/50, and 
ET605/70; AHF Analysentechnik AG), and a DU-897 Ixon EMCCD camera (Andor 
Technology). In addition, a triple-band dichroic beam splitter was used to separate laser 
excitation from fluorescence emission (Di01-T405/488/568/647; Semrock, Rochester, 
NY). The excitation was controlled with a tunable acousto-optic filter (Gooch & Housego, 
Ilminster, UK). FRAP experiment were done by first acquiring 5 frames, then applying a 
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bleaching pulse for 5 s and finally acquiring 300 frames. The chosen time interval between 
consecutive frames was 2 s. Proteins used for this experiment were unlabeled Cab45 wild 
type (5.3.3), Alexa647 labeled COMP (5.3.4) and LyzC-Cy5 purchased from Nanocs (New 
York, USA).  
5.6.6 Three-dimensional structured illumination (3D-SIM) microscopy 
For Super-resolution imaging, cells were seeded and treated as described above in section 
5.6.1. Three-dimensional structured illumination microscopy was performed with a 
DeltaVision OMX v3 (GE, Fairfield, USA) equipped with a 100x/1.40 NA PlanApo oil 
immersion objective (Olympus, Center Valley, USA), Cascade II:512 EMCCD cameras 
(Photometrics, Tucson, USA) and 405, 488 and 593 nm diode lasers. Samples were 
illuminated with coherent scrambled laser light directed through a movable optical grating. 
Image stacks with 15 images per plane (5 phases, 3 angles) and a z-distance of 125 nm were 
acquired and subjected to a computational reconstruction (softWoRX, Applied Precision, 
Bratislava, Slovakia). 
 
3D SIM raw data were first reconstructed with the GE software softWoRx 6.0 Beta 19 
(unreleased) and corrected for color shifts. A custom-made macro in Fiji was used to 
establish composite TIFF stacks that are subsequently loaded as RGB into the volocity 
calculation software (Volocity 6.1.2 (Perkin Elmer, Waltham, USA). Structures were 
obtained, segmented and measured in all channels by using the threshold commands 
“threshold using intensity” and “exclude objects by size”. Reconstruction artifacts and 
background were also removed. Colocalizing structures were recognized by the “intersect 
and compartmentalize” command, and quantified according to volume and number. 
Several small volumes belonging to one compartment were combined. Cab45 was set as 
100 %. Overlapping volumes were used to calculate the degree of overlap in %. Finally, a 
histogram was calculated using 10 % bins.  
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5.7 Buffers 
Breaking Buffer (BB) 10 mM Tris pH 7.4, 250 mM sucrose 
Cab45 buffer 20 mM PIPES, pH 6.8, 500 mM NaCl, 10 % glycerol vol/vol 
CD buffer 1.3 mM PIPES pH 6.8, 33 mM NaCl and 0.7 % glycerol 
Coomassie solution 40 % v/v methanol, 10 % v/v acetic acid, 0.1 % w/v Coomassie Brilliant 
Blue R 
Destain solution 40 % v/v methanol, 10 % v/v acetic acid 
DNA loading dye 3 % glycerol, 0.15 % OrangeG 
FACS buffer 3 % BSA in PBS 
Freezing medium 90 % FBS, 10 % DMSO 
LB growth medium 1 % w/v Trypsin-Peptone, 1 % w/v NaCl, 0.5 % w/v yeast extract 
Loading dye for SDS Pages 200 µM Tris pH 6.8, 4 µM EDTA, 84.5 % glycerol, 8 % SDS, 4 % b-
mercaptoethanol, 0.05 % bromophenol blue 
His Binding Buffer 50 mM NaP, pH 8.0, 500 mM NaCl. 
His Elution Buffer  50 mM NaP, pH 8.0, 500 mM NaCl, 250 mM imidazole 
MS buffer A 0.1 % formic acid 
MS buffer B 0.1% formic acid and 80% acetonitrile 
MS buffer C 30 % methanol, 1 % trifluoroacetic acid  
MS buffer D 2 % acetonitrile, 0.2 % trifluoroacetic acid 
MS buffer E 60 % acetonitrile, 1.25 % ammonium hydroxide 
MS buffer F 2 % acetonitrile, 0.1 % trifluoroacetic acid 
MS buffer G 80 % acetonitrile, 0.1 % formic acid 
MS lysis buffer  10 mM Tris pH 7.5, 4 % SDS, 10 mM DTT 
PBS 10 mM Na2HPO4, 1.7 mM NH2PO4 pH 7.4; 2.6 mM KCl, 137 mM NaCl 
PEI solution  1.25 mg/ml PEI in sterile water; pH 7.4 
Permeabliization solution 0.2 % TritonX-100 and 0.5 % SDS in 4 % BSA in PBS 
PIPES buffer  20 mM PIPES, pH 6.8, 500 mM NaCl 
Running buffer 25 mM Tris pH 7.4, 190 mM glycine, 0.1 % SDS 
Separating gel (12 %) 375 mM Tris pH 8.8, 12 % v/v acrylamide, 0.1 % w/v SDS, 0.01 % v/v 
APS, 0.0015 % v/v TEMED 
Stacking gel (5 %) 125 mM Tris pH 6.8, 5 % v/v acrylamide, 0.1 % SDS, 0.01 % v/v APS, 
0.001 % v/v TEMED 
Solution A PBS, pH 7.4 
Solution C PBS pH 7.4, 10 mM sodium bicarbonate  
TAE buffer  40 mM Tris, 1 mM EDTA, pH 8.3 
Transfer buffer 25 mM Tris pH 7.4, 192 mM glycine, 20 % v/v methanol 
TBS buffer 25 mM Tris pH 7.4, 150 mM NaCl 
TFE buffer 10% 2-2-2-trifluorethanol, 100 mM ammonium bicarbonate (ABC) 
Trypsinization solution  10 % Trypsin-EDTA in PBS 
TSS buffer  1 % tryptone-peptone, 0.5 % yeast extract, 100 mM NaCl, 10 % PEG 
(MW3000/3500), 5 % DMSO, 50 mM MgCl2, pH 6.5 
Urea buffer 4 M Urea, 25 mM Tris pH 8.0, 10 mM DTT 
Table 8: Summary of buffers used in this thesis. All buffers listed were prepared with Millipore water.  
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6 Results 
The first aim of this thesis was to generate and optimize certain cell biological and 
biochemical tools for analysis of the CFL1/SPCA1/Cab45 machinery in living cells and in 
vitro. Firstly, the purification process needed to be optimized, because the protein yields 
obtained by purification from E.coli cultures via GST-tag, as described before by von 
Blume and colleagues, did not provide suitable protein amounts for extensive in vitro studies 
365. Secondly, the transient overexpression of Cab45 in HeLa cells results in massive 
secretion far beyond the physiological levels, which might influence the natural 
functionality inside the Golgi lumen. Therefore, mutants controlled by the endogenous 
promoter system should be established by the clustered regularly interspaced short 
palindromic repeat (CRISPR/Cas9) technique to maintain adequate protein levels also of 
potential mutants.  
6.1 Cab45 was purified from SF9 cells in high amounts 
In order to obtain higher protein yields of Cab45 for in vitro analyses, several characteristics 
of the purification process were changed. First of all, expression was switched from a 
prokaryotic to the eukaryotic SF9 insect cell system, which provides more suitable 
environmental conditions concerning e.g. pH, salts and lipid composition, for the human 
Golgi protein. Furthermore, Cab45 was expressed as fusion protein with a cleavable His-
SUMO tag to enhance solubility and to facilitate the subsequent purification steps. In 
addition, the fact that overexpression causes secretion of Cab45 was exploited for 
purification, because less unwanted impurities are found in the supernatants and the 
protein can be isolated more easily during less purification steps than from cell lysates.  
Figure 15A illustrates the progress of one exemplary purification of wild type Cab45 from 
one liter SF9 supernatant. The purification of all mutants mentioned throughout this thesis 
was conducted accordingly. The faint band around 65 kDa in the input lane of the 
Coomassie brilliant blue stained SDS page shows that Cab45 was highly expressed in the 
insect cells and that it was the predominant protein in the supernatant. 
The flow through (FT) and the wash lane on the gel prove that the whole amount of 
protein was bound to the Ni-NTA column during the first purification step and, in 
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concordance with the western blot (Figure 15B), only a small amount of protein was lost 
during washing of the column. 
 
 
Figure 15: Successful optimization of Cab45 protein purification from SF9 cell supernatants. (A) Coomassie 
brilliant blue stained SDS page of subsequential steps of the Cab45 purification process. The input lane 
indicates that Cab45 was highly enriched in the supernatants of SF9 cells. The absence of the Cab45 band 
during column application (flow through; FT) and washing (wash) shows that all protein was bound to the Ni-
NTA column and no protein was lost during the washing steps. The final lane depicts the highly-
concentrated protein after purification. (B) Western blot analysis of the samples described in (A) proofs that 
the Coomassie signal is specific and that indeed Cab45 was purified in high amounts from insect cells.  
 
The eluted protein was subsequently concentrated and stored or used for in vitro analysis 
after buffer exchange (see lane “final”). The strong band in the final lane of the SDS page 
indicates that the protein was efficiently isolated and the western blot, detected by an anti-
Cab45 antibody, proofs that the signal observed in the Coomassie brilliant blue stain is 
specific for Cab45. These results imply that Cab45 could be successfully isolated from SF9 
cells and yields between 2 to 3 mg per liter supernatant were sufficient for further in vitro 
studies.  
6.2 Successful generation of two CRISPR/Cas9 cell lines 
The major problem during in-cell analysis of Cab45, was the high amount of aberrant 
secretion after transient expression of the protein in HeLa cells (Figure 16). As a 
consequence of high expression levels, the protein is no longer retained inside the Golgi, 
which might affect its natural function. Therefore, one aim of this thesis was to establish a 
genome editing technique to generate mutants under the control of the endogenous SDF4 
promoter. This would also pave the way to identify new cargos and other interactors by 
reducing overexpression-induced, unspecific interactions. Furthermore, a KO cell line 
Results 
 - 63 - 
would shed light on Cab45 dependent cargo sorting and secretion, and would abolish the 
need of time-consuming siRNA experiments.  
Consequently, the CRISPR/Cas9 method was applied to generate first a KO and secondly 
a cell line containing a multifunctional integrase (MIN) tag (Figure 17). Therefore, the 
Cas9 protein together with single guide RNAs (sgRNAs) was transfected into HeLa cells 
384,398. 
 
 
The combination of the endonuclease with sgRNA induces a specific double strand break 
inside the genomic region of interest, which can be repaired by healthy cells either by non-
homologous end joining (NHEJ) or by homology directed repair (HDR)380,385. During 
NHEJ, cells just re-ligate blunt ends without regard to homologies, which often results in 
deletion or insertion of a few nucleotides potentially leading to a frame shift mutation and a 
premature stop codon (Figure 17) 399. In contrast, the cell mediates HDR by employment 
of an undamaged sister chromatid or a homologous region as template 400,401. This 
pathway enables integration of a sequence of interest into the genomic locus.  
In the framework of this thesis two CRISPR/Cas9 modified HeLa cell lines were 
generated. In a first approach, we applied the NHEJ method to produce a Cab45 KO cell 
line in order to study cellular dynamics and morphology according to the protocol of Ann 
Ran and colleagues 384. Furthermore, we integrated a MIN-tag by HDR after the 
endogenous signal sequence of Cab45 to establish a genetic platform for the integration of 
Cab45 mutants for analysis of those under the control of the endogenous promoter 386. 
 
Figure 16: Transient overexpression of Cab45 results in 
secretion of the Golgi resident protein from Hela cells. Western 
blot analysis with a-Cab45 antibody of supernatants (SN) and 
cell lysates (WCL) indicate secretion of Cab45 in cells 
overexpressing the protein in contrast to HeLa wild type cells. 
WCL blot indicates similar cellular amounts of both samples. 
Characteristic double band (black arrows) of secreted Cab45 in 
the SN is due to differential glycosylation patterns as observed 
before by Lara-Lemus and colleagues 374.  
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Figure 17: Schematic depiction of CRISPR/Cas9 system. The endonuclease Cas9 (yellow) is guided to the 
SDF4 genomic locus by the sgRNA, a fusion construct of complementary crRNA (pink) and the tractRNA 
(purple). There, a double strand break is mediated 3 bp upstream of the PAM recognition sequence NGG 
(dark green). This DNA damage is subsequently repaired by the cell´s innate machinery (light green) by either 
non-homologous end joining (NHEJ; left pathway) or by homology directed repair (HDR; right pathway). 
During NHEJ the cells re-ligate the blunt ends of the DNA often causing insertions or deletions (brown) in 
this area which both can result in a frame shift mutation and a premature stop codon (red). In HDR a 200 bp 
fragment transfected together with the CRISPR/Cas9 machinery serves as homologous sequence or repair 
template. This enables insertion of the MIN tag (orange) into the SDF4 genomic locus during DNA repair 
processes. Figures were adjusted from Ran et al., 2013 384 and Crevenna et al., 2016 387.  
6.2.1 CRISPR/Cas9 KO targeting by two different sgRNAs was highly 
efficient 
Because the efficiency of different sgRNAs can differ due to accessibility of the target and 
Cas9 expression levels, we targeted the second exon of SDF4 by two different sgRNAs in 
parallel 383,402.  
 
Figure 18: Schematic depiction of CRISPR/Cas9 targeting approaches. For the generation of Cab45 KO 
Hela cell lines the second exon of the SDF4 genomic locus (black lines, Arabic numerals) were target by two 
different sgRNAs (red) after the initial ATG codon (orange) and the signal peptide encoding sequence (dark 
blue). In the same region, the sgRNA for the MIN tag integration (dark green) hybridized with the genomic 
DNA for insertion of the MIN tag just behind the signal peptide (black arrow).  
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After antibiotic selection and expansion of single cell colonies the clones were initially 
screened by western blot (Figure 19) and then verified by immunofluorescence microscopy 
(Figure 20) and sequencing (Figure 21).  
 
 
 
For western blot analysis Cab45 expression of the KO clones was compared to HeLa wild 
type cells (Figure 19). The CRISPR/Cas9 KO clones show no Cab45 band at the expected 
size of around 55 kDa, while the HeLa wild type fraction indicates a double band, i.e. 
normal expression of the protein. The actin loading control confirms equal loaded amounts 
of lysate.  
6.2.2 CRISPR/Cas9 KO cell lines show no change in Golgi morphology 
To further verify the Cab45 KO, the protein and the Golgi marker GM130 were stained 
by antibodies for analysis by immunofluorescence microscopy (Figure 20). In the wild type 
control Cab45 is localized in the Golgi region. The signal nicely colocalizes with GM130, 
while the DAPI stain indicates the correct localization of both proteins in the perinuclear 
region. In contrast, images of both KO cell lines confirm the absence of Cab45. However, 
the staining by the marker protein and DAPI indicates intact Golgi and nuclear signal also 
in the absence of Cab45.  
 
Figure 19: Western blot analysis of CRISPR/Cas9 
Cab45 KO clones. Western blot analysis of cellular 
lysates of HeLa wild type cells and CRISPR/Cas9 
Cab45 KO cell lines indicates specific Cab45 bands at 
the expected size for the control. In contrast, the cells 
treated with sgRNA1 or sgRNA2 lack the protein 
specific band, which indicates the successful KO of 
Cab45. Detection of actin levels prove comparable 
loading amounts. 
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Figure 20: Immunofluorescence analysis of Cab45 KO cell lines. Cab45 KO cell lines were analyzed with 
respect to overall cell morphology by immunofluorescence microscopy. HeLa wild type cells exhibit 
characteristical, tube-like staining pattern of the Golgi in the perinuclear region by marker protein GM130 
(red channel). In these cells, Cab45 localizes to the same area (green channel) and merged picture indicates 
high levels of co-localization of both proteins (yellow). In KO cells, GM130 distribution seems comparable to 
wild type cells, but Cab45 is no longer present at the Golgi (green channel). However, DAPI and Golgi 
marker underline normal Golgi and nuclear morphology. Scale bars represent 10 µm. 
 
6.2.3 CRISPR/Cas9 KO could also be verified on genomic level 
Finally, the introduced changes on DNA levels were analyzed by sequencing. To this end, 
genomic DNA of the KO clones was isolated and the region of interest amplified by PCR. 
The resulting PCR product was subjected to sequencing.  
As an example, the sequencing results of the KO clone of sgRNA1 are shown, as this clone 
was subsequently used throughout the whole thesis. 
Figure 21A indicates, that 8 base pairs of the original HeLa sequence were excised in the 
sgRNA1 clone due to incorrect cellular repair mechanisms after double strand break by 
Cas9. This deletion led to a frameshift, which resulted in a stop codon after 15 subsequent 
base pairs. In addition, the location of the deletion corresponds nicely to the described 
Cas9 cutting site three bp upstream of the PAM 384,398. This finding and also the 
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experiments mentioned above, support the success of the KO of Cab45 in the HeLa cell 
line.  
The majorly discussed drawback of the CRISPR/Cas9 system is the generation of so-called 
off-target effects 403,404. Off-target effects can occur by annealing and cleavage of the 
sgRNA/Cas9 complex to unintended target sites. 
 
 
Figure 21: Sequencing analysis of SDF4 KO clone. (A) Extract of sequencing result of SDF4 KO clone was 
compared to HeLa wild type genome. While points indicate accordance of the two sequences the eight 
horizontal lines signal missing bases in the SDF4 KO sequence. The observed deletion in this area matches 
either the sgRNA binding site (blue) and the predicted cutting site of Cas9 three bp upstream of the PAM 
sequence (green). This mutation leads to a frameshift and an early stop codon, which supports the findings of 
the absence of Cab45 in these KO cells described above. (B) Sequencing result of off-target region. The first 
off-target region calculated by the online tool was sequenced and compared to HeLa wild type genome. The 
black dots indicate complete homology of both sequences in the region of the unintended sgRNA binding 
(blue). Also, close to the PAM recognition sequence (green) no changes are detectable. This finding indicates 
that the Cab45 genomic locus was efficiently targeted by the used sgRNA and that changes in protein 
secretion are probably not caused by other reasons than Cab45 KO.  
 
This can happen because the short sequence of 20 bp might appear similarly more often in 
the whole genome and because certain mismatches might only decrease, but not abolish 
binding. The potential off-target sites for our guides were determined by the online tool of 
the Zhang lab available at crispr.mit.edu and evaluated by a score value which reports the 
reliability of the guide. The calculated Score of 77 was based on potential 124 off-target 
sites, whereof 43 of these sites were located in an exonic area (first three are shown in Table 
9). To study the actual impact of sgRNA1 off-targets, the first exonic target was analyzed 
by sequencing (Figure 21B).  
 
 Sequence of off-target site  Score Number of 
mismatches 
Gene name 
1. TGGCCGAGGCCGCGGAGCCG GAG 1.3 4 NM_053277 
2. ACGATGAGGACGTGGAGCCG CAG 1.2 3 NM_174911 
3. CTGAGGCCGACGCGGAGCCG GGG 0.9 4 NM_020764 
Table 9: Overview of first three sgRNA1 off-targets sites. Mismatches to original guide sequence were 
highlighted in red, seed sequence of sgRNA1 in yellow and PAM in green. Scores and gene names were 
obtained by CRISPR design tool available at crispr.mit.edu.  
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All three off-target sites share at least one mismatch in the PAM sequence (highlighted in 
green), but most of the mismatches were located outside the seed region (highlighted in 
yellow), the 10-12 bp adjacent to the PAM sequence, which is especially important for 
proper annealing 401,405. 
This resulted in a comparably high score and high probability of a double stand break 
induced by Cas9 on unintended target regions. Nonetheless, the sequencing result 
demonstrated a correct DNA sequence (Figure 21B). The sequence is identical with the 
HeLa wild type genome and the site seems not to have been modified during the 
CRISPR/Cas9 KO targeting. This finding supports the idea, which subsequent changes in 
cargo sorting and secretion are not due to unwanted effects, but caused by Cab45 absence.  
6.2.4 Modified cell lines proliferate normally 
To further analyze the phenotype the CRISPR/Cas9 cells, I performed a proliferation 
assay of control versus Cab45 KO or MIN-tagged cells. Therefore, cell numbers were 
counted on four consecutive days (Figure 22). The figure demonstrates that the three cell 
lines proliferate in a comparable manner. The Cab45 KO cell line (orange) and the Cab45 
MIN-tagged line (black) exhibit a similar proliferation rate as HeLa wild type cells (blue). 
Therefore, a KO of Cab45 does not seem to have an effect on cell division.  
 
 
Figure 22: Growth assay of SDF4 CRISPR/Cas9 cell lines shows no significant difference in cell 
proliferation. HeLa control cells (blue), SDF4 CRISPR/Cas9 KO (orange) and MIN-tagged cells (black) were 
counted each 24 h and growth curves were depicted in the units cells/ml. All three cell lines proliferate to 
comparable levels, also in the absence of Cab45. Depicted is the mean of data points with SEM. Assays was 
conducted three times in triplets. 
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6.2.5 CRISPR/Cas9 KO cell lines mimic siRNA KD phenotype in secretion 
assays 
Finally, the KO clones were compared functionally in secretion assays. Experiments 
performed previously with siRNA KD of Cab45 and SPCA1 in HeLa cells showed a 
missorting phenotype of Cab45-dependent cargo proteins including COMP and LyzC 365. 
In both cases absence of Cab45 resulted in accumulation of the secreted proteins inside the 
cell, while TGN sorting, export and secretion was inhibited. This phenotype could also be 
observed for both Cab45 KO cell lines (Figure 23).  
 
 
Figure 23: Secretion assays with Cab45 KO cell lines. Functionality of Cab45 KO cell lines was tested in 
secretion assays as described before by Vivek Malhotra’s group 365. The secretion of two known cargo 
proteins, COMP (A and B) and LyzC (C and D) in HeLa and Cab45 KO cells was analyzed by western blot. 
Both proteins are present either in the cellular fractions (WCL) and in the supernatants (SN) of control cells. 
However, upon Cab45 KO especially LyzC accumulates inside the cells and secretion is strongly diminished. 
This phenotype is in line with results obtained from Cab45 and SPCA1 siRNA KD experiments published in 
365.  
 
Especially LyzC fractions increased in the lysate in comparison to wild type HeLa cells, 
while only faint bands remained detectable in the supernatants, which indicated that 
protein secretion was impaired (Figure 23A and C). The quantifications of the western 
blots underline that protein secretion was significantly reduced for COMP and LyzC with 
both sgRNAs to around 40 % of wild type levels (Figure 23B and D).  
This experiment demonstrated that KD and KO of Cab45 caused the same defects in 
protein sorting and secretion at the TGN and the generated KO cells are suitable on a 
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genomic and functional basis for further analysis of the CFL1/SPCA1/Cab45 sorting 
machinery.  
6.2.6 MIN-tag was successfully integrated into SDF4 locus 
For the integration of the so-called MIN-tag by HDR, to generate a genetic platform for 
easy modification of the Cab45 genomic locus, only one sgRNA was used 386;Figure 18). In 
addition, a 200 bp donor fragment containing homology arms and an attB site was 
transfected together with Cas9-GFP and a specific MIN sgRNA. After FACS sorting and 
single clone expansion, clones were lysed for genomic DNA isolation. DNA was used as 
template for amplification of the genomic region of interest by PCR. The PCR product 
was then subject to restriction enzyme digest. Positive clones could be identified on agarose 
gel by a shift, as an additional HincII cutting site was integrated along with the attB 
cassette.  
One of 250 screened clones contained the correct insertion of the MIN tag. For this clone, 
the complete PCR product obtained from the genomic region of interest (around 450 bp) 
was digested by HincII to around 220 bp, as no band is longer visible at the size of the wild 
type control (Figure 24A). This proves that the clone received a homozygous insertion of 
the MIN tag, as a heterozygous clone would exhibit a double band.  
 
 
Figure 24: Characterization of MIN-tag SDF4 HeLa cell line. (A) Agarose gel analysis after HincII restriction 
digest of the PCR fragment of the SDF4 integration site in comparison to HeLa wild type control. The shift 
in the SDF4 MIN from 450 bp to around 220 bp hints to correct integration of the MIN-tag after the 
endogenous signal sequence. The absence of a band at the wild type level proofs homozygous integration of 
the MIN-tag in this clone. (B) Western blot of WCLs of HeLa wild type and SDF4 MIN cell line suggests that 
Cab45 protein expression was abolished due to MIN-tag integration. Actin control attests similar amounts of 
loaded protein.  
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Surprisingly, the specific Cab45 band on the western blot, comparing WCLs of HeLa wild 
type and the MIN-tagged clone, remained absent (Figure 24B). This indicated that protein 
expression was abolished in the clone, although the MIN tag was correctly inserted.  
This finding was also supported by the microscopy analysis as no Cab45 signal was 
detectable by immunofluorescence. Again, the GM130 marker indicated no morphological 
changes of the Golgi as observed before for the intended KO clones (Figure 20). Finally, 
also the proliferation of this clone was comparable to the behavior of the KO cell line 
(Figure 22).  
 
 
Figure 25: Immunofluorescence analysis of MIN-tag SDF4 cell line. Microscopy analysis of MIN-tagged 
SDF4 clone verifies absence of Cab45 protein from Cab45 MIN cells in comparison to Hela wild type control 
(green channel). The GM130 Golgi marker (red channel) and the nuclear DAPI staining (blue channel) reveal 
the typical cellular structures and therefore no morphological changes, comparable to the KO cell lines 
described above (Figure 20). Scale bars represent 10 µm. 
6.3 Cab45 oligomerizes in a calcium-dependent manner 
Already in the first description in 1996, six stretches that match the consensus motif of EF 
hands were described in Cab45 226. Consequently, Cab45 was considered as calcium 
binding protein, although the influence and function of this interaction have never been 
studied in detail. Therefore, the second aim of this thesis was to analyze the effect of 
calcium binding on Cab45 function.  
The first indications that Cab45 is mainly dependent on its calcium binding sites were 
found in 2012, as treatment of HeLa cells with an ionophore led to secretion of Cab45 
from HeLa cells (365; section 3.5.3.4). Furthermore, disruption of the calcium binding 
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motifs by point mutations resulted in deficient cargo binding in IP experiments, but the 
direct impact of calcium on Cab45 remained obscure at this point.  
6.3.1 Cab45 exhibits high molecular weight fraction in NativePage analysis 
The key finding that calcium might be responsible for the oligomeric state of the protein 
was revealed by a Blue NativePAGE analysis of recombinant Cab45. Purified Cab45 was 
either left untreated or incubated with a high calcium concentration in the absence or 
presence of EGTA (Figure 26A). After separation by gel electrophoresis the calcium sample 
without EGTA showed two main fractions of Cab45, one lower band, matching the size of 
the western blot on a denaturing SDS PAGE (below), and one high molecular weight 
fraction of about 1000 to 1500 kDa.  
 
 
Figure 26: Blue NativePAGE analysis of recombinant and endogenous Cab45 reveal high molecular mass 
fraction in the presence of calcium. (A) Blue NativePAGE comparison of purified recombinant Cab45, which 
was either untreated or in the presence of high calcium or incubated with calcium and EGTA. While the 
calcium only sample reveals a high molecular weight fraction in addition to monomeric Cab45, this oligomer 
is absent in the untreated sample or the presence of EGTA. (B) Isolated Golgi membranes were incubated 
under control (DMSO) or calcium depleted conditions (BAPTA-AM) and analyzed by Blue NativePAGE and 
western blot. Similar to the recombinant protein, endogenous Cab45 exhibited a high molecular weight 
fraction in the presence of calcium.  
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This upper band was less prominent in the presence of EGTA or the untreated sample. 
This indicated that Cab45 might appear in more than one molecular state, probably with a 
high molecular weight fraction. 
To gain further insights into the change of the oligomerization state of Cab45 by calcium 
in living cells a similar assay was performed with endogenous protein. Therefore, purified 
Golgi membranes were incubated under control or calcium depleted conditions (in the 
presence of the calcium chelator BAPTA-AM) and subjected to Blue NativePAGE analysis 
and western blotting (Figure 26B). As observed for recombinant proteins, the cells treated 
by BAPTA-AM lacked the band of high molecular mass, which was detected in the control 
sample. These two experiments indicate the presence of an oligomeric form of Cab45 exists 
in living cells, which might be crucial for its physiological function.  
6.3.2 Recombinant Cab45 forms oligomers in vitro 
Based on those findings above, the oligomerization process of ATTO488 fluorescently 
labeled protein was visualized by confocal microscopy (Figure 27).  
 
 
Figure 27: Principle of microscopy based oligomerization assay. Fluorescently labeled Cab45 (blue circles) 
can form oligomers (accumulation of blue stars) in the presence of high calcium concentrations (black dots). 
Sufficiently big oligomers can subsequently be visualized by confocal microscopy.  
 
In buffer conditions, no fluorescent signal was detectable, i.e. no oligomers could be 
observed at this stage. However, addition of 1 mM calcium induced formation of multiple 
fluorescent dots, which represented the Cab45 oligomers, observed before during the Blue 
NativePAGE analysis. The subsequent addition of an equimolar amount of EGTA 
reversed the effect and dispersed the oligomers almost completely (Figure 28A).  
To examine the calcium specificity for this reaction, a control assay was conducted with 
magnesium, another two-valent cation (Figure 28B). While 1 mM magnesium induced no 
oligomer formation, 10 mM of magnesium revealed a very low number of oligomers (white 
arrows). However, the effect was not comparable to calcium-induced oligomerization. 
Hence, the process seems to be calcium specific.  
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Figure 28: Confocal microscopy of fluorescently labeled recombinant Cab45 for visualization of 
oligomerization process. (A) ATTO488-labeled recombinant Cab45 was monitored by confocal microscopy. 
In the absence of calcium, no oligomers were detectable. Excess of calcium formation of fluorescent dots, 
which represent Cab45 high oligomeric weight fraction. Addition of EDTA reversed the calcium effect and 
dispersed the oligomers. (B) In the control experiment the same assay as described in A was conducted in the 
presence of the two-valent cation magnesium. Magnesium did not induce oligomerization at a concentration 
of 1 mM, and only very slightly at 10 mM (white arrows). However, amounts of oligomers were not 
comparable to calcium experiment. Scale bars represent 10 µm.  
 
6.3.3 Calcium binding induces conformational change of Cab45 
In many cases like calmodulin or the LDL receptor, calcium binding was attended by a 
conformational change of the protein 406. Therefore, Cab45 was tested by circular 
dichroism (CD) spectroscopy for changes in its secondary structure in the presence of 
calcium (Figure 29).  
In the initial experiment Cab45 was first measured in buffer conditions (blue line). Here, 
the graph constantly decreases between 250 and 215 nm. Then a steeper drop with a 
minimum around 205 nm follows, before the values increase constantly until 190 nm. 
However, the ellipticity here remains on a low level. In contrast, a significant 
conformational shift is detectable in the presence of an excess of calcium (green line). The 
cation induces a faster decrease at the beginning of the measurement and causes two 
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minima around 222 nm and 208 nm. In addition, ellipticity strongly increases after the 
second minimum. Based on model substrates, this curve progression indicates that Cab45 
adopts a more alpha-helical fold in the presence of calcium 407.  
 
Figure 29: CD spectra of Cab45 wild type in presence and absence of calcium and calcium titrations. (A) 
Recombinant Cab45 was analyzed in the presence and absence of an excess of calcium by circular dichroism 
(CD) spectroscopy. In comparison to buffer conditions (blue line) the spectra of Cab45 in the presence of 10 
mM calcium (green line) exhibit two minima around 222 and 208 nm, which indicate a shift to a more a-
helical fold. This conformational change can be partly reversed by addition of EGTA (orange line). (B) and 
(C) Titration experiments reveal that the shift is induced around 50 to 100 µM calcium (black line in C and 
light blue line in B and C) and that the reaction is finished at concentrations above 150 µM (brown, green 
and purple lines).  
 
Results of the secondary structure analysis by the CONTIN software supported the 
conformational shift from b-sheet (average decrease from 0.32 to 0.25) to increased a-
helicity (average increased from 0.14 to 0.22) without significant alterations in random coil 
Cab45 oligomerizes in a calcium-dependent manner 
 - 76 - 
content (Supplementary Table 1). Finally, equimolar addition of EDTA reversed the effect 
calcium, however, only partly (orange line). The presence of the chelator could not re-
establish completely the fold of untreated Cab45. Instead, both curves represent some kind 
of folding intermediate between untreated and calcium bound Cab45.  
In a second approach calcium was titrated stepwise to Cab45 to investigate the calcium 
sensitivity. Therefore, two independent experiments were conducted with different calcium 
ranges. In the first measurement (Figure 29B), the curves representing calcium 
concentrations between 0 and 10 µM (blue, red and black line) exhibit similar progressions 
as observed before for untreated Cab45 (Figure 29A). However, 100 µM calcium induced a 
conformational change to a more a-helical fold (light blue line). This shift was further 
intensified by 1 mM calcium (brown line). As no differences can be observed between 1 
mM (brown line) and 10 mM (green line) calcium, the reaction was obviously already 
saturated at this point.  
The second set of CD spectra (Figure 29C) focused on the area between 0 and 250 µM 
calcium, as this represents the range of the physiological calcium concentrations assumed 
for the trans regions of the Golgi apparatus 178,408. The results of this measurement are in 
line with the previous one, as no change in conformation was detectable with 10 µM 
calcium or below (blue and red line). However, the first switch was noticeable at 50 µM 
(black line), which intensified at 100 µM (light blue line). At 150 µM or above (brown, 
purple and green line) Cab45 has achieved its final shape.  
Taken together the CD spectra proof that Cab45 undergoes indeed a conformational shift 
during calcium binding. Furthermore, calcium titration experiments reveal that around 
150 µM calcium are necessary to induce this change. Given that the physiological calcium 
levels range around 130 µM in the TGN (Figure 8), the oligomers we observed during 
NativePage analysis (Figure 26) and microscopy experiments (Figure 28) likely represent 
the form of Cab45 found in the Golgi of living cells.  
6.3.4 Only four of six EF hand motifs are required for calcium binding and 
oligomerization 
To further assess the calcium binding properties of Cab45 a set of four mutants, containing 
point mutations of critical amino acids of the EF hand motifs, should be purified and 
analyzed in the assays described above (Figure 30).  
The Cab45 6EQ mutant contains six E to Q amino acid exchanges, one in each EF hand 
motif. Based on the publication of Lam and colleagues 367 these modifications disrupt the 
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calcium binding sites and also cargo interaction as shown before by von Blume and 
colleagues in IP experiments 365. 
 
Figure 30: Schematic depiction of Cab45 and its calcium-binding deficient mutants. Cab45 (light blue box) 
contains a signal peptide (marked with SP) from amino acid 1 to 36 and a putative glycosylation site at N39 
(green line) 226. The six EF hands (dark blue boxes; marked by Roman numerals) are located between amino 
acid 39 and 361. In the 6EQ mutant six point mutations in the EF hand motifs (indicated by orange lines) 
were introduced to disrupt calcium binding sites. EFh1, EFh2 and EFh3 contain only two point mutations in 
adjacent EF hand motifs.  
 
The other Cab45 mutants (EFh1, EFh2 and EFh3) comprise point mutations in two 
adjacent EF hand motifs, respectively (Figure 30). These alterations were based on a 
predicted 3D model by Bianca Habermann`s Group (former MPI of Biochemistry, now 
IBDM Marseille) (Figure 31). The model give rise to the assumption that two neighboring 
EF hand motifs reside in close spatial proximity and coordinate calcium ions in a manner 
dependent upon each other.  
To get a first idea about the importance of the calcium binding sites for Cab45 function the 
6EQ mutant was analyzed in comparison to Cab45 wild type in biochemical and cell 
biological assays.  
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The first striking observation was that more of the 6EQ mutant is secreted, when 
overexpressed on Cab45 KO background (Figure 32A, SN blot). Furthermore, the faint 
band in the lysate of 6EQ (WCL blot) indicates that also less of the calcium-binding 
deficient mutant can be retained inside the Golgi.  
 
 
Figure 31: Predicted structural model of human Cab45 indicates paired EF hand motifs. 3D Model of Cab45 
designed with MacPyMOL software (as described in Crevenna et al., 2016 387. The model depicts front and 
rear views of the Cab45 protein coordinating calcium ions (spherical structures) by EF hands 1 and 2 (dark 
red), EF hands 3 and 4 (bright red) and EF-hands 5 and 6 (magenta). EF hand motifs exhibit the typical helix-
loop-helix structure found in parvalbumin by Kretsinger and Nockolds 229 and pairwise assembly of EF hands 
in the 3D model. The N-terminus of protein is rather globular, while the C-terminus is mainly unstructured. 
Figure published in 409.  
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Figure 32: The Cab45 6EQ mutant is secreted in high amounts and forms no high oligomeric weight 
fractions. (A) HeLa Cab45 KO cells overexpressing either wild type Cab45 or the 6EQ mutant secreted more 
6EQ into the supernatant (SN). The western blot of the cell lysates (WCL) also indicates that less of the 
mutant is retained inside the cells. (B) Western blot analysis of Blue NativePage presents isolated Golgi 
fractions of Cab45 KO cells or KO cells overexpressing wild type Cab45 or 6EQ. The bands demonstrate 
that only Cab45, but not the mutant can form high oligomeric weight fractions under physiological 
conditions. (C) and (D) Western blots of SDS Pages show that same amounts of Cab45 proteins or the TGN 
marker TGN46 were loaded for the analysis.  
 
Secondly, isolated Golgi fractions from Cab45 KO cells, or Cab45 KO cells 
overexpression either wild type Cab45 or the 6EQ mutant were subjected to Blue 
NativePage analysis (Figure 32B). The western blot of the NativePage demonstrates that 
only Cab45, but not the calcium-binding deficient mutant can form high molecular weight 
fractions under physiological conditions. Furthermore, the Western Blots of the denaturing 
SDS pages depicted in Figure 32C and D prove that similar protein amounts were loaded 
for the experiment.  
Finally, the 6EQ mutant was tested concerning its ability to sort cargo proteins properly by 
secretion assays (Figure 33).  
Therefore, Cab45 wild type or the 6EQ mutant were stably expressed on Cab45 KO 
background (Figure 33A) and the secretion of COMP (Figure 33B) and LyzC (Figure 33C) 
were analyzed by Western Blotting. Both, COMP and LyzC, were less secreted upon 
Cab45 KO as observed before (compare Figure 23). However, overexpression of wild type, 
but not 6EQ, was able to rescue the secretion, as only weak bands are detectable in the 
6EQ sample.  
Based on these insights, the impact of the single calcium binding sites should be addressed 
by analysis of the pairwise EF hand mutants EFh1, EFh2 and EFh3 in vitro (Figure 30). 
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Therefore, the set of mutants was purified by the established insect cell system as described 
in section 6.1 and labeled with a fluorescent dye. Subsequently, the EFh mutants were first 
tested with respect to their ability to form oligomers in the presence of calcium.  
 
The results arranged in Figure 34 demonstrate that the ATTO488 labeled Cab45 
oligomerized in the presence of 1 mM calcium as observed before (Figure 28). In contrast, 
EFh1 showed only very little green dots and therefore basically no polymerization (white 
arrow). EFh2 indicated many green clusters and oligomerization capacity seems 
comparable to wild type behavior. Finally, EFh3 exhibited some, but not many green spots 
in the microscopy experiment, which indicates some residual oligomerization, however, 
explicitly below wild type levels (white arrows). In summary, only one mutant, namely 
EFh2, is able to properly polymerize in the presence of calcium, while for EFh1 and EFh3 
only residual oligomerization is observable.  
 
 
Figure 33: The Cab45 6EQ mutant cannot rescue the 
Cab45 KO phenotype in secretion assays. (A) Cab45 wild 
type or the calcium-binding deficient mutant were 
overexpressed on top of the Cab45 KO background. As 
observed before, less 6EQ is retained in the cell. (B) and 
(C) Secretion assays with COMP or LyzC demonstrate 
that secretion is reduced upon Cab45 KO in comparison 
to HeLa cells. Overexpression of Cab45 wild type, but not 
the 6EQ mutant, can rescue the phenotype for both cargo 
proteins.  
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Figure 34: Oligomerization assay of Cab45 calcium-binding deficient mutants. In confocal microscopy 
Cab45 wild type labeled with ATTO488 dye exhibited oligomerization in the presence of 1 mM calcium 
(green dots), but not in its absence, as observed before (Figure 28). In contrast, the EFh1 and EFh3 mutant 
only showed some green dots (highlighted by white arrows) in the presence of the cation. EFh2 showed 
proper polymerization behavior comparable to wild type levels. Scale bars represent 10 µm. 
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6.3.5 Only EFh2 undergoes conformational change in the presence of 
calcium 
To see if the results of the EFh mutants is in concordance with their presumptive change in 
secondary structure, the three proteins were subject to CD spectroscopy. While the control 
experiment with wild type Cab45 (Figure 35A) presents the same curve progression as 
found earlier for 1 mM and even 250 µM calcium (Figure 29), the graphs of EFh1 and 
EFh3 show no change in secondary structure after addition of the cation (Figure 35B and 
D). However, the curve of EFh2 (Figure 35C) demonstrates that this mutant indeed gains a 
more alpha helical fold in the presence of 250 µM calcium. Interestingly, while addition of 
more calcium has no effect on the wild type protein (Figure 35A), addition of higher 
calcium concentrations (1 mM) leads to a stronger structural change of EFh2. In line with 
this observation the titration of the EFh2 mutant in the range between 0 and 250 µM also 
exhibited a slight delay during the transition to the calcium bound state (Supplementary 
Figure 1).  
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Figure 35: CD spectra of calcium-binding deficient mutants in the presence and absence of calcium. (A) 
Control experiment with wild type Cab45 in the presence and absence of calcium by circular dichroism (CD) 
spectroscopy. In comparison to buffer conditions (blue line) the spectra of Cab45 in the presence of 250 mM 
calcium (black line) exhibit two minima around 222 and 208 nm, which indicate a shift to a more a-helical 
fold. Addition of more calcium (1mM; green line) did not change the spectrum further. (B to D) CD spectra 
of calcium-binding deficient mutants EFh1, EFh2 and EFh3. The results show that EFh1 and EFh3 are not 
able to change their secondary structure in the presence of neither 250 µM (black lines) nor 1 mM calcium 
(green lines). In contrast, EFh2 shows comparable behavior as wild type control 250 µM calcium (black line), 
although alpha helical fold intensified upon 1 mM cation concentration (green line).  
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6.3.6 All EFh mutants mimic the phenotype of the 6EQ mutants in cells 
The next step was to address the function of this multimerization process inside living cells. 
Thus, the calcium-binding deficient mutants were stably expressed in HeLa cells and the 
localization of the proteins was visualized by immunofluorescence (Figure 36).  
 
 
Figure 36: Immunofluorescence analysis of calcium-binding deficient Cab45 mutants in HeLa cells. Cab45 
wild type or mutants were stably overexpressed in HeLa cells and detected by an anti-HA antibody (green 
channel). As Golgi marker, p230 was co-stained (red channel). In contrast to wild type control all mutants 
exhibit vesicular dotty structures (white arrowheads) in addition to the normal strong Golgi-located signal. 
Golgi signal colocalizes with marker protein as expected (merge). Number of vesicles are quantified in Figure 
37). Scale bars represent 10 µm. 
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Cab45 and its mutants were therefore detected by a C-terminally a-HA antibody and an 
a-p230 antibody was used as Golgi marker protein in this experiment. Cab45 reveals a 
strong signal in Golgi area where it colocalizes with p230. Surprisingly, all EF hand 
mutants including 6EQ exhibit a multitude of dotty structure around the Golgi apparatus, 
which have an appearance distinct of the wild type ER staining (white arrowheads). 
However, the number of these putative vesicular structures differ between the mutants. 
While in the 6EQ and EFh3 samples numerous of them are detectable, less are visible in 
the EFh1 and EFh2 probes. The corresponding quantification of vesicle numbers supports 
this finding (Figure 36). All mutants, although to a different extent, demonstrate significant 
increase in vesicular structures containing Cab45 in correlation to the wild type control.  
 
 
 
In summary, the observations above indicate that especially EFh1 and EFh3 are crucial for 
calcium binding and the oligomerization process, because both mutants show neither a 
conformational shift in CD spectroscopy nor oligomerization in microscopy experiments. 
The EFh2 mutants behaves mainly like wild type Cab45 as it is still able to acquire a more 
a-helical fold in CD in the presence of high calcium, although maybe with little less affinity 
than the control, and it is still capable of multimerization.  
6.3.7 Predicted oligomerization-prone mutant can still oligomerize 
Subsequently, two different approaches were applied to identify a putative oligomerization 
domain. Firstly, an online tool was used to identify aggregation prone areas in the amino 
acid sequence of Cab45. Secondly, Cab45 was divided into an N- and a C-terminal 
fragment (Figure 39), purified and subjected to microscopy analysis (Figure 40).  
Figure 37: Quantification of vesicles 
in HeLa cells overexpressing Cab45 
wild type or calcium-binding 
deficient mutants. The quantification 
of IF pictures in Figure 36 
demonstrates that all mutants show 
significantly elevated levels of 
vesicular structures in HeLa cells (n = 
18 for all cell lines). In concordance 
with the microscopy analysis, 6EQ 
reveals highest levels of vesicles, while 
mutants range between wild type and 
6EQ. The scatter blot depicts 
medians of values with interquartile 
range.  
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Figure 38: Characterization of putative aggregation-inhibited Cab45 MVKR mutant. (A) Result of TANGO 
algorithm analysis of wild type Cab45 (left graph) and MVKR mutant (right graph). The curve progression 
indicates two main peaks, i.e. aggregation prone areas, in the sequence of wild type Cab45 (blue). As the first 
hotspot is located in the SP of the protein and therefore no part of the mature protein this area was neglected 
during subsequent analyses. Mutations of two adjacent amino acids abolished the aggregation propensity in 
this area around amino acids 105 (red box in graph and cartoon) completely. (B) CD spectroscopy of MVKR 
mutant exhibits similar curve progression as the wild type protein. In the presence of calcium also the mutant 
performs a conformational change to a more helical fold (green line). (C) In vitro oligomerization assay with 
ATTO488 labeled Cab45 wild type and MVKR mutant. Both proteins show comparable oligomerization 
potential in the presence of 1 mM calcium. 
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The first approach was based on the TANGO online tool, a prediction tool of aggregating 
regions in unfolded polypeptide chains (http://tango.crg.es). This algorithm tries to 
identify hydrophobic areas within the protein sequence, which might favor 
multimerization. The result of the analysis indicated two main hotspots inside the protein, 
which fulfill the necessary requirements. The first hotspot is located inside the SP of Cab45, 
an area that should be cleaved off during co-translational ER import and therefore not be 
part of the mature protein (compare also section 3.2.2). Thus, this area was neglected 
during the subsequent analysis. However, the second hotspot was a small region of 6 amino 
acids directly before the first EF hand motif (Figure 38A). This area was mutated at two 
amino acids, which abolished the oligomerization potential according to the TANGO 
algorithm. The protein was purified, labeled and analyzed by microscopy (Figure 38C). 
However, the mutant still exhibited polymerization potential comparable to wild type 
levels. Therefore, Cab45 was alternatively divided into a N- and a C-terminal part to limit 
the area of a potential oligomerization domain.  
 
 
Figure 39: Schematic depiction of Cab45 N- and C-terminal fragments for identification of oligomerization 
domain. Cab45 wild type was divided into a N- and a C-terminal fragment in the area between EF hand 
motif II and III (dark blue boxes; Roman numerals). The C-terminal fragment starts from amino acid 207, 
whereby a signal peptide (SS) was added at its N-terminus. Cab45 C-Fragment comprises the complete EFh2 
and EFh3. Green line marks putative glycosylation site at amino acid N39.  
 
6.3.8 N- and C-terminal fragments of Cab45 oligomerize independently 
To generate two fragments of Cab45 with similar length and without disrupting the EF 
hand structures, the N-Fragment was cut off in the loop after EF hand motif II at amino 
acid 206 (Figure 39). For proper localization, a SP was added to the C-Fragment, which 
contains the complete EFh2 and EFh3 region. Both proteins were labeled and analyzed by 
the oligomerization assay (Figure 40). In the control experiment Cab45 wild type labeled 
with either ATTO488 or Cy5 were incubated together in the presence of 1 mM calcium. 
The overlap in the merge picture proves that both proteins form oligomers together. 
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Figure 40: Oligomerization assay of N- and C-terminal fragment of Cab45. In the wild type control 
experiment Cab45 was labeled either with ATTO488 or Cy5 dye and incubated together in the presence of 1 
mM calcium. Either the green and the red channel indicate oligomerization of the wild type protein as 
expected. The merge of both channels proves that both proteins are present in the same structure, i.e. that 
they polymerize together. The same is true for the N- and the C-fragment, as both proteins are able to form 
oligomeric structures together with wild type Cab45. Scale bars represent 10 µm.  
 
As the same results are observable for the ATTO488-labeled N- and C-Fragment, the 
experiment indicates that both, the N-terminal as well as the C-terminal part of Cab45 are 
able to directly interact with wild type Cab45. This suggests, that both fragments contain 
domain capable of binding the wild type protein, e.g. a potential oligomerization domain. 
Therefore, currently smaller fragments are generated to determine the minimal 
requirements for oligomerization.  
6.4 Oligomeric Cab45 directly interacts with cargo via tyrosine 
residues 
The third aim of this thesis focused on the Cab45 cargo interaction. Although it was 
already published earlier that Cab45 interacts with certain secreted proteins in 
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immunoprecipitation experiments from HeLa cell lysates 365, the interaction was so far not 
characterized in detail.  
6.4.1 The Cab45-cargo interaction is direct 
For this reason, first the direct interaction of purified protein in in vitro pull down 
experiments should abolish the possibility that Cab45 interacts with its cargo via adaptor or 
other proteins. For this approach, recombinant purified Cab45 was attached to beads and 
incubated either with buffer as control condition or with the previously demonstrated 
recombinant cargo proteins LyzC or COMP. Cathepsin D (CathD) was used as negative 
control here, as the lysosomal hydrolase should be transported via a Cab45 independent 
pathway to early endosomes.  
 
 
Figure 41: In vitro immunoprecipitation assays with recombinant, purified Cab45 and cargo proteins. To 
demonstrate direct interaction between Cab45 and cargo proteins recombinant Cab45 was attached to beads 
and incubated either with a buffer control or the previously published cargo molecules LyzC and COMP. 
The Coomassie stained SDS Pages of both experiments indicate that Cab45 can pull down both LyzC and 
COMP from the sample, as the last pull down lane clearly shows the expected bands at around 15 kDa or 
around 100 kDa, respectively. The first input lane proves that there was no unspecific interaction of the cargo 
with the beads. As expected, the band in the gel of the negative control CathD remained absent and proves 
that no interaction between Cab45 and CathD occurred in this assay.  
 
The Coomassie stain of the SDS pages reveal that Cab45 can indeed directly interact with 
LyzC and COMP (Figure 41). On both gels, the bands at the expected sizes (around 15 
kDa for LyzC and around 100 kDa for COMP) appear in the last pull down lane, when 
both proteins are present. The control (first pulldown lane) proves that the interaction is 
real and only detectable if Cab45 is present and not due to unspecific binding of the cargos 
to the beads. In contrast, CathD exhibits no interaction with Cab45, as the CathD band in 
the last pulldown lane is absent, although clearly visible in the input. This result proves for 
Oligomeric Cab45 directly interacts with cargo via tyrosine residues 
 - 90 - 
the first time, that Cab45 interacts directly with cargo molecules, independently of other 
proteins.  
6.4.2 Cab45 oligomerizes together with cargo 
Subsequently, the question arose, if Cab45 is capable of oligomerization and cargo binding 
in parallel. To address this, oligomerization assays were performed with recombinant, 
fluorescently labeled Cab45 and cargo (Figure 42).  
 
 
Figure 42: Schematic depiction of oligomerization process of Cab45 in the presence of cargo molecules. 
Fluorescently labeled Cab45 forms oligomers in the presence of calcium. Cab45 oligomers subsequently bind 
differently labeled cargo molecules and form hetero-oligomeric structures, which can be visualized by 
confocal microscopy.  
 
In theory, Cab45 should oligomerizes together with the cargo and both proteins should be 
detectable in the same structures under the microscope. According to the 
immunoprecipitation experiments LyzC-Cy5 and COMP-Alexa647 were used as model 
cargos and CathD-Cy5 as negative control.  
 
The microscopy results of the oligomerization assay indeed prove that Cab45 and the 
cargo oligomerize together in the presence of 1 mM calcium. Furthermore, the merge of 
both channels underlines that both proteins are part of the same hetero-oligomeric 
structures. In addition, the multimers dissolve completely upon addition of EGTA. In 
contrast, CathD does not colocalize with Cab45 wild type, which is in concordance with 
the idea that CathD is sorted independently of Cab45 inside the secretory pathway. 
Control experiments with LyzC and COMP prove that clustering was not induced by 
fluorescent dyes (Supplementary Figure 2).  
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Figure 43: Oligomerization assay of Cab45 in the presence of cargo molecules. Recombinant ATTO488 
labeled Cab45 was incubated either with Cy5 labeled LyzC or Alexa647 labeled COMP in the presence of 1 
mM calcium. Either the Cab45 channel and the LyzC/COMP channel indicate that the proteins form 
cation-induced multimers. The merge proves that the proteins are part of the same structures. The negative 
control CathD does hardly colocalizes with Cab45 and therefore does not interact with the protein. Scale bar 
represents 20 µm.  
 
6.4.3 Formed Cab45-cargo oligomers are highly stable in vitro 
Because the hetero-oligomers of Cab45 and cargo proteins appeared to form comparably 
stable structures during the in vitro characterization, a Fluorescence Recovery After 
Photobleaching (FRAP) experiment was conducted to analyze the dynamics of the 
complexes. Therefore, unlabeled Cab45 and labeled cargo were incubated together and 
fluorescence of formed oligomers were bleached out by laser pulse and fluorescence 
recovery was subsequently tracked for 10 min.  
The diagrams of LyzC and COMP show that fluorescence intensity does not recover 
within the monitored time frame as the intensity value remains on a constant low level. In 
addition, the pictures of the inset support the finding that no exchange of proteins took 
place during this measurement, because no fluorescent signal is observable after 590 s.  
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Figure 44: FRAP experiment for analysis of Cab45-cargo oligomer dynamics. FRAP analysis of LyzC-Cy5 
and COMP-Alexa647 were incubated with unlabeled Cab45 in the presence of calcium. The diagrams 
represent the normalized fluorescence intensities during a monitored time of 10 min. The black line is the 
mean signal, whereas the light blue trace represents one SD on either side (n = 13 for LyzC and 15 for 
COMP). The insets show examples of a Cab45-cargo oligomer before (prebleach) and immediately after 
(bleach) bleaching and after around 10 min (590s). Scale bar represents 2 µm.  
 
This result indicates that the Cab45-cargo complexes are not dynamic and further 
unknown modifications or other factors are required to modulate or dissolve the multimers 
in a physiological context. 
 
6.4.4 Cab45 colocalizes with SPCA1 and LyzC but not p230 in super-
resolution microscopy 
To visualize the Cab45 cargo interaction in living cells, HeLa cells were subjected to 3D-
SIM super-resolution microscopy (Figure 45). First, the localization of Cab45 with respect 
to SPCA1-HA was analyzed (Figure 45A). SPCA1-HA (blue channel) overlaps nicely with 
the signal of endogenous Cab45 (red channel). Both proteins show a characteristical 
staining of the elongated Golgi cisternae. In addition, Cab45 also colocalizes strikingly with 
the LyzC signal (blue channel; Figure 45B). In contrast, the trans Golgi marker p230 (red 
channel; Figure 45C) shows no overlap with the calcium binding protein, although both 
proteins seem to reside in close vicinity. The probability (e.g. normalized frequencies) of 
Cab45 colocalization with SPCA1, LyzC or p230 are depicted in Figure 45D.  
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Figure 45: Analysis of Cab45, SPCA1 and LyzC localization in HeLa cells using the 3D-SIM super-
resolution microscopy technique. (A) HeLa cells overexpressing HA-tagged SPCA1 were stained for actin 
(phalloidin, green) and endogenous Cab45 (red channel). Overlapping regions (pink color) indicates 
significant SPCA1 and Cab45 colocalization. (B) HeLa cells overexpressing LyzC (blue channel) depict 
significant colocalization of Cab45 and LyzC. (C) Staining of endogenous p230 (blue channel) and 
endogenous Cab45 (red channel) in HeLa cells reveals that proteins do not show colocalization, but both 
proteins locate to characteristical Golgi structures in close vicinity. (D) Graphical evaluation of probability 
(e.g. normalized frequencies) of colocalization for indicated protein combination. Scale bars represent 5 µm.  
 
6.4.5 Tyrosine residues are crucial for the Cab45-cargo interaction 
One further important question that remained elusive in previous publications was a 
potential Cab45 cargo recognition motif. The initial SILAC-based screen in HeLa cells 
revealed around 20 secreted proteins differentially sorted by the SPCA1/CFL1/Cab45 
machinery340. Five of these, LyzC, COMP, TIMP1, MGP and RCN3, were confirmed to 
interact with Cab45 in immunoprecipitation experiments 365; partly unpublished). To 
expand the set of potential Cab45 cargos, the secretomes of HeLa wild type cells and 
Cab45 CRISPR/Cas9 KO cells were compared in a mass spectroscopy based screen.  
In this setup, several proteins were identified as differentially secreted upon Cab45 
depletion. These protein sequences were bioinformatically analyzed by the Group of 
Bianca Habermann (former MPI of Biochemistry, now IBDM Marseille) and the following 
recognition motif was extracted:  
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[DE]-X-Y-A-X-(X)-[VI]-[FY]-G-Y-[NQ] 
 
Due to the fact that the motif was short (10 amino acids), I established a pulldown assay to 
test the putative interaction of the motif or variations of that with Cab45. Therefore, the in-
house biochemical service facility synthesized the peptides and added a biotin modification. 
These peptides were subsequently immobilized on magnetic streptavidin-covered beads, 
which were in turn incubated with lysates obtained from HeLa cells stably overexpressing 
Cab45 wild type. The interaction of the peptides was then evaluated by Cab45 detection 
via western blot.  
In the first assay three peptides corresponding to the original sequences of the known 
Cab45 interactors MGP, COMP and RCN (for subsequent experiments named MGP1, 
COMP1 and RCN1) were analyzed by this setup (Figure 46A). As negative control 
scrambled peptides were used, as well as a bead control without peptide. The result of the 
western blot demonstrates that the three peptides of MGP, COMP and RCN indeed bind 
Cab45 wild type. The bead control revealed only mild binding of Cab45 to the bead 
surface. Surprisingly, also the scramble controls show strong interaction with our protein of 
interest. As this unspecific interaction might be due to charges within the sequence, four 
mutants of MGP1 (MGP1-1 to MGP1-4) containing different alanine substitutions (marked 
with red letters) were designed and synthesized (Figure 46B). Firstly, western blot analysis 
revealed that the result of the MGP1 and the scramble peptide was reproducible. In 
addition, a poly GS peptide as negative control showed no Cab45 interaction, which 
strengthened the finding of the first experiment. Secondly, the four mutated peptides 
indeed exhibited differential binding properties. While MGP1-2 bound to Cab45 in a 
manner comparable to the wild type sequence, MGP1-3, and especially MGP1-1 and 
MGP1-4 showed drastically reduced binding levels. Considering the alanine substitutions 
in these mutants, all three of them lack two nearly adjacent tyrosine residues. Therefore, 
these sites were systematically analyzed in the next pulldown assay (Figure 46C). The 
tyrosines were substituted alone against alanine (MGP1-5), against phenylalanine (MGP1-
6) to evaluate the importance of the aromatic ring structure, against negatively charged 
glutamic acids (MGP1-7), or individually substituted against alanine (MGP1-8 and MGP1-
9). Cab45 bound to the MGP1 reference as observed previously, while repeatedly no 
interaction was observable for MGP1-1. However, Cab45 was able to interact with MGP1-
5, which suggests that also the first and not only the last two tyrosine residues are crucial 
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for the interaction. While the aromatic ring structures of phenylalanine seems not to 
influence this behavior the introduction of negative charges actually completely abolishes 
Cab45 binding capacity of MGP1-7. In line with MGP1-5, the individual substitutions do 
not affect binding of Cab45. Based on the finding that the additional negative charges of 
MGP1-7 had such a strong effect on Cab45 cargo interaction, one may reasonable expect 
that a modification like phosphorylation might also have an impact on binding. Therefore, 
in the next screen three phosphorylations were introduced at the tyrosine residues (MGP1-
10 to MGP1-13).  
 
 
Figure 46: Immunoprecipitation experiments of Cab45 peptide interaction studies. Synthesized peptides were 
immobilized by biotin modification on streptavidin-covered beads. Interaction of peptides with Cab45 was 
studied by incubation of beads with cell lysate from HeLa cells, overexpressing Cab45 wild type. (A) Peptides 
or scramble controls of the three known Cab45 targets MGP (MGP1), COMP (COMP1) and RCN (RCN1) 
were tested and interaction was analyzed by western blotting. All peptides including the scramble controls 
were able to interact with Cab45. (B) Four different variants of the MGP1 peptide revealed binding 
deficiencies of the mutant peptides lacking tyrosine residues. (C) In detail analysis of tyrosine residues 
demonstrated further the importance of the first tyrosine residue and that introduction of negative charges 
additionally regulates interactions negatively. (D) Phosphorylation of two of three tyrosine residues abolished 
peptide-Cab45 interaction.  
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Modification of the first (MGP1-10) and the second tyrosine (MGP1-11) and as a 
consequence also the triple mutant (MGP1-13) actually abolished Cab45 binding. 
However, MGP1-12 still exhibited proper interaction with Cab45, which proves that not 
the negative charge itself, but also the location inside the protein is important. 
In summary, these pulldown assays indicate that Cab45 interacts with the extracted protein 
sequence in vitro and that phosphorylation of two certain tyrosine residues can abolish cargo 
binding. They further support the idea that phosphorylation might function as signal for 
cargo release and vesicle packaging also in a physiological context.  
6.4.6 Mutation of cargo binding site and KO of Cab45 show same delay in 
export dynamics 
In order to prove that the found tyrosine modifications also influence Cab45 dependent 
sorting in cells, MGP constructs for the Retention Using Selective Hooks (RUSH) system 
were cloned (Figure 47). The principle of the RUSH system is based on a hook protein 
containing a streptavidin and the KDEL sequence, which retains the hook inside the ER. 
In addition, the protein of interest is fused to an EGFP and a streptavidin-binding protein 
(SBP), which bind the streptavidin of the hook. Upon addition of an excess of biotin to the 
cell culture medium the SBP is displaced from its binding site and the protein of interest is 
transported along the secretory pathway to the Golgi and further to the plasma membrane 
for secretion. This secretion process and its kinetics can be easily tracked and visualized by 
confocal microscopy.  
 
 
Figure 47: RUSH principle. The retention using selective hooks (RUSH) method uses a hook consisting of 
streptavidin protein (blue) fused to the KDEL retention motif (grey), which interacts with a streptavidin 
binding protein (SBP, purple). SBP in turn is fused to a EGFP (green) and the protein of interest – here MGP 
(orange). Upon biotin (red) addition SBP is displaced from streptavidin due to the high biotin-streptavidin 
affinity. The transport of the released MGP fusion protein from the ER to the Golgi and later to the PM can 
be tracked by confocal microscopy via the EGFP tag. Figure was adjusted from Boncompain et al., 2012 410.  
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The immunofluorescence stainings of the time points 0, 20 and 40 min after biotin addition 
show that the MGP wild type is already in vesicles after 20 min (Figure 48). While the 
MGP 3A mutant also shows some, however less, vesicular structures, the MGP wild type 
on the Cab45 KO background exhibits hardly any Golgi export. In line with this, after 40 
min biotin incubation the MGP wild type protein is still released from the Golgi of the 
HeLa wild type cells, either for MGP and MGP 3A. However, still only very few vesicles 
are detectable even after 40 min in the Cab45 KO cells.  
 
 
Figure 48: Microscopy analysis of the RUSH construct of MGP in HeLa and Cab45 KO cells and the 3A 
mutant. For visualization of the RUSH kinetics of MGP cells were incubated for 0, 20 or 40 min with biotin 
and fixed and stained afterwards. MGP exhibits many vesicles after 20 min (first column), while less are 
observable for the 3A mutant (second column) in the HeLa background. Hardly any vesicles formed at this 
time point in the Cab45 KO cell line (third column). After 40 min biotin incubation, this delay in Golgi 
export is still striking in the Cab45 KO background. The MGP/MGP 3A GPF fusion constructs are depicted 
in green, the p230 Golgi comarker is depicted in red. Scale bars represents 10 µm.  
 
For quantification, the number of vesicles was counted after 20 min and 40 min of biotin 
addition of all three cell lines (Figure 49). The data of the scatter blot proves that both the 
MGP 3A mutant and the MGP wild type on KO background show a delay of Golgi vesicle 
Cab45 is phosphorylated by Fam20C 
 - 98 - 
export, especially after 40 min. This and also the observation that all cell lines show strong 
Golgi staining after 20 min, might hint to the fact that especially Golgi export, but not ER 
to Golgi transport, is delayed.  
 
 
 
In summary, the RUSH system supported the in vitro data above, as indeed the 3A 
mutation of MGP exhibits the same delay in sorting as observed for the Cab45 KO cell 
line.  
6.5 Cab45 is phosphorylated by Fam20C 
Phosphorylation is generally known as a widespread and fast posttranslational modification 
of proteins throughout the cell and key mediator of cell signaling. However, although the 
existence of phosphorylated secretory pathway proteins was evident from early on, the 
issue is only poorly understood so far, mainly also due to the lack of suitable kinases.  
Recently, the identification of the serine/threonine kinase Fam20C massively promoted 
the interest in this research field 152. Therefore, many new insights were gained on the 
secretory pathway phosphoproteome in the last years. The question, which proteins are 
modified inside the Golgi and if secretory cargo sorting is influenced by this modification, 
was addressed by a mass spectrometric approach, which should identify potential 
phosphorylated sites from isolated Golgi fractions. In this screen, more than 8200 
phosphorylation sites were identified, whereby nearly 86 % of them were modified serine 
residues (Figure 50A). Few threonine residues were phosphorylated (13.7 %) and only very 
Figure 49: Quantification of vesicles 
of RUSH assay. For quantification, 
the number of vesicles per cell was 
counted for the three different cell 
lines HeLa MGP (circles), HeLa 
MGP 3A (boxes) and Cab45 KO 
MGP (triangles). The data shows that 
the delay in vesicle export from the 
Golgi is significant for either HeLa 
MGP 3A and Cab45 KO MGP in 
comparison to HeLa MGP (n=35; 
P<0.05). Both cell lines show less 
vesicular structures after 20 and after 
40 min. Scatter blots depicts mean 
values with SD.  
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few (0.8 %) tyrosine residues, which can be considered as not significant. The 
phosphorylation pattern, which can be extracted from the found hits were S-X-E and T-X-
E (Figure 50B). The former matches exactly the published Fam20C phosphorylation site 
152. The threonine modifications in this context seem not surprising as many kinases have 
affinities for both amino acids, although often to a different extend 411.  
 
 
Figure 50: Results of mass spectrometric analysis of the phosphoproteome in Fam20C or Fam20C-KD 
overexpressing cells. (A) The pie chart depicts the amount and relative percentage of phosphopeptides 
identified in the mass spectrometric screen. Most of the modified residues were serines (purple), a few 
threonines (green) and only around 0.8 % tyrosine residues (orange). (B) The recognition motif of the 
Fam20C kinase which could be extracted from the hits was S/T-X-E. The short motif was described before 
as pattern for Fam20C-dependent phosphorylation 150. (C) The bar chart correlates the identified 
phosphoproteins with annotated keywords. (D) The volcano blot depicts the phosphoproteins identified in the 
mass spectrometric screen. Proteins annotated as secreted, which are enriched in the Fam20C overexpressing 
fraction, are highlighted in red.  
 
Figure 50C depicts the amount of proteins, which were annotated to different 
characteristics of secretory pathway proteins like signal peptide, glycoproteins or secreted. 
The amount of those proteins found in this screen underlines that indeed many proteins of 
the secretory pathway and the Golgi were found to be modified by phosphorylation, which 
might have an effect on their respective conformation and proper function.  
In addition, the volcano blot of secreted proteins (indicated by red dots) shows that many of 
the phosphorylated proteins are enriched when the wild type kinase, but not its dominant 
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negative mutant is overexpressed (Figure 50D). This also proves that Fam20C affects a 
multitude of proteins not only inside the cell, but also in the extracellular space.  
 
Position Amino acid Sequence window 
99 S GKDLGGFDEDAEPRISRRKLMVIFSKVDVNT 
131 T RKISAKEMQRWIMEKTAEHFQEAMEESKTHF 
142 S IMEKTAEHFQEAMEESKTHFRAVDPDGDGHV 
193 T ADAIRLNEELKVDEITQEVLENLKDRWYQAD 
349 S LEPEEVLKYSEFFTSKLVDYARSVHEEF 
Table 10: Overview of Fam20C-dependent Cab45 phosphorylation sites identified by mass spectrometry. 
Analysis of phosphorylated peptide was performed in Golgi fractions isolated from S3 cell overexpressing 
either Fam20C wild type or the dominant negative mutant. Five phosphosites on either serine or threonine 
were identified (phosphorylated residues are highlighted in red in sequence windows).  
 
Finally, the screen revealed also five Cab45 phosphorylation sites (Table 10). As depicted in 
the volcano blot (Figure 51A), these phosphosites are highly enriched in the Golgi 
apparatus of cells overexpressing Fam20C wild type. Among these hits, three serine and 
two threonine residues were identified. Four of these modified sites reside in the area 
around EF hand motif 1, 2 and 3, i.e. more in the N-terminal region of Cab45 (highlighted 
in cartoon in Figure 51B).  
In summary, the mass spectrometric screen revealed that Fam20C indeed phosphorylates a 
multitude of proteins inside the secretory pathway and of the extracellular matrix as 
proposed before 150. However, this screen also revealed so far unknown Cab45 
phosphorylation sites, which are highly abundant in Fam20C overexpressing cells.  
Unfortunately, the role of this serine/threonine modification and its effect on Cab45-
mediated sorting of secretory cargo proteins under physiological conditions remains elusive 
at this point and requires further in vitro and in vivo verifications and investigations, which 
are currently ongoing in the von Blume lab.  
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Figure 51: Vulcano blot of mass spectrometric screen highlights five Fam20C-dependent Cab45 
phosphorylation sites. (A) Vulcano blot of mass spectrometric screen depicts enrichment of phosphopeptides 
in the presence of high Fam20C expression (blue dots of left branch). Cab45 specific phosphosites are 
highlighted in red. Two of the found peptide had a multiplicity of 2, therefore 7 dots are highlighted. (B) 
Cartoon of Cab45 visualizes the positions of the identified phosphosites (red lines) within the protein 
structure. Four of the five phosphopeptides accumulate in the region of EF hand motif 1, 2 and 3 (dark blue 
boxes; Roman numerals).  
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7 Discussion 
Tissue integrity and cell-cell communication are two indispensable features to guarantee 
viability and proper function of a cellular system. To achieve these goals, cells interact by 
secretion of different factors such as hormones, cytokines or extracellular matrix 
components. As the malfunction of this protein secretion processes leads to severe diseases 
like diabetes, autoimmune disorders, skeletal dysplasia or cancer, the secretion machinery 
is under constant and tight surveillance and regulation 412-416.  
One pivotal checkpoint is the sorting of proteins at the TGN. Proteins arrive at the TGN 
after their co-translational insertion into the ER and transport through the Golgi stack. 
Over the past decades, the mechanisms for sorting of transmembrane proteins have been 
described extensively 417, however, the molecular mechanism for sorting and packing of 
soluble proteins destined for secretion have remained largely unknown.  
Although the idea that soluble proteins are secreted by unselective bulk flow or by 
receptor-dependent mechanisms prevailed for a long time in the research field, in recent 
years it became evident that nature established regulated processes like the sorting by the 
CFL1/SPCA1/Cab45 machinery for this purpose 358,362-365  
Unfortunately, the details of this unique system are only at the beginning of their complete 
comprehension. Therefore, this thesis was focused on the in-detail characterization of the 
central component Cab45. In this study, state-of-the-art techniques were applied to analyze 
the intrinsic oligomerization potential of this protein and the implications for cellular 
retention. Additionally, Cab45-cargo interaction studies revealed, how intra-Golgi calcium 
levels can substantially influence the sorting process inside the Golgi lumen.  
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7.1 The CRISPR/Cas9 system - Boon and Bane 
The CRISPR/Cas9 system was praised as extremely easy and highly efficient tool for 
genome editing of mammalian cells. Indeed, the flexible design of the sgRNAs, as well as 
the high efficiency for KO approaches make this system superior to comparable 
approaches like TALEN or Zink finger nucleases, even in HeLa cells with a difficult 
genomic environment. Furthermore, also knock-in approaches seem to work with 
reasonable efficiency. However, in addition to the widely-discussed drawbacks of the 
system like off-target effects, CRISPR/Cas9 bears in some cases additional risks 418. For 
example, highly dynamic systems with overlapping fields of activity like kinase networks 
might circumvent KOs of single components easily. Therefore, short transient KD 
approaches might show different phenotypes than a constant KO of a gene as observed e.g. 
with morpholinos against egfl7 in zebrafish or for the DOCK6 gene in HeLa cells 419,420. 
Also, single cells in culture start to compensate the KO, which can result in a strong spread 
of data in microscopy experiments until they lose the phenotype completely. For example, 
the data points of the RUSH experiments depicted in Figure 49 in the KO cell line 
indicate that, although all cells derive from a single cell clone, the cell line is not 
homogenous, i.e. that some cells start to compensate the KO effect, while others show still 
strongly impaired transport characteristics. 
 
 
Figure 52: Schematic depiction of MIN tag integration sites. For the integration of the MIN tag the second 
exon of the SDF4 genomic locus (black lines, Arabic numerals) was first targeted by the sgRNA (dark green) 
in the area behind the signal peptide encoding sequence (dark blue). As this approach resulted surprisingly in 
a KO of Cab45, a second trial will target the area after the initial ATG codon (orange) to establish a 
functional platform for knock-in of Cab45 mutants behind the endogenous promoter.  
 
The MIN-tag integration into the SDF4 locus presented above (section 6.2.6) resulted in an 
unexpected KO phenotype of Cab45. This finding was surprising as the integration of 
either an HA-tag of comparable length or a GFP tag in the same position in a construct for 
transient HeLa cell expression exhibited normal expression levels (Supplementary Figure 
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3). This might be due to the fact that processes like mammalian transcription initiation or 
termination, splice processes or genomic regulation are only insufficiently understood so far 
421,422. This adds additional obstacles to efficient genome targeting, because knock-in of tags 
or fluorescent labels can prevent proper gene processing and expression.  
Based on these results, it seems not possible to generate a functional MIN-tagged cell line 
behind the endogenous signal sequence of SDF4. Therefore, the generation of a new MIN-
tag SDF4 cell line directly after the initial ATG start codon is currently in progress (Figure 
52), because to date no alternative method provides such a multitude of applications to edit 
the mammalian genome within a few weeks and study proteins on endogenous levels.  
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7.2 Cab45 oligomerizes in a calcium-dependent manner under 
physiological conditions 
The few studies on Cab45 published at the beginning of this thesis were performed in cells 
or in organisms. However, no publication, except one, presented data on recombinant, 
purified protein 365. Therefore, successful purification of wild type Cab45 and its three EF 
hand mutants as a His-SUMO fusion protein in high amounts was one major 
accomplishment and paved the way for detailed in vitro analysis (Figure 15). Unfortunately, 
the 6EQ mutant did not express properly, probably due to misfolding or insolubility and 
could therefore not be purified by this approach or neither by an alternative test in 
HEK293 cells 423. 
NativePage analysis (Figure 26) and oligomerization studies with fluorescently labeled 
protein by confocal microscopy (Figure 28) proved that Cab45 is able to form oligomers in 
the presence of calcium. For this task, especially EF1 and EFh3 seems to be required, as 
these mutants lose the wild type feature (Figure 34 and Figure 35).  
This behavior was observed several times before for other calcium binding proteins 424,425. 
For example, based on data of the crystal structure and small-angle X-ray experiments, 
calsequestrin can acquire different oligomeric states from dimer to long branched polymers 
dependent on calcium concentrations 426.  
Also proteins of the PEF protein family like peflin, ALG-2 or sorcin are known to form 
homo- or heterodimers via their unpaired last EF hand motif in a calcium-dependent 
manner, which seems essential for their overall stabilization 424,427,428. Now, the 
experiments presented above indicated for the first time that also Cab45 has a higher 
oligomeric state.  
Furthermore, experiments with magnesium excluded the possibility of unspecific protein 
aggregation with a two-valent cation (Figure 28). In line with these observations, CD 
spectroscopy visualized the conformational change within the secondary structure of the 
protein upon calcium binding (Figure 29). This shift in secondary structure might expose 
hydrophobic regions, which can serve as trigger for oligomerization or for other 
interactions, e.g. with lipids. This characteristic was observed before for proteins like 
calmodulin and casein 429-431.  
Besides, Cab45 might change its conformation upon calcium binding in a way that some 
calcium ions become covered inside the core of the protein. Those might be harder to 
release even in the presence of the calcium chelator EGTA (Figure 29).  
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7.2.1 But is this oligomeric phenotype of Cab45 physiological relevant?  
The first hint that these multimers have indeed physiological relevance were given by 
experiments with isolated Golgi fractions, which indicated oligomers of the endogenous 
Cab45 of similar size as the recombinant protein on NativePage analyses (Figure 26). 
Furthermore, tests with STORM super-resolution microscopy in HeLa cells, which were 
performed in collaborations in the framework of this thesis, showed that oligomeric 
structures existed also inside the cells, but only when calcium was maintained at normal 
levels, and not after treatment with ionomycin 387.  
Of course, the calcium concentrations used in some of the assays were high in comparison 
to published levels in the secretory pathway 178. However, a face blot analysis, which 
correlates the protein and calcium concentrations necessary for polymerization 
demonstrated that high concentrations of Cab45, which might exist inside the TGN due to 
limited volume, reduce the amount of needed calcium immensely 387. Furthermore, 
calcium titrations in CD spectroscopy supported the idea that changes in secondary 
structure of Cab45 occur already between 50 and 150 µM, which ranges in the published 
area (Figure 29; 178).  
Similar arguments hold true for the size of the oligomers observed during in vitro assays. 
Limitations of space and protein inside the TGN lumen will restrict the size of the 
oligomers. In addition, STORM images indicate that the oligomers inside the cell might be 
significantly smaller than observed in confocal microscopy (Figure 28). This fact was also 
described before for the ER resident chaperone BiP, which forms huge agglomerations in 
vitro, but only smaller oligomers in cells (personal communication with David Ron, CIMR, 
Cambridge, UK).  
Finally, Cab45 oligomerization might be influenced by several additional factors in a 
physiological context. For example, the impact of differential glycosylation of the human 
Cab45 might play a critical role for the endogenous Cab45, as observed for the von 
Willebrand factor 432. Besides sugar modifications, the multimerization process might be 
strongly pH dependent, which would at the same time prevent the premature reaction 
inside the ER lumen. Also, high local calcium concentrations in the direct vicinity of the 
SPCA1 calcium pump, the area of localization of Cab45 found in Crevenna et al., 2016, 
may act as trigger point for Cab45 dependent sorting of soluble cargo proteins. In 
summary, deeper insights into current research topics like the overall regulation of calcium 
homeostasis at the TGN are necessary to reach a final conclusion on these profound 
questions.  
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7.2.2 The remaining problem of the Cab45 oligomerization domain 
Naturally, the amount of data on Cab45 oligomerization evokes the requirement for a 
potential oligomerization domain. Unfortunately, so far, no defined domain inside the 
protein structure could be identified. The aggregation prone area detected by the TANGO 
algorithm and the thereof resulting MVKR mutant did not exhibit impaired oligomeric 
potential (Figure 38). Also, the stepwise approach to analyze fragments of Cab45 did not 
result in the identification of a potential hotspot (Figure 40). However, this might be due to 
the fact that Cab45 might oligomerize via one of its EF hands, as observed before for other 
EF hand proteins like Alg2 433. This would also give a potential explanation for the 
problem that Cab45, considering the size of the polymers, needs more than one 
oligomerization domain. Based on these considerations, more research on this topic is 
necessary to answer the open question satisfyingly.  
7.2.3 Oligomerization might be a potential retention mechanism for Cab45 
Another critical topic was the Golgi retention of Cab45. As Cab45 contains no 
hydrophobic stretch long enough to span the membrane 226 and no transmembrane 
interactor is known to date as for the other secretory pathway calcium binding protein 
Calnuc, which interacts with COX1 and COX2 434,435 the mechanism how Cab45 remains 
in the Golgi lumen while cargos are packed into vesicles remained subject of discussions.  
At the very C-terminal end of Cab45 the four amino acids HEEF were suggested several 
times in literature as Golgi retention signal 225,227,370 analogous to the well-studied KDEL 
retention peptide of the ER 373. But although Lara-Lemus and colleagues 374 showed a C-
terminal truncation mutant (Cab45 308 Myc) to be unphysiologically secreted from COS cells, 
this study unfortunately lacked a wild type control. As a consequence, the possibility that 
secretion of this mutant was due to overexpression, but not lack of the HEEF signal, as it 
was observed by 436 in HeLa cells, cannot be excluded. Furthermore, the C-terminal 
HDEF motif of CALU also seems to be insufficient as retention signal, as CALU is found 
throughout the secretory pathway and also secreted under natural conditions 227,245,437. 
However, exactly this HDEF motif was suggested by another publication as a sufficient 
retention signal for the endoplasmic reticulum 438. In addition, the ER located UGGP 
enzyme, contains a HEEL sequence, which triggers ER localization 52. In contrast, 
multimerization itself was suggested as a general mechanism for protein retention inside 
organelles 439,440. This is based on the observation, that for example calsequestrin forms a 
matrix-like or gel-like structure inside the transverse tubuli of the sarcoplasmic reticulum in 
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a calcium-dependent manner and that also ER located calcium binding proteins are 
released from cells upon calcium depletion by ionophores 441. The Cab45 oligomers might 
reflect a preform of this gel-like matrix, which forms under physiological conditions inside 
the Golgi and retains it, while cargo is secreted.  
Nonetheless, the matrix-forming potential of Cab45 needs further investigation, but also 
the HEEF-based retention needs to be analyzed with endogenous proteins levels. In 
addition, a potential Golgi receptor, the counterpart of the ER KDEL receptor, would be 
necessary to convincingly support this theory. 
7.3 Cab45 releases cargo upon phosphorylation 
Immunoprecipitation experiments with GST-tagged Cab45 indicated already in 2012 that 
Cab45 can interact with cargo proteins like COMP or LyzC in cell lysates 365. In this thesis, 
we could finally show that this interaction is indeed direct and no additional adaptor 
proteins are needed (Figure 41). Furthermore, fluorescence correlation spectroscopy (FCS) 
measurements of one of our collaborators indicate that only calcium bound Cab45 is able 
to interact with cargo proteins 387. However, the in vitro complexes formed by Cab45 and 
cargo are very stable in FRAP experiments (Figure 44). Hence, cellular environments 
obviously provide additional mechanisms for subsequent cargo release.  
One putative signal for cargo release might be tyrosine phosphorylation. IP experiments 
with synthetic peptides proved that phosphorylation of two different tyrosine residues of the 
MGP cargo protein abolishes Cab45 interaction completely (Figure 46). In addition, 
phosphorylation of a third tyrosine in direct vicinity had no effect. This finding was also 
supported by RUSH assays. Here, a significant delay in cargo transport across the 
secretory pathway was detectable after 40 min when tyrosine residues were mutated in 
MGP (Figure 48). This phenotype was also mimicked by the KO of Cab45 in HeLa cells.  
However, which is the kinase responsible for this mechanism? One potential candidate, is 
TPK-PKDCC or VLK. TPK-PKDCC was described as sensitive not only for magnesium, 
but also for calcium 169. Furthermore, overexpression of VLK caused delay in Golgi export 
of a transmembrane protein, which might be due to enhanced sorting and packaging of 
Cab45-dependent, soluble cargos 166. Finally, a phosphosite database (phosphosite.org) 
contains the entry, that MGP was found several times in human cells to be phosphorylated 
at tyrosine residue Y82, one of the identified phosphosites of the peptide pull-downs 442-444. 
Unfortunately, no consensus pattern for TPK-PKDCC phosphorylation is known to date.  
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Indeed, all this data supports the idea, that phosphorylation plays a crucial role in Cab45-
dependent cargo sorting. However, although we know already from the mass spectrometric 
screen of Golgi fractions (Figure 51) that not only the cargo, but also Cab45 is 
phosphorylated, the specific role of this modification is unclear. The accumulation of 
phosphorylation site in the N-terminal region of the protein might either hint to the fact, 
that Cab45 is more accessible in this area for the kinase, or less accessible for the 
corresponding unknown phosphatase due to protein conformation. However, spatial-
temporal synergy of all those modification events remains to be elucidated in detail.  
 
 
Figure 53: Sorting mechanism by CLF1/SPCA1/Cab45 machinery. Active CFL1 (light green crescent) binds 
via a patch formed by four amino acids to the second cytosolic loop of SPCA1 (green/brown). As a 
consequence, SPCA1 pumps calcium (grey circles) in an ATP-consuming manner into the TGN lumen. 
Calcium is then bound by Cab45 (blue circles/stars) which forms oligomers. In this state, Cab45 binds cargo 
molecules and accumulates then in a certain subdomain of the TGN and, through this, separates them from 
other soluble proteins. Phosphorylation of cargo (green circles) by TPK-PKDCC kinase (rose triangles) 
trigger release of the cargo and packaging into vesicles for transport to the PM. Cab45 is retained in the 
Golgi due to the size of the oligomers, Cab45 can be reused for a new round of soluble cargo sorting.  
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Besides, phosphorylation of the cargo, instead of Cab45 itself as a release signal, would 
offer a possibility to maintain phosphorylations necessary for functions in the extracellular 
matrix of cargo proteins. Furthermore, dephosphorylation of Cab45 would not be 
necessary before a new cycle of cargo sorting at the TGN can begin. 
Finally, the Cab45 oligomers decorated with cargo proteins might not be accessible enough 
for the kinase. Therefore, the role of Cab45 phosphorylation by Fam20C remains a 
mystery to date. 
In summary, the results of this thesis contributed to gain a better understanding of the 
mechanism underlying Cab45-dependent cargo sorting at the TGN. Based on the data 
presented above and previous publication by the von Blume group, we propose the 
following model for the sorting of soluble proteins by CFL1/SPCA1/Cab45 sorting 
machinery (Figure 53):  
Active CFL1 interacts with the second cytosolic loop of SPCA1 via a patch of four amino 
acids and recruits actin to the TGN membrane. This CLF1-SPCA1 interaction activates 
the calcium pump, which transports calcium in a ATP-consuming manner across the Golgi 
membrane. On the luminal side Cab45 binds the newly imported calcium ions, which 
triggers a conformational switch of the protein and oligomerization. In parallel, cargo is 
bound by Cab45 oligomers and accumulated in the Golgi for subsequent vesicle packaging 
and export. This process probably occurs in a subdomain of the TGN, which is devoid of 
other Golgi resident proteins, as suggested by the results of the superresolution microscopy 
(Figure 45). Upon cargo phosphorylation, the cargo is released from the hetero-oligomer 
and while secretory proteins are transported to the PM, Cab45 is retained by its oligomeric 
form inside the lumen. After calcium release, Cab45 monomers are available of a new 
round of cargo sorting.  
 
 
Outlook and open questions 
 - 111 - 
8 Outlook and open questions 
In this thesis, several to date unknown aspects of secretory cargo sorting were elucidated. 
However, some aspects require additional research to consolidate the data presented 
above. In future studies, newly established tools, like the CRISPR/Cas9 KO HeLa cell line 
and also the recombinant protein will help to address profound questions around this 
sorting mechanism. For example, no data exists how calcium homeostasis by SPCA1 is 
regulated in living cells, i.e. if the CFL1-SPCA1 dependent pumping mechanisms is 
constitutive, or initiated by an extra- or intracellular signal. This would also give a hint, 
under which conditions cargo molecules are exported from the TGN, or if for example 
high amount of cargo proteins can signal “inside-out” to activate the SPCA1 machinery.  
In this line, the Cab45-calcium interactions requires further examinations. Although it is 
now evident that calcium binding is required for the conformation of Cab45, detailed 
dissociation constants of the different EF hand motifs would further support our overall 
understanding. Also, the cooperativity of the calcium binding by the determination of the 
Hill coefficient. Finally, the release of the bound calcium is a critical step and under current 
investigation.  
Another aspect of interest is how many proteins are under influence of the 
CLF1/SPCA1/Cab45 machinery. Although this thesis augmented the number of potential 
cargos from around 20 of the initial screen to around 140 candidates, further mass 
spectrometric screens might further increase the number. Besides, the sequence pattern 
around the tyrosine residues found in MGP might serve as template for a bioinformatics 
search to identify new unknown interactors. As a follow up, the RUSH method will 
provide a powerful tool to study the dynamics of cargo export of already known and new 
cargo proteins.  
Additionally, many biochemical aspects including the influences of Cab45 phosphorylation 
by Fam20C, pH dependency and the effect of differential glycosylation need to be 
examined further. Finally, the identity of vesicle, which transport the cargo proteins to the 
plasma membrane, will help to understand this complex mechanism of basic research. 
Immunofluorescence studies will also elucidate the difference between transport carriers 
and the vesicles containing the calcium-binding deficient mutants of Cab45.  
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Taken together, the answers to all these questions will help to understand the mechanisms 
of sorting of secretory cargo sorting, and as a consequence, will also deepen our insights in 
the fundamental role of the Golgi apparatus in cellular homeostasis and integrity.  
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9 Supplementary Figure and Tables 
 
 
Supplementary Figure 1: CD spectroscopy of titration experiment with EFh2 mutant. EFh2 mutant was 
analyzed with different calcium concentrations between 0 and 250 µM by CD spectroscopy. The change in 
secondary structure begins at around 50 µM (black line). Similar to the wild type protein EFh2 is in a 
transitional state at 100 µM (turquoise line). However, EFh2 has not completely finished its conformational 
shift at 150 µM (brown line), but is still sensitive to calcium changes up to 250 µM (green line).  
 
 
 
Supplementary Figure 2: LyzC and COMP only oligomerize in the presence of Cab45. (A) and (B) Control 
experiments with LyzC-Cy5 and COMP-Alexa647 for oligomerization assays in the absence of Cab45. Both 
proteins were incubated in buffer in the presence and absence of 1 mM calcium. Under these conditions, 
neither COMP nor LyzC depict any oligomers. After addition of Cab45 both proteins form clusters as 
observed before. 
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Supplementary Figure 3: Analysis of HeLa cells overexpressing wild type Cab45 with C-terminal HA tag, 
Cab45 with N-terminal HA tag or an N-terminal GFP tag. The microscopy analysis of all cells 
overexpressing differently tagged constructs of Cab45 show strong expression of the proteins regardless of the 
position of the HA or the GFP tag (green channel). In all cell lines Cab45 resides in the vicinity of the GM130 
Golgi marker (red channel and merge) and exhibit normal nuclear morphology (blue channel). Therefore, 
integration of the MIN tag in the position of the N-terminal HA or GFP tag, which resulted in a KO of 
Cab45, was not to be expected. Scale bars represent 10 µm.  
 
 
a-helical 
content (w/o 
calcium) 
a-helical 
content (with 
calcium) 
b-sheet 
content (w/o 
calcium) 
b-sheet 
content (with 
calcium) 
Random coil 
content (w/o 
calcium) 
Random coil 
content (with 
calcium) 
0.096 0.201 0.346 0.271 0.558 0.518 
0.170 0.213 0.301 0.248 0.530 0.539 
0.150 0.256 0.307 0.241 0.541 0.503 
0.139 0.223 0.318 0.253 0.543 0.520 
Supplementary Table 1: Summary of secondary structure prediction by CONTIN software of three 
replicates of Cab45 conformational change in presence of 1 mM calcium. Reported values for the alpha-
helical and beta sheet content were the sum of regular and distorted fractions for each secondary element.  
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